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Abstract 
The molybdenum cofactor (Moco) is an essential component present in nearly all domains of 
life. In mammals, Moco is part of four currently known enzymes and constitutes a crucial 
redox-active center involved in a number of fundamental cellular reactions. Moco-dependent 
enzymes are present in the cytosol but also in or at mitochondria, where Moco is integrated 
into sulfite oxidase (SO) and the mitochondrial amidoxime-reducing component (mARC), 
respectively. The family of mitochondrial Moco-enzymes is of particular interest considering 
the cytosolic synthesis of enzymes and cofactor, which requires a coordinated mitochondrial 
transport and assembly process. In the current study, the mitochondrial maturations of SO 
and mARC1 were thus analyzed to obtain a mechanistic understanding of the processes 
starting with the cytosolic syntheses of apo-proteins all the way to the formation of the 
mature mitochondrial enzymes.  
The first part of this work uncovered the cellular assembly of SO, a soluble protein of the 
mitochondrial intermembrane space, and revealed a Moco-dependent mitochondrial 
targeting mechanism. In spite of its functional bipartite N-terminal targeting signal, about 70% 
of SO mislocalized to the cytosol if Moco was not present. Following the identification of SO 
processing by the inner membrane peptidase (IMP) complex, prevention of this cleavage and 
thus anchoring of SO in the inner mitochondrial membrane resulted in an efficient 
mitochondrial targeting even in absence of Moco. SO was thereby identified to undergo a 
reverse translocation to the cytosol in absence of Moco, which is required to trap SO in the 
intermembrane space and to constitute in addition a vectorial driving force for completion of 
SO translocation across the TOM complex. The integration of Moco is not only essential for 
correct sub-mitochondrial localization, but also a prerequisite for in vivo heme integration and 
homodimerization of SO. In conclusion, the identified molecular hierarchy of SO maturation 
represents a novel link between the canonical pre-sequence pathway and folding-trap 
mechanisms of mitochondrial import.  
The other mitochondrial Moco-enzyme mARC1 was recently discovered and its sub-
mitochondrial localization had remained unclear. In the second part of this study, mARC1 
was shown to be localized to the outer mitochondrial membrane. As a result of the 
translocation process, the C-terminal catalytic core of the protein remains exposed to the 
cytosol and confers an N(in)-C(out) membrane orientation of mARC1. This localization is 
mediated by the N-terminal domain of the enzyme, being composed of a classical but weak 
N-terminal targeting signal and a downstream transmembrane domain. Thereby, the 
transmembrane domain of mARC1 is sufficient for mitochondrial targeting, while the N-
terminal targeting signal seems to function as a supportive receptor for the outer 
mitochondrial membrane. According to its localization and targeting mechanism, mARC1 is 
classified as a novel signal-anchored protein. Considering the membrane integration of 
mARC1, an SO-similar demand of Moco for mitochondrial retention of mARC1 is not required 
and its N-terminal targeting motifs are sufficient for adequate mitochondrial localization. 
During mitochondrial import, mARC1 is not processed and membrane integration proceeds 
membrane potential independently but requires external ATP, which finally results in the 
assembly of mARC1 into high-oligomeric protein complexes.                                                  
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Zusammenfassung 
Der Molybdän-Cofaktor (Moco) ist ein essentieller Bestandteil in allen Organismenreichen. In 
Säugetieren bildet Moco ein wichtiges redox-aktives Zentrum von bisher vier bekannten 
Enzymen und ist dadurch an einer Vielzahl fundamentaler, zellulärer Reaktionen beteiligt. 
Moco-abhängige Enzyme liegen sowohl im Zytosol als auch in Mitochondrien vor, wobei 
Moco hier in die Sulfitoxidase (SO) und in die mitochondriale Amidoxim-reduzierende 
Komponente (mARC) eingebaut ist. Unter Berücksichtigung der zytosolischen Synthese von 
Moco, SO und mARC ist die Familie der mitochondrialen Moco-Enzyme dabei von 
besonderem Interesse, da diese einen koordinierten mitochondrialen Transport und einen 
entsprechend regulierten Reifungsprozess der beiden Enzyme verlangt. In dieser Arbeit 
wurden die mitochondrialen Reifungsprozesse von SO und mARC analysiert, um ein 
mechanistisches Verständnis dieser Prozesse zu erlangen.  
Im ersten Teil wurden dabei hierarchische Stufen zur zellulären Reifung der SO aufgedeckt. 
SO ist ein lösliches Protein des mitochondrialen Intermembranraums und zeigte dabei eine 
Moco-abhängige mitochondriale Lokalisierung. Ungeachtet der zweigeteilten N-terminalen 
mitochondrialen Zielsequenz wurden in Abwesenheit von Moco etwa 70% des Enzyms im 
Zytosol detektiert. Nachdem die Innere-Membran-Peptidase (IMP) als SO-prozessierende 
Protease identifiziert wurde, konnte eine über Mutationen verhinderte Prozessierung und 
damit eine Verankerung der SO in der inneren Membran eine vollständige mitochondriale 
Lokalisation auch in Abwesenheit von Moco erreichen. Dieses Experiment belegte, dass die 
SO einer reversen Translokation in Richtung Zytosol unterliegt, wenn Moco nicht eingebaut 
werden kann. Moco ist dabei für die Initiierung der SO-Faltung verantwortlich und verhindert 
dadurch zum einen den Rücktransport ins Zytoplasma und greift dadurch zum anderen auch 
aktiv in die Translokation der SO ein, indem die Faltung eine zusätzliche vektoriell getriebene 
Kraft für die vollständige Translokation in den Intermembranraum darstellt. Der Einbau des 
Moco ist nicht nur für die Lokalisation der SO essentiell, sondern auch eine Voraussetzung 
für den Einbau des Häm-Cofaktors und die Homodimerisierung der SO. Insgesamt stellt die 
dargestellte molekulare Hierarchie der SO-Reifung eine neue Verbindung zwischen dem 
kanonischen Prä-Sequenz Importweg und faltungsabhängigen Importmechanismen dar.  
Das mitochondriale Moco-Enzym mARC1 wurde erst kürzlich entdeckt, wobei seine sub-
mitochondriale Lokalisation unklar blieb. Im zweiten Teil dieser Arbeit konnte nun die 
Assoziation von mARC1 mit der mitochondrialen Außenmembran demonstriert werden. Als 
Resultat des Translokationsprozesses bleibt die C-terminale katalytische Domäne dem 
Zytosol exponiert und verleiht mARC1 eine N(innen)-C(außen) Membrankonformation. Diese 
Lokalisation wird über die N-terminale Domäne des Enzyms gesteuert, welche aus einem 
klassischen aber schwachen N-terminalen Ziel-Signal und einer folgenden 
Transmembrandomäne besteht. Die Transmembrandomäne ist dabei hinreichend für die 
Lokalisation, wobei das Ziel-Signal als unterstützender Rezeptor für die mitochondriale 
Außenmembran zu dienen scheint. Sowohl die Lokalisation als auch der 
Transportmechanismus klassifizieren mARC1 dabei als ein neues Signal-verankertes 
Protein. Aufgrund der Membranverankerung von mARC1 ist der Einbau des Moco kein 
essentieller Bestandteil des Translokationsprozesses, welcher ausschließlich von den beiden 
N-terminalen Motiven gesteuert wird. Während des Importprozesses wird mARC1 nicht 
prozessiert und der Membraneinbau erfolgt unabhängig vom Membranpotential, erfordert 
jedoch die externe Zufuhr von ATP. Dies führt final zur Integration von mARC1 in hoch-
oligomere Proteinkomplexe in der Außenmembran.    
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1 Introduction 
1.1 Molybdenum and Moco 
Molybdenum (Mo) belongs to the group of transition metals and constitutes an essential 
trace element for animals, plants and microorganisms. In nature, Mo occurs in different 
chemical compounds and exhibits a rich coordination and redox chemistry, as illustrated by 
its extended spectrum of oxidation states ranging from –ll to +Vl. Therefore, Mo depicts a 
potent catalyst of a large variety of redox reactions in biological systems. Although Mo is of 
very low abundance in the cell, its uptake requires an adequate and efficient mechanism to 
guarantee a constant supply of Mo. Amongst different forms and oxidation states of Mo 
occurring in nature, the molybdate anion (MoO4
-2) constitutes the only Mo compound that 
organisms can acquire from their environment (Llamas et al., 2011). While bacteria mediate 
uptake of molybdate by means of a high-affinity ATP-binding-cassette transporter (Maupin-
Furlow et al., 1995), a homologous system has not been found in eukaryotes, yet. Instead, 
plants contain two different molybdate transporters referred to as MOT1 and MOT2, showing 
distant relations to sulfate transporters of the SULTR family (Tejada-Jimenez et al., 2007). 
Animals lack MOT1, while recently, MOT2 was identified as the first molybdate transporter in 
animals (Tejada-Jimenez et al., 2011). 
Upon its successful uptake from the environment, Mo is complexed by a pterin 
compound to build the biologically active molybdenum cofactor (Moco). Moco is composed of 
a tricyclic pterin coordinating Mo via a dithiol group within the third pyrano ring. With the 
exception of bacterial nitrogenase, in which a unique iron-molybdenum cofactor confers 
catalytic activity, all other Mo-dependent enzymes contain a pterin type cofactor (Hille, 1996). 
Eukaryotic Moco occurs in two different forms that share a common backbone but differ in 
the coordination of Mo. In one variant, Mo is covalently bound to a conserved cysteine 
residue of the Moco binding domain (Figure 1.1 A), while in the other variant instead a third 
terminal sulfur ligand is bound to Mo with the cofactor remaining non-covalently bound to the 
respective protein (Figure 1.1 B) (Schwarz and Mendel, 2006). Integration of Mo into both 
types of Moco permits the positioning of Mo within the protein active site, thus controlling its 
redox behavior on the one hand and aligning the pterin ring system for electron transfer from 
or to Mo on the other hand (Mendel, 2007). In respect to its involvement in electron transfer, 
the pterin moiety is fully reduced and thus believed to be prone to oxidation. In addition, the 
isolated coordination of Mo by means of the dithiol group is fragile, finally resulting in 
destabilization of Moco in protein free environments (Rajagopalan and Johnson, 1992). 
Consequently, Moco was assumed not to occur free in the cell but rather to be associated 
rapidly with its respective target-enzymes.   
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1.2 Moco synthesis 
The biosynthesis of Moco is highly conserved from bacteria to eukaryotes and is composed 
of four enzymatic steps (Figure 1.2), which are catalyzed by six gene products in eukaryotes.  
 The first step of the Moco synthesis cascade starts out from GTP, which is converted 
to cyclic pteranopterin monophosphate (cPMP) by two proteins (MOCS1A and MOCS1B in 
humans) in a complex reaction mechanism. MOCS1A contains two [4Fe-4S] clusters and 
belongs to the group of S-adenosyl-methionine dependent radical enzymes (Hanzelmann et 
al., 2004). Although the overall mechanism of cPMP synthesis is not fully understood, 
MOCS1A and MOCS1B are believed to build a complex with S-adenosyl-methionine and 
GTP (Hanzelmann et al., 2002) to generate cPMP as a fully reduced tetrahydro-
pteranopterin backbone (Santamaria-Araujo et al., 2012). The subcellular localization of both 
MOCS proteins have remained uncharacterized in mammals, their N-terminal mitochondrial 
targeting signals however strongly suggest the synthesis of cPMP to take place in 
mitochondria. Moreover, the plant homologues Cnx2 and Cnx3 have been exclusively 
detected in mitochondria (Teschner et al., 2010).  
 The second step of Moco synthesis occurs in the cytosol, suggesting that cPMP is 
exported from mitochondria to become converted to the next intermediate. In plants, the 
inner mitochondrial membrane transporter Atm3 has been shown to be involved in the export 
of cPMP to the cytosol (Teschner et al., 2010). Following its mitochondrial export, two sulfur 
atoms are transferred to cPMP to build molybdopterin (MPT) dithiolate. This reaction is 
 
A B 
Figure 1.1 Structures of two eukaryotic types of Moco. Within eukaryotic enzymes, Mo is 
either (A) covalently connected to a conserved cysteine or (B) non-covalently bound to the 
protein and instead exposing a third terminal sulfur ligand. Figure modified from (Mendel and 
Bittner, 2006). 
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catalyzed by MPT-synthase, a hetero-tetrameric complex consisting of two large (MOCS2A 
in humans) and two small (MOCS2B in humans) subunits. While the large subunits mediate 
oligomerization, the small subunits each carry a single sulfur atom as thiocarboxylates being 
sequentially transferred to cPMP (Gutzke et al., 2001). Following the completion of a reaction 
cycle, the small subunits dissociate from the MPT-synthase and transiently bind to the 
MOCS3 protein, where they are re-sulfurated in an ATP-dependent reaction (Matthies et al., 
2004). 
 The third and fourth steps of the Moco synthesis pathway are catalyzed by gephyrin 
in humans. Gephyrin is composed of an N-terminal G-domain and a C-terminal E-domain, 
which are both involved in separate reactions during the last steps of Moco synthesis 
(Schwarz and Mendel, 2006). First, the G-domain binds and adenylates MPT in an Mg2+ and 
ATP dependent manner, yielding MPT-AMP as the last intermediate of the Moco synthesis 
pathway. The reaction mechanism was uncovered in plants and revealed the binding of MPT 
to the homologous Cnx1G protein and the subsequent transfer of AMP to the terminal 
phosphate of MPT (Llamas et al., 2004). In the last step of Moco synthesis, Mo is attached to 
the dithiolate of the MPT backbone by the gephyrin E-domain. As again first discovered for 
the plant protein, MPT-AMP is hydrolyzed by the homologous Cnx1E protein and Mo is 
simultaneously transferred to the MPT dithiolate, finally resulting in the formation of Moco 
(Llamas et al., 2006).  
 
Figure 1.2 Human Moco biosynthesis. 
Structures of all intermediates are given and 
names are depicted in red. Catalyzing 
proteins are colored green. Step 1 occurs in 
mitochondria and is schematized accordingly. 
The in vivo sulfur source for MOCS3 (X-S) is 
not known. SAM, S-adenosyl-methionine. 
GEPH, gephyrin. See text for details. 
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1.3 Moco dependent enzymes 
Following the completion of its synthesis, Moco becomes incorporated into a multitude of 
different Mo-enzymes to fulfill its biological function. More than 50 Moco-dependent enzymes 
were described so far, most of them catalyzing redox reactions that are important for the 
global cycles of nitrogen, carbon and sulfur (Schwarz et al., 2009). The majority of these 
proteins exclusively occur in prokaryotes, while to date five Moco-dependent enzymes are 
known in eukaryotes.  
One of these enzymes, nitrate reductase (NR), is solely present in plants and fungi 
and plays a key role during nitrogen assimilation by catalyzing the reduction of nitrate to 
nitrite. Moco is covalently bound by a conserved cysteine as depicted in figure 1.1 A. Apart 
from Moco, NR requires the integration of a cytochrome b5 type heme and a FAD-cofactor as 
well as homodimerization to achieve catalytic activity. Thereby, electrons are transferred 
from NAD(P)H to FAD and via heme to the Moco domain, which harbors the active site 
where nitrate is reduced.  
Animals do not have a NR, while they comprise a subset of four other Moco enzymes, 
which can be classified into two groups according to their active site structure as well as sub-
cellular distributions. The first group is composed of the cytosolic proteins aldehyde oxidase 
(AO) and xanthine oxidoreductase (XOR), both sharing the terminal sulfide group, while 
mitochondria constitute the second site of Moco-activity and harbor sulfite oxidase (SO) as 
well as the mitochondrial amidoxime reducing component (mARC 1+2), each having a 
cysteine linked Moco in their active site (Chamizo-Ampudia et al., 2011, Rajapakshe et al., 
2011).   
 
1.3.1 Mammalian cytosolic Moco enzymes 
AO and XOR can be grouped according to their cytosolic localizations, but they also share 
significant structural and functional similarities. Both proteins contain Moco within their C-
terminal domains, which also mediate homodimerization in each case. In contrast to NR and 
mitochondrial molybdoenzymes, Moco is not covalently bound by a protein derived 
conserved cysteine, but instead contains a third terminal sulfido group as illustrated in figure 
1.1 B. This sulfur atom is added to the cofactor by the enzyme Moco sulfurase in a final 
maturation step (Hille et al., 2011). As additional redox active domains, AO and XOR contain 
N-terminal [2Fe-2S] clusters and a central FAD domain to build the conserved tripartite 
structure of the AO/XOR enzyme family.   
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 AO acts on a large array of substrates, but the general types of reactions imply 
hydroxylation of heterocycles and oxidation of aldehydes to the corresponding carboxylic 
acids (Garattini et al., 2008). Mechanistically, substrates are oxidized in the substrate binding 
pocket at the Mo-center. Electrons are transferred from Moco via the [2Fe-2S] clusters to 
FAD. During electron transfer, the [2Fe-2S] clusters act as electron sinks to store reducing 
equivalents during catalysis (Hille, 2002). While the human genome harbors a single AO 
gene, other vertebrates contain several different AO isoforms. Physiological functions of AO 
are poorly understood, an AO knockout mouse however revealed a function in the 
biosynthesis of retinoic acid (Terao et al., 2009). Furthermore, mammalian AOs represent an 
import drug-metabolizing system in the cytoplasm of hepatic cells. Thereby, AOs are 
proposed to act in concert with the microsomal cytochrome P450 system and to activate or 
inactivate various types of drugs and toxic compounds (Garattini et al., 2008).  
 XOR resembles AO in respect to structure and reaction mechanism, but catalyzes the 
hydroxylation of a different subset of substrates, which is much better defined as for AO. 
XOR mediates the oxidation of hypoxanthine to xanthine and the downstream reaction of 
xanthine to uric acid (Hille and Nishino, 1995). XOR exists in two forms, as xanthine 
dehydrogenase (XDH), constituting the primary gene product, and as xanthine oxidase (XO), 
arising from XDH by formation of internal disulfide bonds. While XD favors NAD+ as a 
primary electron acceptor, XO does not bind NAD+ and instead transfers electrons to O2. 
Therefore, numerous reactive oxygen species (ROS) are formed, that are proposed to 
function in the innate immune response (Vorbach et al., 2003) and together with the 
antioxidant uric acid act in the regulation of the cellular redox potential (Droge, 2002). While 
no isolated forms of AO-deficiency are known, inactive XOR, either occurring in response to 
mutations in the XOR gene (Ichida et al., 1997) or secondary caused by the loss of Moco-
sulfurase (Ichida et al., 2001), results in xanthinuria. The symptoms of the disease are not 
lethal, but affected patients suffer from xanthine stones due to elevated levels of xanthine. 
 
1.3.2 Mammalian mitochondrial Moco enzymes 
1.3.2.1 Sulfite oxidase 
Sulfite oxidase (SO) is generally referred to as the most important eukaryotic Moco enzyme, 
as its depletion results in a severe neurodegenerative phenotype (see chapter 1.3.2.2 for 
details). SO catalyzes the essential oxidation of toxic sulfite to nonhazardous sulfate and 
thereby mediates the final step in the oxidative degradation of the sulfur-containing amino 
acids methionine and cysteine (Figure 1.3 A).  
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In contrast to AO and XOR, SO covalently binds Moco by a conserved cysteine in the 
central domain of the protein. Furthermore, Moco is deeply buried within the protein, forming 
numerous stabilizing hydrogen bonds to several residues of the central Moco-binding 
domain, as illustrated by the chicken SO crystal structure (Figure 1.3 B) (Kisker et al., 1997). 
To become catalytically active, SO requires the integration of a cytochrome b5 type heme as 
a second metal containing cofactor. Although not covalently attached to the protein, heme is 
stably integrated into the N-terminal domain of SO with two conserved histidines 
symmetrically coordinating the heme iron (Kisker et al., 1997). In analogy to structurally 
related plant NR and also both cytosolic Moco enzymes, SO undergoes homodimerization 
mediated by a large interface of the C-terminal domain. Upon the integration of both 
cofactors and homodimerization, SO is catalytically active and ready for sulfite oxidation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Reaction mechanism and crystal structure of animal SO. (A) Sulfite is oxidized at the 
Mo-active site of SO (depicted in blue with all three domains) and sulfate is released. The two 
electrons are sequentially transferred to the b5 heme and cytochrome c as the final electron acceptor. 
Monomeric SO is depicted for simplicity. (B) Crystal structure of mature chicken liver SO. The N-
terminal heme domain is depicted in red, the central Moco domain in yellow and the C-terminal 
dimerization domain in green. Moco and heme are shown in ball-stick representations. The gray 
dotted lines connect the metal centers of the cofactors, the red dotted lines indicate a loop region, 
which is weakly defined in the electron density. Figure modified from (Kisker et al., 1997).  
 
A 
B 
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Sulfite oxidation takes place in the mitochondrial intermembrane space (IMS) in 
mammals, where cytochrome c is reduced as the physiological and final electron acceptor. 
The catalytic mechanism of mammalian SO starts with the oxidation of sulfate at the Mo-
active site to generate a two-electron reduced Mo(IV) state (Hille, 1994). In a one-electron 
transfer reaction, b5 heme is reduced to generate the EPR visible Mo(V)/Fe(II) intermediate 
of SO (Astashkin et al., 2002). This part is referred to as the reductive half reaction, resulting 
in the release of sulfate and the formation of fully reduced SO. In the oxidative half reaction, 
the electron is passed to cytochrome c to build a one electron reduced Mo(V)/Fe(III) form of 
the enzyme. In analogy to the first electron transfer reaction from the Mo center to 
cytochrome c, the second electron is transferred to a second equivalent of cytochrome c to 
regenerate the fully oxidized Mo(VI)/Fe(III) form of SO (Feng et al., 2007). As a multi-redox 
center enzyme, SO performs rapid electron transfer between Mo- and heme-domain to 
achieve an efficient oxidation of sulfite (Pacheco et al., 1999). However, the crystal structure 
of chicken SO revealed a comparatively large distance of ~32Å between both domains 
(Kisker et al., 1997). This conflict has led to the proposal of domain movements prior to 
electron transfer in order to bring Mo- and heme-domain in closer proximity. Consistently, the 
electron transfer rate of SO was shown to be dependent on solution viscosity and dropped in 
the presence of increasing concentrations of sucrose or polyethylene-glycol (Feng et al., 
2002).  
SO is mainly present in the liver as the predominant site of methionine and cysteine 
catabolism, but it is also abundant heart, kidney and to a lesser extent in brain to ensure 
comprehensive protection from sulfite accumulation (Moriwaki et al., 1997). Using 
cytochrome c as the final electron acceptor of the sulfite oxidation, SO is localized in the IMS 
of mitochondria as a soluble enzyme (Ito, 1971). As most mitochondrial proteins, SO is 
synthesized in the cytosol and imported into mitochondria. The mechanism of mitochondrial 
translocation of SO was investigated by pioneer work of Ono and Ito in the early 1980’s. 
While the presence of ribosomes on the surface of mitochondria suggested a co-translational 
import of some precursors (Kellems et al., 1975, Ades and Butow, 1980), the translation of 
SO was demonstrated to take place on free ribosomes in the cytosol, indicating a post-
translational import of SO (Ono et al., 1982). Following its translation, SO was shown to enter 
mitochondria ATP- and membrane potential-dependently and the inner mitochondrial 
membrane was found to be involved in the translocation process (Ono and Ito, 1982b). 
Import of SO is accompanied by processing, as illustrated by a truncated mature enzyme 
compared to the precursor during in vitro mitochondrial import experiments (Ono and Ito, 
1984). Upon completion of import, the half-life of SO was measured to last between three 
and four days (Ono and Ito, 1982a).  
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 The significance of sulfite oxidation is not restricted to animals, but also an important 
reaction in plants and bacteria. In plants, a protein homologous to animal SO was discovered 
(Eilers et al., 2001). Its primary and crystal structure however revealed a number of 
differences to animal SO, as plant SO (PSO) lacks a heme cofactor and Moco thus 
constitutes the only redox center of the enzyme (Schrader et al., 2003). Accordingly, PSO 
does not use cytochrome c but instead molecular oxygen as a physiological electron 
acceptor with the corresponding reaction taking place in peroxisomes. Bacteria oxidize sulfite 
by means of a sulfite dehydrogenase, a heterodimer of a large Mo-binding subunit and a 
small heme c-containing subunit (Kappler et al., 2000). While the sulfite dehydrogenase 
sequence is not related to mammalian SO, the heme c containing subunit revealed structural 
similarities to the b5 heme domain of mammalian SO (Kappler and Bailey, 2005). 
1.3.2.2 Sulfite oxidase- and Moco-deficiency 
The physiological relevance of SO is displayed by a severe neurodegenerative disorder 
termed isolated SO-deficiency, rapidly evolving in absence of functional SO. Affected 
patients suffer from neurological abnormalities such as microcephaly, mental retardation and 
seizures, usually accompanied by death in early infancy (Figure 1.4). The disease follows an 
autosomal recessive trait and is very rare, with less than 30 described cases in the literature 
(Johnson et al., 2002, Tan et al., 2005). SO-deficiency either occurs in response to mutations 
in the SO gene or based on a secondary loss of activity caused by mutations in one of the 
four genes involved in Moco biosynthesis. The latter causes a simultaneous loss of all five 
mammalian Moco enzymes with the corresponding disease termed Moco-deficiency 
(Schwarz, 2005). The clinical symptoms of Moco-deficiency are however hardly 
distinguishable from those of isolated SO-deficiency, demonstrating the loss of SO to be the 
predominant cause of the pathophysiology in Moco-deficiency and SO to be the most 
important Moco enzyme in humans.  
 In absence of functional SO, sulfite initially accumulates in the liver as the main site of 
methionine and cysteine catabolism and subsequently spreads out the entire body via the 
blood circulation and finally reaches the brain. The pathogenesis of SO- and Moco-deficiency 
is not completely understood and may derive from sulfite toxicity, a lack of sulfate or the 
accumulation of sulfur-containing compounds that are formed in response to excessive 
sulfite accumulation. Sulfite is a strong nucleophile breaking disulfide bridges and thereby 
affecting numerous proteins and cellular functions. In addition, sulfite exposure to mouse 
neuronal cells was shown to increase reactive oxygen species (ROS) and to simultaneously 
decrease intracellular ATP production. The concomitant inhibition of glutamate 
dehydrogenase by sulfite led to the proposal of a general neuronal energy deficit during SO 
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deficiency, resulting in neuronal ischemia followed by brain lesions, as seen in most patients 
(Zhang et al., 2004).  
Accumulation of sulfite within the cells also leads to the excess formation of sulfur 
compounds like s-sulfocysteine, a structural analog of glutamate potentially contributing to 
neuronal death by hyperactivating NMDA-receptors (Olney et al., 1975, Salman et al., 2002). 
Finally, inactive SO causes a cellular deficit of sulfate, which is required for the 
synthesis of myelin stabilizing sulfatides in the brain. A lack of sulfate was thus proposed to 
result in myelin destabilization and the following neurologic dysfunctions observed upon SO-
deficiency. Characterizations of neuropathological changes in isolated SO-deficiency 
however revealed normal sulfatide levels, contradicting a deficiency of sulfate to be the 
primary cause of the SO-deficiency symptoms (Rosenblum, 1968).   
    
 
 
 
 
  
 
Efficient therapeutic treatments of isolated SO-deficiency are not available so far, 
given that a cellular enzyme replacement therapy as the most obvious and promising 
solution would fail due to inefficient cellular uptake of externally applied SO. The 
mitochondrial localization of SO increases this problem and would interfere with successful 
sub-cellular sorting of cofactor loaded and folded SO upon a hypothetical cellular uptake. 
Therefore, mostly unsuccessful attempts to attenuate the symptoms of isolated SO-
deficiency have been reported. Low protein diets aiming in a decrease of sulfite production 
(Touati et al., 2000) or inhibition of NMDA-receptor channels to circumvent their potential 
hyperactivation during disease progression (Kurlemann et al., 1996) did however not 
sustainably improve the symptoms.  
 In contrast to isolated SO-deficiency, an efficient therapy is available for a group of 
patients suffering from Moco-deficiency. Treatment of patients with externally applied Moco 
could theoretically cure all types of Moco-deficiency, but is less likely due to the high 
A B Figure 1.4 Severe neurological 
symptoms of SO deficiency. Axial 
magnetic resonance imaging (MRI) 
scan of an isolated SO deficiency 
patient brain. (A) MRI scan 11 days 
after birth revealed a diffuse loss of 
gray-white distinction and (B) severe 
encephalomalacia and increasing 
neurodegeneration after 3.5 months. 
Figure modified from (Tan et al., 
2005).  
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instability of protein-free cofactor (Deistung and Bray, 1989). However, cPMP as the first and 
most stable precursor of the Moco synthesis pathway turned out to be able to significantly 
improve the phenotypes of patients suffering from mutations affecting the first step of Moco 
synthesis (Veldman et al., 2010).         
1.3.2.3 Mitochondrial amidoxime reducing components 
Numerous drugs and drug candidates contain strongly basic functional groups like amidines, 
which interfere with efficient absorption by the gastrointestinal tract in response to their 
protonation under physiological conditions. Therefore, a so-called prodrug principle was 
developed to enhance oral bioavailability of such molecules (Ettmayer et al., 2004). By N-
hydroxylation of certain functional groups, the latter become less basic and unprotonated 
under physiological conditions, thus increasing intestinal uptake by diffusion. These N-
hydroxylated prodrugs must then be converted to the active drug upon cellular assimilation 
by reduction and reformation of the basic functional groups. The functionality of this principle 
and its application on a wide range of different drugs implied the presence of a cellular N-
reductive system catalyzing the reduction and activation of N-hydroxlated prodrugs (Clement, 
2002).  
In mammals, outer mitochondrial membrane proteins cytochrome b5 and its reductase 
as well as a third unidentified component were shown to be involved in these prodrug 
activating reductions (Kadlubar and Ziegler, 1974, Clement et al., 1997). In a screen for the 
missing third component of the N-reductive system, Havemeyer et al. (2006) identified a 
novel mitochondrial protein annotated as MOSC2 (Moco-sulfurase C-terminal domain) 
according to its similarities to the C-terminal domain of the Moco-sulfurase, which sulfurates 
Moco in XO and AO. Due to its involvement in the reductive activation of N-hydroxylated 
prodrugs, the enzyme was termed the mitochondrial amidoxime reducing component 2 
(mARC2). The human chromosome 1 harbors a second gene in tandem orientation to 
MOSC2, revealing striking sequence similarities and being annotated as MOSC1. The 
corresponding protein was shown to have similar functions in the reduction of N-hydroxylated 
prodrugs and was hence termed mARC1 (Gruenewald et al., 2008).  
Considering the structural analogies of both mARC proteins to Moco sulfurase, their 
potential Moco incorporation was tested and thereby indeed revealed mARC1 and mARC2 to 
be novel mammalian Moco enzymes. In contrast to cytosolic animal Moco enzymes, Moco of 
both mARC proteins was shown not to contain a third terminal sulfido group (Wahl et al., 
2010). Instead, pulsed EPR spectroscopy suggested a protein derived equatorial Moco 
ligand and both mARC proteins to join the SO/NR family covalently binding Moco by a 
conserved cysteine (Rajapakshe et al., 2011). This was confirmed and extended by 
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characterizations of the Chlamydomonas reinhardtii homologue crARC, which revealed 
cysteine 252 to be essential for Moco binding and catalysis (Chamizo-Ampudia et al., 2011).   
The mARC proteins confer a number of unique traits that distinguish it from all other 
eukaryotic Moco enzymes. First, purification and oligomerization analyses revealed both 
mARC proteins to be monomeric (Wahl et al., 2010), while most other eukaryotic Moco 
enzymes require homodimerization for catalytic activity. Moreover, mARC proteins contain 
Moco as a single redox active center and do not contain any further cofactors, qualifying 
mARC as the simplest animal Moco enzyme. Instead, mARC is integrated into a three 
component enzyme system with the overall cofactor composition mirroring eukaryotic NR 
proteins (FAD, heme, Moco). Interestingly, the electrons pass from NADH to FAD containing 
cytochrome b5 reductase and via heme containing cytochrome b5 to Moco within the mARC 
subunit, which harbors the active site for substrate reduction (Figure 1.5). Thereby, not only 
cofactor composition, but also cofactor arrangement and electron flow of the N-reductive 
system are similar to NR.    
 
 
 
 
 
 
 
While many N-hydroxylated compounds were identified as substrates for native and 
recombinant mARC proteins, the physiological functions of mARC remain poorly understood. 
So far, the only known physiological role of both mARC proteins accounts for their 
involvement in the regulation of nitric oxide (NO) synthesis (Kotthaus et al., 2011). NO 
synthases catalyze the oxidation of arginine to citrulline and NO via the intermediate N-
hydroxy-arginine (NOHA). NO is an essential cellular signaling molecule with versatile 
functions in vascular homeostasis and innate immune response. However, overproduction of 
NO can cause severe diseases like ischemia or septic shocks, thus requiring a balanced 
regulation of NO synthesis (Moncada et al., 1991). Both mARC proteins were shown to be 
involved in one of those regulative mechanisms and to catalyze the reduction of NOHA to 
arginine in cooperation with cytochrome b5 and its reductase (Kotthaus et al., 2011).  
Figure 1.5 Composition and electron transfer in the N-reductive system. NADH is oxidized 
by FAD containing NADH cytochrome b5 reductase (NADH Cytb5R) and electrons are passed 
to heme integrating cytochrome b5 (Cytb5). Moco binding mARC receives electrons from Cytb5 
and reduces the substrate within the active site. 
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1.4 Mitochondrial architecture and function  
Mitochondria harbor SO and mARC and thereby exert crucial cellular functions in sulfite 
detoxification and NO synthesis regulation. These reactions however only represent a small 
fraction of the multitude of essential cellular processes and functions mitochondria are 
involved in. In addition to their central role in ATP production by oxidative phosphorylation, 
they play key roles in the metabolism of amino acids and lipids as well as in iron-sulfur 
cluster biogenesis (Lill, 2009, Osman et al., 2011). Further, mitochondria are fundamental for 
the regulation of programmed cell death and mitochondrial dysfunction is hallmark of many 
neurodegenerative diseases (Zeviani, 2004, Wang and Youle, 2009). 
 The cellular functions of mitochondria are tightly linked to its architecture, which is 
characterized by two membranes of distinct structure. The outer mitochondrial membrane 
builds the border to the cytosol and harbors voltage dependent anion channels (VDAC), 
which permit passive exchange of small molecules and metabolites between the cytosol and 
the mitochondrial IMS. The outer membrane also contains the translocase of the outer 
membrane (TOM) complex as the main entry gate for proteins, the sorting and assembly 
machinery (SAM) as well as mitofusins being involved in fusion of mitochondria.  
The inner mitochondrial membrane constitutes a significantly larger surface area than 
the outer membrane and can be divided into two main regions. The inner boundary 
membrane (IBM) is juxtaposed to the outer membrane with the diameter of the IMS not 
exceeding 2-3 nm (Neupert, 2012). The IBM is rich in proteins involved in transport of other 
proteins as well as metabolites and harbors the translocase of the inner membrane (TIM) 
complex. Invaginations of the IBM, termed cristae, form a multitude of shapes from tubular to 
lamellar structures and comprise the second compartment of the inner mitochondrial 
membrane. Cristae membranes mainly contain components of the respiratory chain and the 
F1F0-ATP-synthase. IBM and cristae membranes are connected by narrow tubular openings 
called cristae junctions, which are believed to limit diffusion between both membranes and 
between intracristae space and the remainder of the IMS (van der Laan et al., 2012). The 
mechanisms controlling the ultrastructural organization of mitochondria had remained largely 
unknown, until the mitochondrial inner-membrane organizing system (MINOS) was recently 
discovered in Saccharomyces cerevisiae (S. cerevisiae) as the first protein scaffold 
regulating mitochondrial architecture (Harner et al., 2011, Hoppins et al., 2011, von der 
Malsburg et al., 2011). This large complex is composed of at least six subunits and is 
involved in the maintenance of inner membrane organization by regulation of cristae 
morphogenesis and controlling the lateral diffusion of membrane components between IBM 
and cristae. The MINOS complex further interacts with the TOM and SAM complex of the 
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outer mitochondrial membrane and thus permits contact sites between inner and outer 
mitochondrial membranes (Neupert, 2012). Mitochondria do not only require organization 
and regulation of their internal ultrastructures, but they also build physical links to the 
endoplasmic reticulum (ER). A protein complex tethering ER and mitochondria was recently 
identified and termed ERMES (ER-mitochondria encounter structure) (Kornmann et al., 
2009). This complex is composed of transmembrane proteins residing in the ER and 
mitochondria, with proposed functions in interorganellar Ca2+ and phospholipid exchange, 
regulation of mitochondrial protein import and mitochondrial DNA maintenance (Kornmann 
and Walter, 2010).  
Mitochondria form extended and dynamic networks within the cell continually 
undergoing fusion and fission events. While mitochondrial fusion is regulated by the large 
dynamin-like GTPases MFN1 and MFN2 in the outer membrane and OPA1 in the inner 
membrane, mitochondrial fission is exerted by the dynamin related GTPase DRP1 and the 
outer membrane proteins MFF and FIS1 (Chan, 2006, Zhao et al., 2012). Balanced fusion 
and fission permit interaction of mitochondria and are fundamental to maintain their shape 
and function.    
 
1.5 Mitochondrial protein import  
The spectrum of mitochondrial functions as well as regulation of mitochondrial architecture 
depends on 1000-1500 different mitochondrial proteins present within the organelle (Baker et 
al., 2007). Although mitochondria have retained their own genome during endosymbiontic 
evolution, the majority of genes have been lost over the period of evolving from an 
endosymbiont to an organelle. Today, only ~1% of mitochondrial proteins are encoded by 
mitochondrial DNA. The remaining proteins are encoded by nuclear genes and become 
synthesized by cytosolic ribosomes. The cell has therefore developed sophisticated 
mechanisms to enable transport of proteins to and within mitochondria. 
In spite of partial co-translational protein import to mitochondria (Kellems et al., 1975, 
Ades and Butow, 1980, Knox et al., 1998), the vast majority of mitochondrial proteins are 
synthesized as cytosolic precursors and imported by post-translational mechanisms. 
Chaperons are thereby required to guide the precursor proteins to receptors at the outer 
mitochondrial membrane and to keep them in an unfolded and import competent state 
(Wiedemann et al., 2004a). Considering the complex two-membrane architecture of 
mitochondria, several protein import pathways have evolved to ensure routing towards the 
correct mitochondrial sub-compartment.  
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Mitochondrial precursor proteins can be divided into two main classes. Pre-proteins 
designated for the mitochondrial matrix and a number of proteins residing in the inner 
membrane or the IMS carry cleavable N-terminal extensions of 10-30 residues in length 
(Wiedemann et al., 2004a). These pre-sequences form amphipathic α-helices and direct the 
protein across both the TOM and TIM complexes. The second class of mitochondrial proteins 
is synthesized as non-cleavable precursors and contains internal motifs triggering 
translocation.  
Almost all mitochondrial precursors enter mitochondria via the TOM complex as the 
universal protein entry gate of the outer membrane. It consists of seven different subunits, 
which can be subdivided into three groups according to their individual functions during the 
translocation process. TOM20, TOM22 and TOM70 expose cytosolic domains and serve as 
receptors initially binding different types of precursors (Ahting et al., 1999). The general 
import channel is formed by the beta-barrel protein TOM40 (Hill et al., 1998), while the small 
proteins TOM5, TOM6 and TOM7 have TOM complex stabilizing functions and may also 
participate in the transfer of precursor proteins (Honlinger et al., 1996, Dietmeier et al., 1997, 
Kato and Mihara, 2008). Following their mitochondrial entry via the TOM complex, precursors 
diverge into different pathways in order to reach their destined mitochondrial sub-
compartment.  
 
1.5.1 Import of proteins containing cleavable pre-sequences   
Almost half of all mitochondrial precursors contain cleavable N-terminal extensions, which 
are also called matrix sequences, as they transport the N-terminus of a given protein across 
the inner membrane into the matrix (Neupert and Herrmann, 2007). After cytosolic synthesis, 
precursors are initially recognized by the outer membrane surface receptor TOM20, based 
on the hydrophobic surface of their amphipathic helix (Abe et al., 2000). Interactions to the 
negatively charged carboxy-terminus of TOM22, mediated by the positively charged helix-
surface, and binding to TOM5 trigger the subsequent transfer to the import pore TOM40 (Brix 
et al., 1997). According to the so-called binding chain hypothesis, the process of outer 
membrane translocation is driven by gradually increasing affinities between precursors and 
the mentioned TOM components (Milenkovic et al., 2007). After translocation via TOM40, the 
pre-sequence binds to the IMS domain of TOM22 (Komiya et al., 1998).  
 Following translocation through the TOM complex, pre-sequence containing 
precursors are transferred to the pre-sequence translocase of the inner membrane, the 
TIM23 complex. TIM23 constitutes the channel-forming protein and together with TIM17 
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builds the membrane embedded core of the complex. Pre-sequences leaving the TOM 
complex are recognized by the IMS domains of TIM23 and TIM50 as the primary pre-
sequence receptor at the inner membrane (Schulz et al., 2011). Insertion of precursors into 
the TIM23 channel depends on an intact membrane potential across the inner membrane, 
which constitutes an electrophoretic driving force towards the mitochondrial matrix. 
 Two main classes of proteins enter the TIM23 complex based on their cleavable pre-
sequences. The first group of proteins is destined to reach the mitochondrial matrix. The 
second class of proteins contains bipartite targeting signals with a transmembrane domain 
downstream of the pre-sequence serving as a stop-transfer signal, thus resulting in an arrest 
of translocation in the inner mitochondrial membrane. Accordingly, two different forms of the 
TIM23 complexes exist, either mediating membrane potential dependent translocation 
towards the matrix or insertion into the inner mitochondrial membrane (Figure 1.6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Mitochondrial import of pre-sequence containing precursors. Proteins containing a 
cleavable pre-sequence are imported by TOM and two forms of TIM23 complexes. Inner membrane 
or IMS proteins contain a hydrophobic stop transfer signal downstream of the matrix targeting peptide 
and are membrane potential dependently imported. Matrix proteins lack transmembrane domains and 
require the ATP dependent PAM complex as an additional driving force for complete import into the 
matrix. Figure modified from (Milenkovic et al., 2007).   
                                                                        
Dissertation Julian Klein                                                                                          Introduction 
 
16 
 
Both types share TIM23, TIM17 and TIM50 as essential core subunits of the complex. TIM21 
is a unique subunit of the so-called sorting form of the TIM23 complex, which allows lateral 
integration of precursors into the inner membrane (Milenkovic et al., 2007). The function of 
TIM21 is not completely understood, but it was shown to interact with the IMS domain of 
TOM22, suggesting a role in the interactions between TIM and TOM complexes (Chacinska 
et al., 2005). Proteins with bipartite targeting signals either remain anchored within the inner 
membrane, or they become proteolytically cleaved downstream of the transmembrane 
domain to generate a soluble IMS protein. 
Mitochondrial matrix proteins lack transmembrane domains and therefore completely 
cross the TIM23 complex. This is mediated by a different type of TIM23 complex, which does 
not contain TIM21, but instead binds the pre-sequence translocase-associated motor (PAM) 
within the mitochondrial matrix. The PAM complex consists of mitochondrial HSP70 
(mtHSP70), the nucleotide exchange factor GRPE (Mge1 in S.cerevisiae), TIM44, linking 
mtHSP70 to the TIM23 complex, and the three co-chaperons PAM16, PAM17 and PAM18. 
HSP70 thereby exerts a crucial function as a motor protein, ATP-dependently pulling the 
incoming precursor entirely towards the mitochondrial matrix. The translocation of pre-
sequence containing precursors is completed by cleavage of the matrix targeting signal by 
the mitochondrial processing peptidase (MPP) (Neupert and Herrmann, 2007). 
 
1.5.2 Import of proteins lacking cleavable pre-sequences   
Mitochondrial proteins lacking a cleavable pre-sequence retain their primary structure during 
mitochondrial transport and are targeted to the organelle by internal motifs. According to their 
designated sub-compartments and import mechanisms, these proteins can be subdivided 
into four main classes.  
1.5.2.1 Insertion of proteins into the inner membrane  
While inner membrane proteins containing a single transmembrane domain usually become 
imported based on cleavable pre-sequences as described above, multi-membrane-spanning, 
mostly carrier proteins of the inner membrane as well as membrane embedded components 
of the TIM complex are imported by the alternative TIM22 import pathway (Milenkovic et al., 
2007).  
Following their synthesis, these precursors are bound by cytosolic chaperons owing 
to their hydrophobicity and targeted to TOM70 as the primary import receptor of solute carrier 
proteins (Young et al., 2003). Upon translocation through the TOM complex, precursors are 
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bound by hexameric complexes composed of TIM9 and TIM10 and are chaperone assisted 
through their way to the soluble IMS (Curran et al., 2002, Vial et al., 2002, Baker et al., 
2009). With the help of TIM12, the precursors dock onto the carrier translocase of the inner 
membrane (TIM22 complex), which is composed of TIM22 as the essential core of the 
complex, mediating the membrane insertion of carrier proteins. In addition, TIM54 as a non-
essential accessory component and TIM18, only found in fungal mitochondria so far, 
assemble into the TIM22 complex (Milenkovic et al., 2007). Yeast succinate dehydrogenase 
subunit 3 (Sdh3) was further recently identified as a novel subunit of the TIM22 complex and 
was proposed to be involved in complex biogenesis (Gebert et al., 2011). The carrier 
proteins are inserted into the two channels of the TIM22 complex in a loop conformation, with 
the membrane potential activating TIM22 and constituting the driving force of the insertion 
(Rehling et al., 2003). Carrier proteins finally dimerize into their native state upon their 
membrane release from the TIM22 complex (Neupert and Herrmann, 2007).   
1.5.2.2 Import of small IMS proteins 
Many proteins of the mitochondrial IMS are imported based on bipartite targeting signals 
followed by downstream proteolytic cleavages as described above. However, the majority of 
IMS proteins is small and becomes imported by alternative mechanisms. These proteins are 
translocated through the TOM complex and, in respect to their size of less than 20 kDa, tend 
to bi-directionally cross the TOM complex if not folded, which also includes their reverse 
translocations to the cytosol (Lutz et al., 2003). Folding of these proteins prevents retrograde 
movements and converts the bi-directional diffusion into a vectorial process. This so-called 
folding-trap mechanism of IMS protein import is based on cofactor mediated folding (Dumont 
et al., 1988, Field et al., 2003) or the formation of intramolecular disulfide bonds. Proteins 
undergoing internal disulfide-bond formations contain conserved Cys-X3-Cys or Cys-X9-Cys 
motifs and require the MIA40 import machinery for the formation of internal disulfide bonds 
(Chacinska et al., 2004). MIA40 is an oxidoreductase and serves as a receptor for small IMS 
precursors upon their import into the IMS. Substrates and MIA40 initially form intermediate 
mixed disulfide bonds, while formation of intramolecular disulfide bonds leads to the release 
of the folded and trapped precursors in a final maturation step. This disulfide-relay system is 
accomplished by reoxidation of MIA40 mediated by the sulfhydryl oxidase ERV1 (Bottinger et 
al., 2012). 
1.5.2.3 Integration of β-barrel proteins into the outer membrane 
The outer mitochondrial membrane contains two distinct classes of integral membrane 
proteins, which are either inserted by α-helical transmembrane segments or based on 
multiple β-strands. Apart from outer mitochondrial membranes, the corresponding β-barrel 
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proteins are only present in outer membranes of chloroplasts and gram-negative bacteria, 
thus presumably reflecting the evolutionary origin of eukaryotic organelles (Walther and 
Rapaport, 2009).  
After their cytosolic synthesis, β-barrel proteins are guided to the TOM complex, 
where they become recognized by TOM20 as well as TOM22 and transported into the IMS 
via the TOM40 import channel (Walther and Rapaport, 2009). Following their translocation 
into the IMS, a number of β-barrel proteins have been shown to associate with the 
chaperone like small proteins TIM8-TIM13 or TIM9-TIM10, respectively (Hoppins and 
Nargang, 2004, Wiedemann et al., 2004b). Integration of β-barrel proteins into the outer 
membrane is mediated by the SAM (sorting and assembly machinery) / TOB (topogenesis of 
β-barrel proteins) complex of the outer mitochondrial membrane (Paschen et al., 2003, 
Wiedemann et al., 2003). In yeast, the SAM machinery is composed of three core subunits, 
with the β-barrel protein Sam50 constituting the main component and the peripherally 
associated components Sam35 and Sam37 being located at the cytosolic surface of the 
SAM complex. While Sam50 (Humphries et al., 2005) and Sam37 (Armstrong et al., 1997) 
have clear homologues in mammals, metaxin2 is proposed to be the functional homologue of 
Sam35, although direct sequence homology is lacking (Neupert and Herrmann, 2007). 
Furthermore, Mdm12 and Mmm1 were identified as yeast SAM complex subunits (Meisinger 
et al., 2007) and Mdm10 has been identified as an additional SAM subunit being specific for 
the assembly of Tom40 (Meisinger et al., 2004).  The mechanisms by which the SAM 
complex mediates membrane insertion of β-barrel proteins are poorly defined. Sam50 is 
however suggested to build a huge pore and to assist in folding of incoming β-barrel proteins, 
finally releasing them laterally into the outer membrane (Paschen et al., 2003). The MINOS 
complex, which interacts with both the TOM and the SAM complex, was recently shown to be 
also involved in β-barrel protein biogenesis, since depletion of mitofilin as the large core 
subunit of MINOS resulted in impaired  β-barrel protein membrane assembly (Bohnert et al., 
2012). 
1.5.2.4 Integration of α-helical proteins into the outer membrane 
The insertion of proteins containing single α-helical transmembrane segments into the outer 
mitochondrial membrane is only partially understood and seems to be divergent. These 
proteins either contain N- or C-terminal transmembrane segments flanked by positively 
charged residues, with the soluble core of the protein being exposed to the cytosol.  
Outer membrane proteins comprising N-terminal α-helical transmembrane domains 
are termed signal-anchored proteins according to the dual function of the hydrophobic 
segment in membrane anchoring and sorting signal. The few known members of this family, 
Dissertation Julian Klein                                                                                          Introduction 
 
19 
 
including TOM20 and TOM70, lack obvious primary sequence similarities in their N-terminal 
region, suggesting that the sorting information is delivered by a conserved structural feature. 
This was confirmed by mutagenesis studies of the N-terminal domains of signal-anchored 
proteins, indicating that a moderate degree of hydrophobicity rather than the length of the 
transmembrane segment is fundamental for correct sorting (Waizenegger et al., 2003). The 
mechanisms of outer membrane integration are not completely understood and seem not to 
follow a common principle of targeting. The import however seems to be independent on the 
primary receptors of the TOM complex and blocking of the translocation pore does not affect 
membrane insertion of the known signal-anchored proteins (Ahting et al., 2005, Meineke et 
al., 2008). Still, TOM40 was shown to play a role in the membrane integration of TOM20 and 
TOM70, which may however represent a specific requirement of these proteins as TOM 
complex subunits (Dukanovic and Rapaport, 2011). Another signal anchored protein that is 
not part of the TOM complex, the yeast signal-anchored protein OM45, has been shown to 
be inserted into the membrane independently of TOM complex subunits and other 
proteinaceous factors involved in membrane protein insertion. Instead, OM45 displayed the 
ability to acquire a transmembrane topology within artificial lipid bilayers. The specific lipid 
composition of outer mitochondrial membranes and the achieved thermodynamic gain upon 
membrane integration was therefore recently proposed to constitute the targeting information 
and driving force for insertion of this signal-anchored protein into the correct membrane 
(Merklinger et al., 2012). The proposed mechanisms of outer membrane targeting of signal-
anchored proteins are summarized in figure 1.7.    
In addition to signal-anchored proteins, the outer mitochondrial membrane contains 
proteins with a C-terminal transmembrane segment, termed tail-anchored proteins, and 
multi-spanning proteins including more than one α-helical transmembrane segment. The 
membrane insertions of tail-anchored proteins seem to be related to those of signal-
anchored proteins, with some components requiring the presence of the TOM core complex 
(Horie et al., 2003) and others being incorporated independently of the TOM components 
(Ross et al., 2009). The schematic proposals of figure 1.7 are therefore also transferable to 
tail-anchored proteins. However, the SAM complex was also suggested to be required for 
membrane insertion of TOM components with single C-terminal membrane anchors 
(Stojanovski et al., 2007). Integrations of outer membrane proteins containing multiple 
transmembrane segments were shown to require the small outer membrane protein Mim1 
(Becker et al., 2011, Papic et al., 2011). These findings were recently extended by the 
identification of Mim2, which interacts with Mim1 to build the MIM complex required for the 
insertion of multispanning outer membrane proteins (Dimmer et al., 2012).    
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1.6 Cofactors and metabolites in mitochondria  
Mitochondrial function does not only require targeted import of proteins, but also a continued 
and diversified flux of cofactors, metabolites and nucleotides into and out of mitochondria. 
The outer mitochondrial membrane contains voltage dependent anion channels (VDAC), 
which permit passive, bi-directional diffusion of molecules up to ~ 5kDa in size (Lemasters 
and Holmuhamedov, 2006). All metabolites and cofactors can hence non-specifically cross 
the outer mitochondrial membrane. In contrast, the inner mitochondrial membrane does not 
contain porins and is rich in cardiolipin, rendering the inner membrane virtually impermeable. 
The transport of solutes is instead specifically coordinated by a family of more than 50 
nuclear encoded and inner membrane embedded proteins called mitochondrial carriers. All 
of these proteins share a tripartite structure of three homologous repeats of approximately 
100 amino acids, each containing two α-helical transmembrane stretches. Mitochondrial 
carrier proteins are homodimers, with each monomer traversing the inner membrane six 
Figure 1.7 Possible import pathways of signal-anchored proteins. The transmembrane domains 
of signal-anchored proteins are presumably engaged by cytosolic factors. Insertion into the outer 
membrane can occur (a) without assistance of any other proteins or (b) mediated by a pre-existing 
TOM complex in case of TOM20 and TOM70. The TOM complex may be involved in the initial steps 
of membrane insertion or (c) TOM complex mediated assembly could occur after membrane 
insertion of the precursor. Figure modified from (Dukanovic and Rapaport, 2011). 
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times, being connected by hydrophilic loops or domains with the N- and C-termini remaining 
exposed to the IMS. The driving force of the transport is mediated by a concentration 
gradient of the solute and/or the electrochemical H+ gradient across the inner mitochondrial 
membrane (Palmieri, 2008). Prominent examples for inner membrane carriers transport 
ADP/ATP (Aquila et al., 1982), phosphate (Kolbe et al., 1984), aspartate/glutamate (Bisaccia 
et al., 1992) or ornithine (Indiveri et al., 1992).    
 
1.6.1 Heme synthesis and transport 
Mitochondria and cytosol cooperate in a large number of metabolic processes and thus 
strictly depend on inner membrane carrier proteins to ensure efficient metabolite exchanges. 
One example is depicted by the synthesis of heme cofactors, which partially occurs in the 
cytosol but is completed in mitochondria. Furthermore, heme is not only incorporated into 
mitochondrial proteins, but also an essential component of a number of non-mitochondrial 
enzymes. Therefore, the heme synthesis pathway including export of the final heme cofactor 
is subject to repeated exchange of intermediates between mitochondria and cytosol.      
 The synthesis of heme (figure 1.8) initiates in mitochondria by 5-aminolevulinate-
synthase mediated condensation of glycine and succinyl CoA to form 5-aminolevulinate.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Mammalian heme biosynthesis. All heme precursors are depicted in black 
boxes, heme as the final product is highlighted red. Green arrows indicate enzymatic 
reactions and names of catalyzing enzymes are given. Black arrows illustrate transport of 
intermediates across mitochondrial membranes. Mitochondrium is schematized in orange, 
matrix and IMS are shown.     
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The subsequent four steps of heme biogenesis take place in the cytosol, thus requiring 
mitochondrial export of 5-aminolevulinate by a currently unknown carrier. 
Coproporphyrinogen III as the final cytosolic product is re-imported into mitochondria, where 
it is first converted to protoporphyrinogen IX and further modified to protoporphyrin IX in the 
IMS. The final step of heme synthesis occurs on the matrix side of the inner mitochondrial 
membrane, where iron is inserted into protoporphyrin IX by ferrochelatase (Ajioka et al., 
2006). The carrier exporting heme to the cytosol remains unknown, while the heme-binding 
protein 1 (Taketani et al., 1998) and the ATP-binding cassette transporter M-ABC2 (Shirihai 
et al., 2000) were proposed to be involved in mitochondrial export of heme or one of its 
intermediates.   
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1.7 Aims of the current study 
The overall aim of the current study was to unravel the mechanisms underlying the cellular 
maturations of the mitochondrial Moco-enzymes SO and mARC. Considering the intrinsic 
instability of Moco and its cytosolic synthesis, the group of mitochondrial Moco-enzymes was 
of particular interest to gain insights into the open questions of cellular Moco transport and 
stabilization. 
 
The first part of this thesis focused on the dissection of SO maturation and the impact and 
stabilization of Moco. This was supposed to answer the following questions: 
1) How is the complex assembly of SO coordinated on the cellular level?  
2) Are the individual steps of SO maturation subject to a molecular hierarchy? 
3) What is the role of Moco during the maturation of SO and where do Moco and SO 
associate? 
4) Which factors trigger mitochondrial localization of SO? 
5) Which peptidase mediates processing of SO in the mitochondrial IMS? 
 
In the second part of this study, the cellular maturation of mARC1 was investigated. 
Considering its recent discovery, a number of fundamental questions have remained 
unexplored so far: 
1) Which mitochondrial sub-compartment is mARC1 residing in? 
2) How is mARC1 targeted to mitochondria and which of the five import pathways does it 
follow? 
3) What is the role of Moco for the mitochondrial localization of mARC1? 
4) What are the characteristics and requirements of the mitochondrial import of mARC1?  
5) What are similarities and differences between the mitochondrial maturations of SO and 
mARC1
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2 Results 
2.1 Assembly and maturation of mammalian SO 
The cellular assembly of SO starting with the cytosolic synthesis of the polypeptide chain all 
the way to the fully functional mitochondrial enzyme implies a complex network of several 
maturation steps. To fulfill its enzymatic activity, SO requires the integration of a cytochrome 
b5 type heme cofactor into the N-terminal part of the protein, the integration of Moco into the 
central domain, homodimerization mediated by the C-termini and the translocation from the 
cytosol to the mitochondrial IMS, accompanied by processing of the first 80 residues (Kisker 
et al., 1997). All these processes have to be precisely regulated and spatially as well as 
temporally coordinated in order to ensure an efficient maturation of the enzyme. In particular, 
the stabilization of Moco upon its cytosolic synthesis until its integration into SO remained 
ambiguous, as Moco is known to be a very unstable molecule in a protein-free environment 
(Schwarz and Mendel, 2006). In this respect, Moco was expected to require an immediate 
association with the respective apo-proteins to achieve its stabilization (Schwarz et al., 
2009). However, cytosolic folding of SO after Moco integration would interfere with the 
properties of the so far known mitochondrial import machinery. Thus, the first part of this 
study was supposed to uncover the cellular organization of the overall SO assembly process 
with a particular focus on the integration of Moco into SO and the mitochondrial transport of 
both components.  
 
2.1.1 Amplification, purification and characterization of mouse SO 
SO variants from different mammalian species are well conserved but slightly differ in their 
N-terminal domains (Figure 2.1), which represent the mitochondrial targeting sequence of the 
proteins. As confirmed by in silico prediction tools (Claros and Vincens, 1996, Kall et al., 
2004), these differences in the primary structure do however not significantly influence the 
chemical properties of this domain, suggesting similar mechanisms for the cellular maturation 
and mitochondrial transport of all mammalian SO variants. Therefore, mouse SO was 
exemplarily chosen as a representative for mammalian SO in the current study.  
After successful amplification of the SO coding sequence from a mouse cDNA library, 
SO was first characterized in vitro prior to the in vivo analysis of the SO maturation process. 
For this purpose, the SO coding sequence was cloned into the pQE80 expression vector for 
heterologous expression of the protein in Escherichia coli (E. coli). The full-length SO protein 
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contains a hydrophobic stretch of about 20 residues in the N-terminal part of the protein, 
which revealed to interfere with an efficient expression and purification from E. coli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Since mature mammalian SO lacks its first 80 residues including the hydrophobic 
stretch following mitochondrial processing (Kisker et al., 1997), a truncated variant of SO 
representing the mature protein was purified from E. coli. This protein variant was expressed 
at high yields and could be enriched to purity by means of sequential Ni-NTA affinity 
chromatography and anion-exchange chromatography (Figure 2.2 A). Expression was 
carried out in E. coli strain TP1000, which is able to synthesize the eukaryotic form of Moco 
(Palmer et al., 1996), while WT-E. coli mainly produces a nucleotide modified form of the 
cofactor. The enzymatic activity of SO requires efficient homodimerization, as monomeric 
mutant variants have been shown to be catalytically inactive (Wilson et al., 2006). The 
Figure 2.1 Multiple sequence alignment of mammalian SO variants. Alignment of mammalian SO 
sequences was conducted with CLUSTALW and images were generated with Boxshade. Residues 
are framed in black (high conservation), gray (moderate conservation) or white (no conservation). 
Protein accession numbers: NP_001029538 (Bovine SO), XP_001491902 (Horse SO), NP_000447 
(Human SO), BAD51985 (Macaque SO), NP_776094 (Mouse SO), NP_112389 (Rat SO). 
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oligomerization of purified SO was analyzed by means of HPLC based size exclusion 
chromatography, revealing the expected distribution of a major dimeric and a minor 
monomeric population of the protein (Figure 2.2 B, blue trace). Apart from the protein derived 
absorption at 280 nm, the heme cofactor mediated absorption at 413 nm was recorded 
during chromatography to assess the integration of the heme cofactor into SO. As the 
absorption of the protein at 413 nm closely followed its absorption at 280 nm, efficient heme 
cofactor integration into SO was observed (Figure 2.2 B, red trace). Next, the incorporation of 
Moco into purified SO was determined by HPLC-mediated detection of the Moco derivative 
FormA-dephospho. SO expressed from E. coli strain BL21, which does not accumulate the 
eukaryotic form of Moco, was supposed to deliver significantly less FormA-dephospho and 
was used as a negative control within the assay. The analysis revealed an approximately 
40% Moco saturation of SO expressed from E. coli TP1000, while SO expressed from strain 
BL21 showed less than 10% Moco integration (Figure 2.2 C). These results are in line with 
values reported for other Moco proteins (Fischer et al., 2006b, Gruenewald et al., 2008). 
 
 
 
 
          
 
 
 
 
 
 
 
 
The homodimerization as well as the integration of heme and Moco resulted in a catalytically 
active enzyme, which was finally determined by means of an in vitro SO activity-assay using 
cytochrome c as the final electron acceptor (Figure 2.2 D). The determined values of SO 
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Figure 2.2 Purification and character-
ization of MSO expressed in E. coli. 
(A) SO was expressed in E. coli strain 
TP1000 for 48 h at room temperature 
and purified by sequential Ni-NTA and 
anion-exchange chromatography. Purity 
of SO preparation was assessed by 12% 
SDS-PAGE and subsequent coomassie 
blue staining. (B) Oligomerization of 
purified SO was determined by HPLC 
based size exclusion chromatography. 
Absorptions were measured at 280 nm 
(blue traces) and 413 nm (red traces). 
(C) Moco saturation of 100 pmol SO 
expressed from E. coli strains TP1000 
and BL21, respectively, was determined 
by HPLC mediated detection of the 
fluorescent Moco derivative FormA. 
Error bars represent standard deviations 
(n=3). (D) Activities of purified SO 
variants from E. coli strains TP1000 and 
BL21 were determined by means of the 
sulfite:cytochrome c SO assay. Depicted 
are velocities of sulfite oxidation per mg 
SO within the reaction well. Error bars 
represent standard deviations (n=3).         
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activity are thereby consistent with SO activities described in the literature (Garrett et al., 
1998) 
 
2.1.2 Moco dependent mitochondrial localization of SO 
The steps of SO maturation described in chapter 2.1.1 result in an active enzyme in vitro. 
The assembly however becomes more complex in vivo, where both SO and Moco 
additionally require a coordinated translocation to mitochondria after their cytosolic synthesis, 
a process which was not understood so far. Premature integration of Moco into SO within the 
cytosol and the concomitant folding would interfere with mitochondrial transport of the 
complex, as only unfolded proteins can enter mitochondria across the TOM and TIM 
complexes (Neupert and Herrmann, 2007). On the other hand, Moco has been shown to be 
a very unstable molecule if not associated to the protective environment of a protein, 
suggesting an immediate association of SO and Moco in the cytosol (Schwarz and Mendel, 
2006).  
To address this conflict and to identify possible mutual impacts of SO and Moco for 
their mitochondrial translocation, SO was transiently expressed in WT and Moco-deficient 
human fibroblasts. Immunostaining using an SO specific antibody (Figure 2.3 A) revealed the 
expected exclusive mitochondrial localization in WT fibroblasts, as demonstrated by the 
complete colocalization of SO and mitochondria stained with Mitotracker Red (Figure 2.3 B). 
To analyze the cellular distribution of SO in absence of Moco, SO was expressed in human 
fibroblasts with a mutation in the MOCS1 gene. The MOCS1 proteins catalyze the first step 
of the Moco synthesis pathway by converting GTP to cPMP in mammals (Hanzelmann et al., 
2002), suggesting that MOCS1-deficient fibroblasts do not contain substantial amounts of 
Moco. While WT fibroblasts significantly reconstituted the Moco-deficient nitrate reductase in 
the nit-1 assay, MOCS1-deficient fibroblasts did not deliver any considerable amounts of 
Moco (Figure 2.3 C). Surprisingly, expression of SO in the latter Moco-deficient fibroblasts 
revealed a diffuse distribution throughout the entire cell body with no clear mitochondrial 
localization left (Figure 2.3 D). No nuclear exclusion of the SO staining was observed, which 
would point to an apparent size of less than 60 kDa as seen for other proteins that are able 
to passively enter the nucleus (Nigg, 1997). 
 To confirm that Moco binding to SO is required for the mitochondrial targeting of the 
enzyme, a mutant variant of SO was designed, which should not be able to bind Moco. In a 
report listing several cases of isolated SO deficiency, two mutations in the Moco binding 
domain of human SO were described. (Johnson et al., 2002). The first mutation affected 
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Arg309, which is involved in the binding of Moco by forming salt bridges with the phosphate 
of the pterin (Kisker et al., 1997). 
  
 
  
        
 
 
 
 
 
 
 
 
 
 
 
The described mutation to histidine at this position was proposed to prevent these 
hydrogen bond formations and to sterically interfere with surrounding residues. The second 
mutation involved Lys322, which binds the N1 as well as the 2-amino group of the pterin and 
also forms a salt bridge to the phosphate. A mutation to arginine was proposed to cause 
sterical problems in response to the larger side chain of arginine compared to lysine. Both 
mutations, R309H as well as K322R, resulted in a disease phenotype of the affected 
patients, suggesting that the activity of SO was disrupted and the integration of Moco might 
not have occurred in response to the structural problems outlined above (Johnson et al., 
2002).  
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Figure 2.3 Moco dependent localization of SO. (A) SO was expressed in HEK-293 cells and 
total protein extract was loaded on a 12% SDS gel. Specificity of the SO-antibody was determined 
by Western blot. (B, D) SO was expressed for 48 h and detected by anti-SO immunostaining 
(green) using confocal laser scanning microscopy. Mitochondria were stained with Mitotracker Red 
CMXRos (mitoTR). Bar, 10 µm. Cartoons illustrate the status of cofactor insertion and 
oligomerization: L, leader sequence; H, heme; Mo, Moco; DD, dimerization domain. (C) Moco 
content of WT and MOCS1-deficient fibroblasts was determined by the nit-1 assay. The depicted 
values represent an average of the nit-1 activities expressed as units per mg total protein. Error 
bars represent standard deviations (n=3).     
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Given that the above mentioned mutant variants were not further characterized 
biochemically, the corresponding double mutation was introduced into mouse SO and the 
respective variant (SO-R367H-K380R) was characterized on cofactor integration and 
oligomerization in this study. SO-R367H-K380R was expressed in E. coli strain TP1000 from 
pQE80 and purified by sequential Ni-NTA and anion exchange chromatography (Figure 2.4 
A). To determine the degree of Moco integration in the mutant variant, HPLC-based FormA 
analyses were conducted. While WT-SO was saturated with at least 40% cofactor, SO-
R367H-K380R did not contain any significant amounts of Moco, demonstrating that 
mutations R367H and K380R as expected collectively interfere with efficient Moco integration 
into SO (Figure 2.4 B). Before analyzing the localization of the Moco-deficient SO variant, the 
status of oligomerization and heme cofactor integration was determined by size exclusion 
chromatography. While heme cofactor incorporation was unaffected as illustrated by the 
similar absorptions at 280 nm and 413 nm, the oligomerization behavior changed because 
SO-R367H-K380R mainly eluted as a monomer (Figure 2.4 C). These observations indicate 
that the integration of Moco into SO is a prerequisite for efficient homodimerization. 
 
    
 
 
 
 
 
 
 
 
 
 
 
In order to confirm the importance of Moco for the sub-cellular localization of SO, the 
distribution of SO-R367H-K380R was analyzed in WT-HEK-293 cells by 
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Figure 2.4 Characterization of a Moco-deficient mutant variant of SO. (A) SO-R367H-K380R 
was expressed in E. coli strain TP1000 for 48 h at room temperature. Purification occurred by 
sequential Ni-NTA and anion exchange chromatography. Purity was assessed by 12% SDS-PAGE 
and subsequent coomassie blue staining. (B) Moco content of 100 pmol WT-SO and SO-R367H-
K380R was analyzed by HPLC mediated FormA analysis. Error bars represent standard deviations 
(n=3).  (C) Oligomerization of purified SO-R367H-K380R was determined by HPLC based size 
exclusion chromatography. Absorptions were measured at 280 nm (blue traces) and 413 nm (red 
traces).    
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immunocytochemistry. WT-SO exclusively localized to mitochondria (Figure 2.5 A), while SO-
R367H-K380R was diffusely distributed within the cell (Figure 2.5 B), as previously seen for 
WT-SO in Moco-deficient cells. To quantitatively assess the degree of colocalization of SO 
and mitochondria and thus to figure out if a minor pool of SO may still be present in 
mitochondria in absence of Moco, the Pearson correlation coeffcients (PCC) were 
determined. The PCC expresses full (100%) colocalization with a number of +1, while 
separate (excluding) localization is classified by -1. Consequently, zero represents a fully 
random, non-correlated distribution. (Manders et al., 1992).  
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Figure 2.5 Cellular distribution of Moco-deficient SO. (A) WT-SO, (B) SO-R367H-K380R and 
(C) SO (Δaa 1-80) were expressed in HEK-293 cells for 48 h and detected by anti-SO immuno-
staining (green) using confocal laser scanning microscopy. Mitochondria were stained with 
Mitotracker Red CMXRos (mitoTR). Bar, 10 µm. Cartoons illustrate the status of cofactor insertion 
and oligomerization: L, leader sequence; H, heme; Mo, Moco; DD, dimerization domain. (D) 
Pearson correlation coefficients were determined by means of the Perkin Elmers VOLOCITY 
software. Error bars represent standard deviations (n=5).  
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Under WT conditions, SO and mitochondria showed an expected average PCC of 
+0.97 (Figure 2.5 D, left panel). For SO-R367H-K380R, an average PCC value of +0.59 was 
determined (Figure 2.5 D, middle panel). As a negative control, a cytosolic variant of SO 
lacking residues 1-80 was used (Figure 2.5 C) and revealed an average PCC of +0.52 
(Figure 2.5 D, right panel), indicating that the theoretically expected reading of “0” is not 
reached. Therefore, the recorded PCC values for Moco-deficient SO are in well agreement 
with the negative control.        
The determination of the PCC values confirmed the obvious mislocalization of SO in 
absence of Moco, but could not quantitatively express if any pool of Moco-deficient SO is 
present in mitochondria. The negative control, SO lacking its N-terminal mitochondrial 
targeting sequence, was not present in mitochondria but still revealed a certain degree of 
colocalization with mitochondria, as mitochondrial areas were not clearly excluded from the 
antibody staining (Figure 2.5 C). Thus, a minor mitochondrial localization was difficult to be 
identified and to be distinguished from a non-mitochondrial distribution by 
immunocytochemistry.  
To more precisely characterize the distribution of SO-R367H-K380R in the cell, the 
latter variant as well as WT-SO, each containing a C-terminal myc –tag, were expressed in 
HEK-293 cells for 48 h. Subsequently, mitochondrial and cytosolic fractions were separated 
by discontinuous density gradient centrifugation and SO variants were detected in both 
fractions by anti-myc Western blotting. Both fractions were efficiently separated, as 
demonstrated by the specific distribution of the marker proteins VDAC and gephyrin in 
mitochondrial and cytosolic fractions, respectively (Figure 2.6 A). Consistent with the 
localization data, WT-SO was exclusively detected in the mitochondrial fraction, while SO-
R367H-K380R was mainly present in the cytosolic pool (Figure 2.6 A). The Moco-deficient 
variant of SO was however also detected in the mitochondrial fraction, finally demonstrating 
that the depletion of Moco did not completely prevent the mitochondrial targeting of SO, but 
that Moco is required for an efficient localization of SO to mitochondria. Quantification of 
band intensities revealed 100% localization of WT-SO in mitochondria (given that no signal 
was found in the cytosolic fraction), while only 30% of the Moco-deficient variant was found 
to be mitochondrial and 70% remained in the cytosol. This distribution was also confirmed by 
the application of Proteinase K (PK) to whole cell extracts after expression of WT and Moco-
deficient SO variants, respectively. The sensitivity to PK was used as an alternative 
illustration of differential holo- and apo-SO distribution, since cytosolic proteins should be 
susceptible to proteolytic digestion, while mitochondrial proteins were expected to be 
protected from PK accessibility. 
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Indeed, the outer mitochondrial membrane protein MFN2 was susceptible to PK, as a 
large domain of the protein is exposed to the cytosol (Figure 2.6 B). In contrast, the IMS 
protein diablo was mainly protected from digestion. Consistent with the previous experiments 
outlined above, WT-SO was almost completely protected from PK, while SO-R367H-K380R 
was susceptible to PK-mediated hydrolysis and only a minor fraction was stabilized due to its 
mitochondrial localization (Figure 2.6 B).       
Altogether, cellular and biochemical localization studies independently pointed out 
that SO requires the integration of Moco for an efficient mitochondrial localization, whereas 
the mechanism of Moco-dependent targeting of SO to mitochondria remained to be 
elucidated. 
 
2.1.3 Mitochondrial import of SO 
The cytosolic localization of SO in absence of Moco appeared to be unexpected, since SO 
contains a predicted mitochondrial targeting signal at its N-terminus (92.6% according to 
MitoProt II), which should be sufficient for the mitochondrial localization of a protein. To 
confirm that SO indeed contains an N-terminal mitochondrial targeting signal and to 
investigate if the impact of Moco for the localization of SO is related to this domain, the first 
80 residues of SO were fused to GFP and expressed in WT and Moco-deficient fibroblasts. 
In both cases, GFP was efficiently targeted to mitochondria, confirming that SO in fact 
Figure 2.6 Western blot analysis of Moco dependent distribution of SO. (A) WT and SO-R367H-
K380R were expressed in HEK-293 cells for 48 h. Cytosolic (lane C) and mitochondrial fractions 
(lane M) were separated from each other and total amounts of protein were determined in both 
fractions. Representative amounts of mitochondrial and cytosolic protein were loaded on a 12% SDS 
gel. VDAC and gephyrin were used as mitochondrial and cytosolic markers, respectively. Myc-tagged 
SO was stained using anti-myc antibodies. Similar results were obtained in three independent 
experiments. (B) WT-SO and SO-R367H-K380R were expressed in HEK-293 cells for 48 h. Whole 
cell extracts were treated with or without PK and loaded on a 12% SDS gel. MFN2 (mitochondrial 
outer membrane marker) and diablo (IMS marker) were detected as control proteins, SO variants 
were detected via their C-terminal myc-tags. 
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contains an intrinsic and functional mitochondrial targeting signal, which functions 
independently of Moco (Figure 2.7 A, B).  
Because the targeting signal of SO was able to localize GFP to mitochondria 
efficiently and independently from the presence or absence of Moco, the question arose of 
why SO and not GFP requires Moco for its mitochondrial localization. To unravel the 
underlying mechanisms of this coherency, the impact of Moco on the mitochondrial import of 
SO was first analyzed, as the diffuse distribution of SO in absence of Moco may result from 
an impaired import to mitochondria. The targeting signal of SO is not present in the mature 
protein (Kisker et al., 1997) and, as other known N-terminal mitochondrial targeting peptides, 
cleaved following mitochondrial import (Ono and Ito, 1984). This cleavage was expected to 
result in a shift of the electrophoretic mobility, serving as a marker for successful import of 
the protein to mitochondria. 
 
 
 
 
 
 
 
 
 
 
 
 
 Therefore, WT-SO as well as the Moco-deficient SO-R367H-K380R variant was 
expressed in HEK-293 cells, while the unprocessed full-length variant was expressed in E. 
coli and subsequently purified. Western blotting against the C-terminal myc-tag revealed a 
similar molecular weight of both, the WT and the Moco-deficient variant of SO, each being 
detected at the same apparent size of approximately 53 kDa. This band size was clearly 
below the size of full-length, non-processed SO, suggesting that in HEK-293 cells, both 
Moco-def. fibroblasts 
merge mitoTR SO (1-80)-GFP 
WT-fibroblasts 
mitoTR merge SO (1-80)-GFP 
A 
B 
Figure 2.7 SO contains an N-terminal mitochondrial targeting signal. The SO leader 
sequence (L, residues 1-80) was fused to GFP and expressed in (A) WT or (B) MOCS1-
deficient fibroblasts for 48 h. Mitochondria were stained with Mitotracker Red CMXRos 
(mitoTR). Bar, 10 µm.  
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variants, WT-SO and SO-R367H-K380R, were processed in the same manner (Figure 2.8). 
Consequently, the primary mitochondrial import of SO and the subsequent cleavage of the 
mitochondrial targeting sequence are not dependent on the presence of Moco and occur 
efficiently in a Moco-deficient background.        
  
 
 
 
 
 
Ono and Ito (1984) reported an ATP- and membrane potential-dependent import of 
SO into mitochondria through the TOM and TIM machineries, while the involved peptidases 
and thus the import mechanism remained uncharacterized. Mature mouse SO lacks the first 
80 residues and contains a predicted matrix processing peptidase (MPP) cleavage site at 
position 19 of the precursor form (Claros and Vincens, 1996). The remaining part of the 
leader sequence contains a predicted, hydrophobic transmembrane stretch at position 56-72 
(Kyte and Doolittle, 1982). This signal sequence structurally resembles the mitochondrial 
targeting motifs of S. cerevisiae cytochrome b2 and the mammalian diablo protein (Figure 2.9 
A). Both proteins have been shown to be imported based on bipartite mitochondrial targeting 
signals and processed by the inner membrane peptidase (IMP) complex (Glick et al., 1993, 
Burri et al., 2005), a hetero-oligomer composed of the two catalytic subunits IMP1 and IMP2 
and a third non-catalytic subunit involved in substrate recognition. Deletion of any of the two 
catalytic subunits destabilizes and silences the complex activity (Nunnari et al., 1993, Gakh 
et al., 2002). In respect to the topological similarities of the N-terminal pre-sequences of SO 
compared to cytochrome b2 and diablo, the question arose if the IMP complex may also 
process SO.  
Thus, the human IMP1 protein was knocked down by shRNA in HEK-293 cells. For 
this purpose, sense and antisense shRNA strands complementary to an appropriate region 
(according to predictions of the Invitrogen shRNA tool) of the human IMP1 coding sequence 
were designed and each cloned into the pJET1.2 vector in fusion with the CMV promoter. 
Following transfection of sense and antisense shRNA-encoding plasmids into HEK-293 cells, 
the effects on processing of co-transfected, myc-tagged SO were examined. Significant 
knockdown of IMP1 was confirmed by Western blot, revealing only 20 % residual expression 
Figure 2.8 Moco independent mitochondrial 
processing of SO. WT-SO and SO-R367H-K380R 
were expressed in HEK-293 cells for 48 h and cell 
extracts were loaded on an 8% SDS gel. As 
control, myc-tagged, full-length SO was expressed 
in E. coli strain TP1000. Proteins were detected by 
Western blot using anti-myc primary antibodies.  
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after shRNA treatment (Figure 2.9 B). The decreased IMP levels resulted in the appearance 
of an additional band for endogenous diablo, representing the unprocessed precursor form in 
the positive control. SO of untreated cells appeared to be completely processed, while the 
shRNA-mediated IMP1 knockdown resulted in an additional accumulation of unprocessed 
SO (Figure 2.9 B). These data suggest that the IMP complex processes SO in the 
mitochondrial IMS to release it as a soluble protein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.4 Retrograde translocation of SO to the cytosol in absence of Moco 
 Successful mitochondrial processing resulted in a truncated variant of WT- as well as 
of Moco-deficient SO-R367H-K380R. The primary mitochondrial import process of SO was 
thus not influenced by the presence or absence of Moco. However, a large SO proportion 
accumulated outside of mitochondria if Moco was not present. In respect to this conflict, the 
eventuality of a reverse translocation to the cytosol after mitochondrial import of Moco-
deficient SO was investigated next. The TOM complex is known to allow bi-directional 
translocation of unfolded, small proteins (<20 kDa). For example, already imported Tim13 
has been shown to re-enter the cytosol upon application of chelators that remove zinc ions 
required for its folding (Lutz et al., 2003). The import of other small proteins is converted into 
a vectorial process by the formation of internal disulfide bonds, thus being trapped by folding 
IMP1 
VDAC 
myc-SO 
0 h 24 h 
diablo – 28 
– 55 
– 28 
– 17 
kDa 
B 
Figure 2.9 Processing of SO by the IMP complex. 
(A) Structural comparison of Smac/Diablo (M. 
musculus), cytochrome b2 (S. cerevisiae) and SO (M. 
musculus). The first and last residues of matrix 
targeting peptide (white box), hydrophobic 
downstream region (light gray box) and mature 
protein (black box) are indicated. (B) Western blot 
analysis of SO (myc-SO), diablo, VDAC and IMP1 in 
response to IMP1 knockdown. Sense and antisense 
shRNA of IMP1 as well as myc-tagged SO were co-
expressed in HEK-293 cells for 0 and 24 h, 
respectively. Mitochondria were enriched by 
differential centrifugation and extracts were loaded on 
a 12% SDS gel.  
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within the IMS (Chacinska et al., 2004). Therefore, SO may require Moco in a similar manner 
to adopt its folding and to thereby prevent a backwards translocation to the cytosol.  
To test a possible retrograde translocation of Moco-free SO, a mutant variant of SO 
was designed, which cannot be proteolytically processed by the IMP complex and should 
therefore remain anchored at the inner mitochondrial membrane, thus preventing a potential 
reverse translocation. Because the exact IMP cleavage site was not known and obvious 
consensus motifs for IMP mediated processing were not found, the SO peptide sequence 
containing the expected cleavage site (residues 66-86) was exchanged against the 
topologically similar part of the TIM50 protein (Figure 2.10 A). TIM50 is a protein of the inner 
mitochondrial membrane and is not processed by IMP, but apart from this follows an import 
pathway similar to that proposed for SO (Mokranjac et al., 2003). First, the SO-TIM50 
chimera was expressed in HEK-293 cells to investigate its susceptibility to processing by the 
IMP complex. Western blotting against the C-terminal myc-tag revealed the accumulation of 
unprocessed SO-TIM50, running at the same size as the unprocessed precursor synthesized 
in E. coli (Figure 2.10 B). Therefore, the chimeric fusion prevented IMP-mediated processing 
of SO and its full release into the IMS, but caused a permanent association of SO with the 
inner mitochondrial membrane.   
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Figure 2.10 Design of an unprocessed SO-TIM50 chimera. (A) Scheme of the proposed import 
mechanism of SO and the known mechanism of TIM50 transport to mitochondria. To avoid 
cleavage and release of soluble SO in the IMS, the region containing the putative IMP cleavage 
site in SO (residues 64-84) was exchanged against the analogous part of TIM50 (residues 66-86), 
thus creating an SO-TIM50 chimera. (B) SO–TIM50 chimera and WT-SO were expressed in HEK-
293 cells and enriched mitochondria were loaded on a 10% SDS gel to detect SO by anti-myc 
Western blot. The increased size of SO-TIM50 correlates well with the size of the unprocessed SO 
derived from E. coli TP1000. 
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 Before analyzing the impact of Moco on the cellular distribution of this variant, its 
proper enzymatic activity had to be ensured to confirm the chimeric fusion did not interfere 
with the overall structure and folding of SO. For this purpose, WT-SO and SO-TIM50 were 
expressed in HEK-293 cells and SO enzymatic activities of whole cell extracts were 
determined in comparison to non-transfected cells. Both, WT and chimeric SO revealed a 
similar increase in SO activity compared to the control, demonstrating that the exchange of 
the respective region did not critically influence the overall structure of the protein (Figure 
2.11).    
 
 
 
 
 
 
 
 
  
 Upon verifying membrane anchoring and full enzymatic activity of SO-TIM50, the 
impact of Moco on the cellular localization was determined next. The chimera was expressed 
in Moco-deficient fibroblasts, in which WT-SO showed a diffuse cellular distribution and no 
clear mitochondrial localization (compare Figure 2.3 D). In contrast, prevention of processing 
and thus anchoring of the protein at the inner mitochondrial membrane resulted in a 
complete mitochondrial localization even in absence of Moco (Figure 2.12).  
In conclusion, the necessity of Moco for the mitochondrial localization of SO can be 
overcome by artificial attachment of the protein to the inner mitochondrial membrane. Both, 
membrane attachment and cofactor integration can hence keep SO within mitochondria. 
Further, these findings suggest that SO undergoes a reverse translocation in absence of 
Moco and that Moco integration into SO initiates folding and thereby trapping of SO within 
mitochondria. 
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Figure 2.11 Similar enzymatic activities of 
WT-SO and SO-TIM50. WT-SO and SO-
TIM50 chimera were expressed in HEK-293 
cells and SO activities in crude proteins 
extracts were determined using the 
sulfite:cytochrome c SO assay. The depicted 
values correspond to the total activity of SO 
in the cuvette (10 µg protein extract). As a 
control, non-transfected HEK-293 cell 
extracts were used representing the intrinsic 
activity of HEK293 cell SO. Error bars 
represent standard deviations (n=3). 
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The data outlined above suggested a mechanism for the mitochondrial translocation 
of SO similar to Tim13 and other small proteins of the IMS. However, with a molecular weight 
of about 50 kDa as a monomer, SO appeared considerably larger than the small IMS 
proteins, which follow a folding-trap mechanism of maturation. Therefore, a retrograde 
movement of SO through the TOM complex after complete import seemed unlikely. Apart 
from small proteins of the IMS, a reverse translocation to the cytosol has been described for 
55 kDa fumarase. This protein ensures its dual cytosolic and mitochondrial localization by 
reentering the cytosol after a partial translocation across the outer mitochondrial membrane 
(Knox et al., 1998, Sass et al., 2001). In contrast to small IMS proteins, fumarase does not 
completely cross the TOM complex before reverse translocation occurs, but keeps its C-
terminus exposed to the cytosol, until folding of the latter domain triggers reverse 
translocation (Knox et al., 1998).  
In this respect, the question arose if SO completes its translocation across the outer 
mitochondrial membrane via the TOM complex in absence of Moco or if Moco integration 
may be required as an additional driving force to “pull” the protein entirely into the 
mitochondrial IMS. To address this issue, SO-TIM50 as well as the Moco-deficient variant 
SO-TIM50-R367H-K380R, each labeled with a C-terminal myc-tag, were expressed in HEK-
293 cells. Likewise WT-SO-TIM50 in Moco-deficient cells, the Moco-deficient chimera was 
efficiently targeted to mitochondria in WT cells (Figure 2.13 A). To assess if the C-terminal 
myc-tag of SO-TIM50-R367H-K380R remained exposed to the cytosol or if translocation was 
completed, mitochondria were enriched by differential centrifugation and exposed to PK 
treatment. All peptide sequences outside of mitochondria, including the C-terminal myc-tag, 
were thereby supposed to be hydrolyzed. While diablo (IMS control) levels remained 
SO-TIM50 mitoTR merge 
Moco-deficient fibroblasts 
Figure 2.12 Moco independent mitochondrial localization of SO-TIM50. The SO–TIM50 
chimera was expressed in Moco-deficient fibroblasts for 48 h and visualized by anti–SO 
immunostaining (green) using confocal laser scanning microscopy. Mitochondria were stained 
with Mitotracker Red CMXRos (mitoTR). Bar, 10 µm. Cartoon illustrates the status of cofactor 
saturation and oligomerization: L, leader sequence; H, heme; DD, dimerization domain. The 
chimeric TIM50 sequence is illustrated in gray.  
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unaffected following PK application, the cytosolic protein gephyrin became entirely 
hydrolyzed (Figure 2.13 B). 
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WT-SO-TIM50 was protected from PK application, demonstrating an efficient 
translocation across the outer mitochondrial membrane. The depletion of Moco in contrast 
resulted in PK accessibility of about 30% of the myc-tagged C-termini (Figure 2.13 C). At first 
glance, this finding appeared divergent from figure 2.6 A, in which 70% of SO-R367H-K380R 
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Figure 2.13 Moco “pulls” SO across the outer mitochondrial membrane. (A) SO–TIM50-R367H-
K380R was expressed in HEK-293 cells for 48 h and visualized by anti–SO immunostaining (green) 
using confocal laser scanning microscopy. Mitochondria were stained with Mitotracker Red CMXRos 
(mitoTR). Bar, 10 µm. Cartoon illustrates the status of cofactor saturation and oligomerization: L, 
leader sequence; H, heme; DD, dimerization domain. The chimeric TIM50 sequence is illustrated in 
gray. (B) SO-TIM50 and SO-TIM50-R367H-K380R, each containing a C-terminal myc-tag, were 
expressed in HEK-293 cells and mitochondria were subsequently enriched by differential 
centrifugation. After treatment with or without Proteinase K (±PK), extracts were loaded on a 10% 
SDS-gel and subsequently stained for diablo as a mitochondrial marker and for myc-SO, using 
Western blot with the respective antibodies. Efficient PK digestion was confirmed by anti-gephyrin 
Western blotting whole cell lysate. (C) Band intensities of SO-TIM50 and diablo upon PK treatment 
were each quantified relative to the respective untreated samples. The quotients of SO-TIM50 
intensities were then determined in relation to those of diablo and depicted in the diagram. Error bars 
represent standard deviations (n=3).    
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were detected outside of mitochondria. However, anchoring of the SO-TIM50-R367H-K380R 
chimera at the inner mitochondrial membrane constituted an artificial driving force towards 
the IMS. Therefore, PK susceptibility of the Moco-deficient chimera was less strong as the 
cellular distribution of Moco-deficient SO would suggest.  
In conclusion, the mitochondrial import of SO across the outer membrane is not 
efficiently completed in absence of Moco but arrested in the TOM complex, finally resulting in 
a reverse translocation of a major SO population to the cytosol. 
 
2.1.5 The role of heme in the mitochondrial maturation of SO 
Apart from Moco, mammalian SO requires a cytochrome b5 type heme as a second 
metal cofactor for its enzymatic activity (Kisker et al., 1997). The integration of heme 
cofactors results in folding of the respective domains and has also been shown to contribute 
to trapping of proteins in the IMS of mitochondria (Dumont et al., 1988, Esaki et al., 1999). 
Therefore, it was surprising that SO was not trapped in mitochondria when Moco was not 
present and that its localization was not rescued by heme integration (Figure 2.3 D, 2.5 B).  
To analyze the role of heme for the mitochondrial localization of SO and to integrate 
this folding event into the overall maturation process, a heme-deficient mutant SO variant 
was designed next. In SO, the heme cofactor is not covalently attached, but is deeply buried 
in a hydrophobic cavity of the N-terminal domain and the iron is symmetrically coordinated by 
histidines 119 and 144 (Kisker et al., 1997). Since depletion of these histidines was expected 
to result in a loss of heme, both were exchanged against alanine using site-directed 
mutagenesis. The resulting SO-H119A-H144A variant was first expressed in E. coli strain 
TP1000 to analyze heme cofactor integration and the impact of the altered heme domain on 
Moco binding and SO oligomerization. Likewise WT- and Moco-deficient SO, SO-H119A-
H144A was efficiently purified by Ni-NTA affinity- and anion exchange chromatography 
(Figure 2.14 A). Heme integration and oligomerization of the purified variant were determined 
by HPLC-based size exclusion chromatography. The marginal remaining heme specific 
absorption at 413 nm revealed that heme cofactor integration was indeed strongly reduced 
by the exchange of the coordinating histidines and demonstrated SO-H119A-H144A to be a 
heme-deficient variant of SO (Figure 2.14 B). In contrast to the primarily monomeric Moco-
deficient SO variant, heme-deficient SO essentially eluted as a dimer, suggesting that heme 
integration is not a prerequisite for oligomerization of SO (Figure 2.14 B). As revealed by 
HPLC FormA analysis, Moco integration into SO-H119A-H144A occurred as efficient as into 
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WT-SO, confirming that binding of Moco to SO is not dependent on prior heme incorporation 
(Figure 2.14 C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 To assess the significance of heme integration on mitochondrial localization of SO, 
the heme-deficient variant was expressed in HEK-293 cells. SO-H119A-H144A exclusively 
localized to mitochondria, suggesting that the heme cofactor is dispensable for mitochondrial 
trapping and that Moco, which was present in the latter variant, is not only essential but also 
sufficient for mitochondrial retention and localization of SO (Figure 2.15).  
The mitochondrial localization of SO-H119A-H144A illustrated that heme 
incorporation and the accompanying folding of the respective domain is not essential for 
mitochondrial retention of SO, but that folding initiated by Moco integration was apparently 
sufficient. Still, the question remained why the presence of heme was not adequate to 
prevent the Moco-deficient SO variant from a reverse translocation to the cytosol. The 
integration of heme represents a folding event, which was shown to be involved in the 
transfer of cytochrome b2 across the outer mitochondrial membrane and its retention in the 
IMS (Esaki et al., 1999). Heterologous expression of SO-R367H-K380R in addition showed 
Figure 2.14 Characterization of a heme deficient mutant variant of SO. (A) SO-H119A-
H144A was expressed in E. coli strain TP1000 for 48 h at room temperature. Purification 
occurred by sequential Ni-NTA and anion exchange chromatography. Purity was assessed 
by 12% SDS-PAGE and subsequent coomassie blue staining. (B) Oligomerization of 
purified SO-H119A-H144A was determined by HPLC based size exclusion 
chromatography. Absorptions were measured at 280 nm (blue traces) and 413 nm (red 
traces). (C) Moco content of 100 pmol WT-SO and SO-H119A-H144A was analyzed by 
HPLC FormA analysis. Error bars represent standard deviations (n=3).    
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that heme cofactor integration was not strictly dependent on Moco integration in E. coli 
(Figure 2.4 C).  
 
 
 
 
 
 
 
 
 
 
 The mitochondrial localization of SO-H119A-H144A illustrated that heme 
incorporation and the accompanying folding of the respective domain is not essential for 
mitochondrial retention of SO, but that folding initiated by Moco integration was apparently 
sufficient. Still, the question remained why the presence of heme was not adequate to 
prevent the Moco-deficient SO variant from a reverse translocation to the cytosol. The 
integration of heme represents a folding event, which was shown to be involved in the 
transfer of cytochrome b2 across the outer mitochondrial membrane and its retention in the 
IMS (Esaki et al., 1999). Heterologous expression of SO-R367H-K380R in addition showed 
that heme cofactor integration was not dependent on Moco integration in E. coli (Figure 2.4 
C).  
Therefore, the principle capability of the heme cofactor for trapping the SO-heme 
domain in the IMS was analyzed. To uncouple Moco insertion from heme integration, the 
isolated heme domains of WT- as well as of SO-H119A-H144A were expressed in HEK-293 
cells. While the WT-heme domain localized to mitochondria (Figure 2.16 A), no clear 
mitochondrial localization, but rather a diffuse distribution within the entire cell body was 
observed for the heme-deficient heme domain (Figure 2.16 B). This finding suggests that in 
absence of heme, the heme domain is not folded and therefore it is able to move in a 
retrograde manner to the cytosol, as seen for full-length SO in absence of Moco.  
SO- 
H119A-H144A mitoTR merge 
HEK-293 
Figure 2.15 Heme independent mitochondrial localization of SO. SO-H119A-H144A was 
expressed in HEK-293 cells for 48 h and visualized by anti–SO immunostaining (green) using 
confocal laser scanning microscopy. Mitochondria were stained with Mitotracker Red CMXRos 
(mitoTR). Bar, 10 µm. Cartoon illustrates the status of cofactor saturation and oligomerization: L, 
leader sequence; Mo, Moco; DD, dimerization domain.  
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 In conclusion, the heme cofactor is competent for trapping the SO heme domain in 
the IMS and following heme integration, reverse translocations from mitochondria to the 
cytosol can be prohibited. Because SO was not efficiently trapped in mitochondria in 
absence of Moco, the heme cofactor seems not to be integrated into SO sufficiently in vivo, 
pointing to a hierarchy of cofactor integration starting with Moco followed by heme insertion.  
 
2.1.6 The impact of homodimerization on the mitochondrial maturation of SO 
 As a third event in the maturation of mammalian SO, homodimerization is required in 
addition to Moco and heme cofactor integration. Although not unequivocally shown in the 
literature so far, oligomerization events are conceivable to contribute to trapping mechanisms 
of mitochondrial IMS proteins. To position SO dimerization within the hierarchy of processes 
SO-heme mitoTR merge 
HEK-293 
SO-heme 
H119A-H144A mitoTR merge 
HEK-293 
A 
B 
Figure 2.16 Heme mediated trapping of the SO heme domain. (A,B) WT-SO heme domain 
(A) and heme deficient SO-H119A-H144A heme domain (B) were expressed in HEK-293 cells 
for 48 h and visualized by anti–SO immunostaining (green) using confocal laser scanning 
microscopy. Mitochondria were stained with Mitotracker Red CMXRos (mitoTR). Bar, 10 µm. 
Cartoon illustrates the status of cofactor saturation and oligomerization: L, leader sequence; H, 
heme.  
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that lead to SO maturation and to investigate the impact of dimerization on the mitochondrial 
localization of SO, a monomeric SO variant was created. This was of particular interest, 
given that Moco-deficient SO was shown to be monomeric too (Figure 2.4 C) and therefore 
the observed mislocalization of SO in absence of Moco could principally also reside from the 
monomeric nature of the resulting enzyme instead of the lack of Moco.  
In mouse SO, glycin 531 is positioned in the dimerization interface of SO and a 
patient carrying a mutation leading to a replacement to aspartate at the respective site of the 
human enzyme suffered from isolated SO deficiency (Kisker et al., 1997). Consequently, this 
mutation was later confirmed to interfere with dimerization and to cause a predominately 
monomeric enzyme (Wilson et al., 2006). To examine the role of dimerization for the 
maturation of SO, glycin 531 was replaced by aspartate using site-directed mutagenesis and 
the respective SO variant was purified from E. coli by Ni-NTA affinity- and anion exchange 
chromatography (Figure 2.17 A). To verify the monomeric nature of the resulting SO-G531D 
variant and to investigate the status of heme integration, the purified protein was analyzed by 
HPLC-based size exclusion chromatography.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17 Characterization of a monomeric mutant variant of SO. (A) SO-G531D 
was expressed in E. coli strain TP1000 for 48 h at room temperature. Purification 
occurred by sequential Ni-NTA and anion exchange chromatography. Purity was 
assessed by 12% SDS-PAGE and subsequent coomassie blue staining. (B) 
Oligomerization of purified SO-G531D was determined by HPLC based size exclusion 
chromatography. Absorptions were measured at 280 nm (blue traces) and 413 nm (red 
traces). (C) Moco content of 100 pmol WT-SO and SO-G531D was analyzed by HPLC 
FormA analysis. Error bars represent standard deviations (n=3).  
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As expected, SO-G531D mainly eluted as a monomer, confirming that the introduced 
mutation indeed interfered with homodimerization. In addition, the strong heme-specific 
absorption at 413 nm revealed an efficient integration of the heme cofactor into SO and a 
mutual independence of heme integration and dimerization during the SO maturation 
process (Figure 2.17 B). The proper integration of Moco was confirmed by HPLC-based 
FormA determination, demonstrating that Moco integration occurs also independently on 
oligomerization of SO (Figure 2.17 C).              
Next, the role of dimerization for the mitochondrial localization of SO was determined 
by expressing SO-G531D in HEK-293 cells. The monomeric variant of SO localized to 
mitochondria, demonstrating that dimerization is not required for mitochondrial retention of 
SO (Figure 2.18). This also confirms that the mislocalization of SO in absence of Moco is 
indeed due to the inaccessibility of Moco and not attributed to the secondary loss of 
homodimerization.  
 
 
 
 
 
 
 
 
 
 
Summarizing the hierarchically organized cellular SO assembly, the integration of 
Moco constitutes a central component, which is not only a prerequisite for efficient 
mitochondrial targeting of SO, but which also triggers all further downstream maturation 
events. Following its translocation to mitochondria, SO becomes processed by the IMP 
complex and integrates Moco to complete the import across the outer membrane and to 
prevent a backwards translocation to the cytosol. The integration of Moco constitutes a pre-
condition for dimerization and heme incorporation in vivo, both of which occur independent 
on each other and without any defined order.    
SO-G531D mitoTR merge 
HEK-293 
Figure 2.18 Dimerization independent mitochondrial localization of SO. SO-
G531D was expressed in HEK-293 cells for 48 h and visualized by anti–SO 
immunostaining (green) using confocal laser scanning microscopy. Mitochondria 
were stained with Mitotracker Red CMXRos (mitoTR). Bar, 10 µm. Cartoon illustrates 
the status of cofactor saturation and oligomerization: L, leader sequence; H, heme; 
Mo, Moco.  
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2.1.7 SO-independent population of Moco in mitochondria 
 The dissection and characterization of the mitochondrial maturation of SO was initially 
triggered by the knowledge that Moco is very unstable and consequently, the question was 
asked how this instability may align with the mitochondrial maturation of SO. The findings of 
the current study contradict a combined mitochondrial transport of SO and Moco, as Moco 
was required for trapping SO in the IMS, suggesting that a SO-Moco complex cannot cross 
the TOM complex. This however opens the question of how Moco is stabilized from its 
cytosolic synthesis until its mitochondrial association with SO. 
 In autotrophic organisms, Moco storage proteins have been identified, which permit 
stabilization and cofactor insertion into the respective apo-enzymes (Fischer et al., 2006b, 
Kruse et al., 2010). In animals, similar Moco-binding chaperons have however not been 
identified so far. To address the problem of Moco stabilization and transport to mitochondria, 
the amount of Moco in mitochondria was quantified and placed in relation to the amount of 
SO activity. This was supposed to unravel if mitochondria contain an SO independent 
population of Moco that might be in transit to SO or bound by a yet not known Moco storing 
component. For this purpose, WT-SO was purified from E. coli strain TP1000 as illustrated in 
figure 2.2 A and mitochondria were purified from murine liver by discontinuous density 
gradient centrifugation (Figure 2.19 A). SO activities of purified SO and purified mitochondria 
were determined by means of the sulfite:cytochrome c SO assay in vitro. In parallel, the 
amounts of Moco were measured in both fractions based on the nit-1 assay (Figure 2.19 B, 
C). For both, SO and mitochondria, dose dependent enzyme- and cofactor-activities were 
recorded with each of them showing a strong linear dependence. Finally, the fractional ratio 
between SO and cofactor activity was determined for the purified enzyme as well as the 
mitochondrial fraction. 
In mitochondria, the amount of Moco referred to SO was twice as high as for isolated 
SO, suggesting a significant pool of Moco not to be attributed to SO. A part of this fraction 
might represent free Moco, which is in transit to SO, or it could be derived from a hitherto 
unknown mitochondrial Moco-binding protein. However, a second mitochondrial Moco-
enzyme, the mitochondrial amidoxime-reducing component (mARC1 and mARC2), was 
recently discovered (Havemeyer et al., 2006) and most likely accounts for a major part of the 
SO-independent mitochondrial Moco activity.  
When assuming an approximately similar contribution of both mARC proteins and SO 
to the nit-1 based Moco activity, the mitochondrial Moco quantification does not promise the 
presence of major populations of free Moco in mitochondria or the presence of a Moco 
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storing component. Rather, these data suggest that SO and Moco immediately associate in 
mitochondria after their import to stabilize Moco and to prevent a reverse translocation of SO. 
  
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
Figure 2.19 Mitochondria contain an SO independent 
population of Moco. (A) Preparative purification of 
mitochondria from murine liver by discontinuous densitiy 
gradient centrifugation. Purity of the mitochondrial fraction 
was confirmed by VDAC staining for the mitochondrial 
fraction (M) and gephyrin staining for the cytosol (C) using 
Western blot. (B,C) SO- and nit-1 activities (representing 
transferable Moco) were determined for different amounts 
of purified SO (B) and mitochondrial protein extract (C). 
The ratio between the slopes of SO- and nit-1 activity were 
taken as a measure to estimate the relative contribution of 
transferable Moco in each fraction. Error bars represent 
standard deviations (n=3). 
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2.2 Mitochondrial maturation of mARC1 
In chapter 2.1.7, a significant amount of SO independent Moco was discovered in 
mitochondria. A major proportion of this fraction is presumably attributed to the recently 
discovered mitochondrial Moco proteins mARC1 and mARC2 (Havemeyer et al., 2006, 
Gruenewald et al., 2008). In respect to the novel and unexpected mechanisms examined for 
SO and to achieve a comprehensive overview of the cell biology of mitochondrial 
molybdoenzymes, the mitochondrial maturation of mARC1 was analyzed in the second part 
of this study and compared to the findings on SO.  
mARC1 was chosen as a representative for both mARC proteins, which closely 
resemble each other according to their primary structure (Figure 2.20) and secondary 
structure predictions (Mitoprot ll, Phobius, (Kyte and Doolittle, 1982)).   
 
 
 
 
 
 
 
The human MOSC1 coding sequence (NP_073583), encoding the mARC1 protein, 
was purchased from ImaGenes and amplified by PCR. Sequencing revealed two 
reproducible polymorphisms resulting in substitution of threonine 165 by alanine and 
methionine 187 by lysine. However, these polymorphisms also appear in the databases, e.g. 
as protein accessions NP073583, AAH10619 and EAW93921 and hence obviously represent 
naturally occurring polymorphisms.  
 
2.2.1 Sub-cellular localization of mARC1 
The mARC2 protein was identified and isolated from mitochondria by Havemeyer et 
al. (2006), suggesting a mitochondrial localization of mARC2. This was later confirmed by 
immunostaining in cell culture (Wahl et al., 2010) and identification of mARC2 in 
mitochondrial fractions purified from rat liver (Neve et al., 2012).  
Figure 2.20 Alignment of human 
mARC1 and mARC2. Alignment of 
human mARC1 and mARC2 was 
conducted with CLUSTALW and 
Boxshade. Residues are framed in 
black (high conservation), gray 
(moderate conservation) or white 
(no conservation). Protein 
accession numbers: NP_ 073583 
(human mARC1), NP_060368 
(human mARC2). 
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The sub-cellular localization of mARC1 was however not investigated so far, while the 
high degree of sequence similarity to mARC2 suggested a similar sub-cellular routing of both 
components. In addition, the exact localization to one of the four mitochondrial sub-
compartments was neither unambiguously shown for mARC1 nor for mARC2 so far. First, 
the sub-cellular and sub-mitochondrial localization of mARC1 was analyzed in silico with the 
aim to identify potential mitochondrial targeting signals and/or transmembrane domains 
(Claros and Vincens, 1996, Kall et al., 2004) to obtain a first indication for its localization 
(Figure 2.21). 
 
   
 
 
 
 
 
 
The analysis of the mARC1 peptide sequence revealed the presence of a potential N-
terminal mitochondrial targeting signal and a downstream transmembrane domain with high 
probability scores. The remaining part of the protein was shown to be catalytically active in 
vitro in absence of residues 1-40 (Wahl et al., 2010), but was not predicted to contain any 
further mitochondrial targeting or transmembrane motifs and was hence termed as the 
catalytical core of the enzyme.  
Considering the mitochondrial localization of mARC2 and the predictions above, 
mARC1 was expected to be directed to mitochondria too. In order to investigate its 
localization, mARC1 was fused to GFP via its C-terminus by expression of the MOSC1 
coding sequence in the pEGFP-N1 vector. Expression of mARC1-GFP in HEK-293 cells 
revealed the expected exclusive mitochondrial localization (Figure 2.22). 
 
 
 
1-20 21-40 41-337 
Predicted N-terminal mitochondrial targeting signal: 60% according to Mitoprot ll 
Predicted transmembrane domain: 99% according to Phobius 
Catalytical core of the protein (Wahl et al., 2010)   
 
 
 
Figure 2.21 Analysis and prediction of mARC1 sequence and structural motifs. The peptide 
sequence of human mARC1 was analyzed by Mitoprot ll (http://ihg.gsf.de/ihg/mitoprot.html) and 
Phobius (http://phobius.sbc.su.se/). Cartoon represents the predicted motifs with numbers 
illustrating the involved amino acids.     
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2.2.2 Localization of mARC1 within the mitochondrial compartments  
Following the confirmation of its mitochondrial targeting, the localization of mARC1 
was further investigated to finally assign it to one of the four mitochondrial subcompartments. 
Given the sequence analysis of mARC1 (Figure 2.21), a membrane association was 
predicted, which could either be the outer or inner mitochondrial membrane. However, as 
also shown for SO in the first part of this study, many mitochondrial proteins contain 
transmembrane domains in their precursor forms, which are lost during maturation in 
response to proteolytic processing, thus resulting in soluble mitochondrial proteins. The 
presence of a transmembrane domain in the precursor form does therefore not necessarily 
account for membrane spanning of the protein in its mature form.        
 To evaluate if mARC1 is either bound to a mitochondrial membrane or appears as a 
soluble protein, mitochondria were purified from HepG2 cells and mitochondrial membranes 
were separated from soluble fractions by alkaline treatment with 0.1 M Na2CO3. Thereby, 
closed vesicles or even whole organelles have been shown to be converted into open 
membrane sheets, accompanied by release of peripheral membrane- or soluble content 
proteins (Fujiki et al., 1982) . Thus, upon incubation of mitochondria in Na2CO3, centrifugation 
resulted in an accumulation of mitochondrial membrane proteins in the pellet, while soluble 
proteins of the IMS or mitochondrial matrix were supposed to remain in the supernatant. This 
was confirmed by the exclusive detection of the respective marker proteins VDAC (outer 
membrane) and COX4 (inner membrane) in the pellet fraction and by the pure accumulation 
of the soluble proteins SMAC (IMS) and HSP60 (matrix) in the supernatant (Figure 2.23). 
Following this separation protocol, endogenous mARC1 protein was only detected in the 
mARC1-GFP mitoTR merge 
HEK-293 
Figure 2.22 Mitochondrial localization of mARC1-GFP. mARC1-GFP (green) was expressed 
from pEGFP-N1 in HEK-293 cells for 48 h and visualized by means of confocal laser scanning 
microscopy. Mitochondria were stained with Mitotracker Red CMXRos (mitoTR). Bar, 10 µm. 
Cartoon illustrates the expression construct with the predicted mitochondrial targeting signal (light 
gray), the transmembrane domain (dark gray), the catalytical core (white) and GFP (green).   
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pellet fraction, demonstrating that mARC1 is membrane bound in its mature form and unlike 
SO, retaining its transmembrane domain during maturation (Figure 2.23).  
 
 
 
 
 
 
 
 
 
 Given that inner and outer membranes were not separated during Na2CO3 extraction, 
the localization of mARC1 was not finally assigned to a single mitochondrial sub-
compartment. In addition, the spatial orientation of mARC1 within the respective membrane 
was not clarified. 
 To finally resolve the exact localization and membrane topology of mARC1, external 
proteases were applied to purified mitochondria in order to interpret protein stability against 
degradation in light of protein localization. Thereby, proteins of the outer membrane 
containing a soluble cytosolic domain were supposed to be degraded, while those residing in 
the inner mitochondrial compartments were expected to be protected from protease 
accessibility. Proteins of the inner membrane exposing a soluble domain to the IMS or 
completely soluble IMS proteins should be degraded only upon specific swelling of the outer 
membrane following the application of a hypotonic solution. The inner mitochondrial 
membrane, constituting a ~2.5-fold larger surface area compared to the outer membrane in 
HeLa cells (John et al., 2005), was expected to tolerate a mild hypotonic treatment, 
suggesting that proteins of the matrix were protected from digestion even after swelling. 
 Mitochondria were purified from HeLa cells to determine the sensitivity of endogenous 
mARC1 against PK. Upon exposure of PK to intact mitochondria, the outer membrane 
protein MFN2 was degraded, while the IMS and matrix control proteins remained unaffected 
(Figure 2.24 A). Swelling of the outer membrane resulted in the additional and complete 
degradation of SMAC upon PK exposure but an ongoing stabilization of matrix-residing 
VDAC 
COX4 
SMAC 
mARC1 
P SN 
HSP60 
Figure 2.23 Association of mARC1 with 
mitochondrial membranes. Mitochondria 
were enriched from HEP-G2 cells by 
differential centrifugation and resuspended in 
0.1 M Na2CO3, pH 11.5. After 30 min 
incubation on ice, mitochondrial fractions were 
separated by centrifugation at 100.000 x g for 
60 min. Pellet (P) was directly resuspended in 
SDS loading buffer while proteins of the 
supernatant (SN) were first precipitated by 
TCA. Distribution of marker proteins and 
mARC1 was analyzed by 12% SDS PAGE 
and subsequent Western blot.      
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HSP60 was seen, demonstrating a specific swelling of the outer membrane and an intact 
inner membrane (Figure 2.24 A). Endogenous mARC1 was degraded following PK treatment 
of intact mitochondria, demonstrating its integration into the outer mitochondrial membrane 
(Figure 2.24 A).    
     
 
 
 
 
 
 
 
 
 
 
  
 
 
Notably, a proteolytic fragment of ~30 kDa of mARC1 was formed upon PK treatment 
of intact mitochondria (Figure 2.24 A), which allowed to examine the topology of mARC1 in 
the outer membrane. The truncated version may either constitute a protease protected 
fragment being exposed to the mitochondrial IMS or be exposed to the cytosol but being 
partially stable to PK application. Considering the predictions in figure 2.21 and the presence 
of the antibody epitope within residues 182-212, two orientations of mARC1 in the outer 
membrane were possible: Either, the C-terminus may be exposed to the IMS and the 20 
residues upstream of the transmembrane domain are facing the cytosol (N(out)-C(in) 
orientation), or the N-terminus may point towards the IMS while the core of the protein 
remains cytosolic (N(in)-C(out) orientation). Compared to the intensity of full-length mARC1 in 
absence of PK, the truncated fragment following PK treatment was hardly detectable. This 
36  
intact swollen 
-PK +PK +PK -PK 
matrix 
control 
(HSP60) 
IMS 
control 
(SMAC) 
OM 
control 
(MFN2) 
marc1 
28 
36  
28  
 -T         +T 
intact 
A B 
Figure 2.24 mARC1 localizes to the outer mitochondrial membrane. Mitochondria were 
enriched from HeLA cells and treated with 100 µg/ml (A) PK or (B) trypsin for 10 min at 4°C. 
Swelling occurred by incubating mitochondria in 10 mM HEPES, pH 7.4 for 10 min prior to 
protease application. After protease inactivation and TCA precipitation, mitochondrial proteins 
were loaded on a Tris/Tricine gradient SDS-PAGE (8-17.5%) with subsequent Western blotting. 
55 55 
28 28 
kDa kDa 
72 72 
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finding together with the size of the sequence preceding the transmembrane domain (2 kDa), 
which would be degraded in the event of an outside orientation, suggests that the weak 
signal at 30 kDa is derived from an incomplete degradation of the large C-terminal catalytic 
core facing the cytosol.  
To confirm the proposed N(in)-C(out) orientation of mARC1, trypsin was chosen as a 
second protease. Assuming the C-terminal core of mARC1 to be directed towards the IMS, a 
similar protease protected fragment as seen upon PK application should appear following 
trypsin treatment. Since no smaller fragment was detected after trypsin exposure (Figure 
2.24 B), the truncated fragment seen in figure 2.24 A was confirmed to form due to 
incomplete degradation by PK and demonstrated the exposure of the C-terminal core domain 
of mARC1 to the cytosol. Following trypsin application, no truncated fragments of mARC1 
were detected, although the full-length protein did not completely disappear. However, in 
analogy to the signal intensity differences between full-length and truncated mARC1 upon 
PK application, the full-length fragment appeared considerably weaker upon trypsin 
exposure, while the IMS control remained unaffected (Figure 2.24 B). This finding in 
aggregate suggests the C-terminal core of mARC1 to be tightly folded and thus to be partially 
stable to PK and trypsin mediated degradation. Taken together, both protease treatments of 
mitochondria revealed the localization of mARC1 in the outer mitochondrial membrane with 
an N(in)-C(out) orientation. 
 
2.2.3 Mitochondrial targeting of mARC1    
Upon determination of its localization and membrane orientation, the question arose of how 
mARC1 is directed to the outer mitochondrial membrane. The predictions of figure 2.21 
suggested the presence of a weak N-terminal mitochondrial targeting signal and a 
downstream transmembrane domain. To determine the functions of both motifs in 
mitochondrial translocation of mARC1, both sequence motifs were fused to GFP and 
localized in HEK-293 cells. 
First, the putative N-terminal mitochondrial targeting signal (MTS) consisting of 
residues 1-20 were fused to GFP. Expression in HEK-293 cells revealed a heterogeneous 
sub-cellular distribution of the fusion with some cells revealing a complete mitochondrial 
localization and others showing a weaker mitochondrial targeting, accompanied by a diffuse 
distribution throughout the cell (Figure 2.25 A). Statistical analyses revealed about 50% of 
the cells to display a complete and efficient mitochondrial targeting, while full-length mARC1-
GFP was exclusively targeted to mitochondria in nearly all cells (Figure 2.25 B). These 
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distributions suggested residues 1-20 to constitute a weak mitochondrial targeting signal and 
are thus in line with the predictions of MITOPROT II and the low amphipathic character with 
only two basic residues within this region.  
Given that classical MTS are usually not present in outer mitochondrial membrane 
proteins (Walther and Rapaport, 2009), the matrix-targeting ability of the N-terminal 20 
residues of mARC1 was investigated in the next step. mARC1 (Δ21-337)-GFP expressed in 
HEK-293-cells accumulated in purified mitochondria and was protected against externally 
added protease, while PK treatment after solubilization of mitochondrial membranes using 
1% Triton resulted in efficient degradation (Figure 2.25 C). Thus, residues 1-20 of mARC1 
were confirmed to constitute a classical but weak MTS, which is able to drive an attached 
marker protein to the mitochondrial matrix.  
However, mARC1 was shown not to be targeted to the mitochondrial matrix and the 
transport efficiency of the full-length protein was demonstrated to exceed the targeting 
capability of the isolated N-terminus. This suggested the presence of an additional targeting 
motif within the mARC1 protein, which would on the one hand ensure a complete 
mitochondrial localization and on the other hand induce sorting of mARC1 to the outer 
mitochondrial membrane. 
In order to analyze the combined impact of N-terminal targeting signal and the 
downstream transmembrane domain for mitochondrial targeting, residues 1-40 of mARC1 
were fused to GFP and expressed in HEK-293 cells. In contrast to the isolated N-terminal 
targeting signal, co-expression with the transmembrane domain triggered GFP translocation 
to mitochondria as efficiently as it was seen with the full-length mARC1 protein (Figure 2.25 
D). The reconstitution of the entire mitochondrial translocation upon fusion of the 
transmembrane domain thus indicated a function of the latter in mitochondrial transport of 
mARC1.  
Consistently, it could be confirmed that residues 21-40, when fused to GFP, were 
sufficient to mediate a complete mitochondrial localization, demonstrating the 
transmembrane domain to constitute a mitochondrial targeting signal on its own (Figure 2.25 
E). Thus, the mARC1 N-terminal domain contains two autonomous motifs triggering 
mitochondrial sorting of mARC1.   
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Finally, the catalytic core of mARC1 was fused to GFP and expressed in HEK-293 
cells. No mitochondrial localization was observed and instead, the construct was diffusely 
Figure 2.25 Mitochondrial 
targeting motifs of mARC1. 
(A) Sub-cellular localization of 
mARC1(Δ21-337)-GFP. (B) 
Statistical quantification of 
mitochondrial localization of 
mARC1(Δ21-337)-GFP 
compared to mARC1-GFP. 
Cells revealing a complete 
mitochondrial localization of the 
respective construct were 
counted and depicted as 
percent. Each 50 cells were 
analyzed, error bars represent 
standard deviations (n=3). (C) 
mARC1(Δ21-337)-GFP was 
expressed in HEK-293 cells for 
48 h. Mitochondria were 
enriched and treated ± 1% 
Triton for 10 min prior to the 
addition of 100 µg/ml PK for 10 
min at 4°C. After protease 
inactivation and TCA 
precipitation, mitochondrial 
proteins were loaded on a 12% 
SDS-PAGE with subsequent 
Western blotting. (D) Sub-
cellular localization of 
mARC1(Δ41-337)-GFP. (E) 
Sub-cellular localization of 
mARC1(Δ1-20,Δ41-337)-GFP. 
(F) Sub-cellular localization of 
mARC1(Δ1-40)-GFP. 
Constructs of (A), (D), (E) and 
(F) were expressed in HEK-293 
cells for 48 h and pictures were 
obtained by means of confocal 
laser scanning microscopy. 
Mitochondria were stained with 
Mitotracker Red CMXRos 
(mitoTR). Bar, 10 µm. 
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distributed within the entire cell (Figure 2.26 F). In conclusion, residues 41-337 of mARC1 do 
not contain any further mitochondrial targeting signals, suggesting that the mitochondrial 
localization of mARC1 is solely mediated by its N-terminal domain.  
Thereby, mARC1 is classified as a novel signal-anchored protein of the outer 
mitochondrial membrane, which share N-terminal transmembrane domains simultaneously 
constituting membrane anchor and targeting signal (Shore et al., 1995). 
In analogy to mARC1, SO likewise contains an N-terminal mitochondrial targeting 
motif. As illustrated in the first part of this study, the SO targeting signal itself was however 
not sufficient for mitochondrial localization, but Moco was in addition required for 
mitochondrial trapping of SO. To determine the role of Moco for the mitochondrial targeting of 
mARC1, the latter was expressed in MOCS1-deficient fibroblasts, in which SO showed a 
diffuse distribution within the cell (Figure 2.3 D). To allow immunodetection in cultured cells, 
mARC1 was expressed with a C-terminal myc-tag. In contrast to SO, mARC1 did not require 
Moco for its mitochondrial localization, but was efficiently targeted even in absence of its 
cofactor (Figure 2.26).  
 
 
 
 
 
 
 
 
 
 
 The Moco independent mitochondrial localization of mARC1 was expected in respect 
to its association with a mitochondrial membrane. The non-mitochondrial distribution of 
Moco-deficient SO was based on its solubility and could be rescued by artificial attachment 
of the protein to the inner mitochondrial membrane. Therefore, a similar demand on Moco for 
Moco-deficient fibroblasts 
mARC1-myc mitoTR merge 
Figure 2.26 Moco independent mitochondrial targeting of mARC1. mARC1-myc was expressed 
in MOSC1-deficient fibroblasts for 48 h and visualized by anti–myc immunostaining (green) using 
confocal laser scanning microscopy. Mitochondria were stained with Mitotracker Red CMXRos. Bar, 
10 µm. Cartoon illustrates the expression construct with the predicted mitochondrial targeting signal 
(light gray), the transmembrane domain (dark gray), the catalytical core (white) and the C-terminal 
myc-tag (black).   
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mitochondrial retention of mARC1 is not required and its N-terminal targeting motifs are 
sufficient for accurate mitochondrial localization. 
 
2.2.4 Mechanims of mitochondrial mARC1 import 
After identification and dissection of the internal motifs responsible for mitochondrial 
localization of mARC1, the overall import mechanism was finally characterized in vitro to 
achieve a comprehensive understanding of the mitochondrial maturation of mARC1. The 
amino terminal 20 residues of mARC1 constitute a classical but weak N-terminal MTS. 
These motifs are usually cleaved after import by mitochondrial peptidases, resulting in N-
terminal truncation of the respective mature proteins. In addition, predictions by MITOPROT 
II (Claros and Vincens, 1996) suggested the presence of a potential peptidase cleavage site 
at position 44. In order to probe a potential mitochondrial processing of mARC1, the apparent 
molecular weight of in vitro translated mARC1 was compared to that of mARC1 synthesized 
in cells using SDS-PAGE and Western blot analysis, assuming that processing will result in a 
reduced size as compared to the in vitro synthesized precursor protein. For this purpose, 
mARC1 was translated in a cell free reticulocyte lysate system and labeled by 35S-methionine 
incorporation. Thereby, untagged mARC1, containing five methionine residues, and myc-
tagged mARC1, containing two additional methionines within the tag, were synthesized to 
compare their radioactive signal intensities (Figure 2.27). 
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Figure 2.27 In vitro translation of 
mARC1. mARC1 (A) and mARC1-myc (B) 
were translated in a cell free reticulocyte 
lysate system. Radioactive labeling 
occurred by integration of 
35
S-methionine 
during translation. In each lane, 2 µl of 
lysate were loaded on a 12% SDS gel and 
detected by subsequent Western blot 
analysis. The membrane was exposed to 
an X-ray film overnight before 
development of signals. Arrows point to 
the respective mARC1 variants at the 
expected sizes.  
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 The analysis of the in vitro translation revealed a considerably stronger intensity of 
myc-tagged mARC1 compared to the untagged variant, but also depicted more impurities, 
presumably representing premature translation termination or alternative sites of translation 
initiation. However, in both cases mARC1 was predominantly synthesized as the expected 
full-length precursor. The significantly bigger size of the myc-tagged precursor is attributed to 
a long C-terminal extension of this variant, which harbors a linker region and the myc-tag.     
 To investigate a possible mitochondrial processing of mARC1, untagged and myc-
tagged mARC1 were comparatively expressed in HEK-293 cells. The molecular weights of 
both variants were each compared to the respective in vitro translated precursors by Western 
blotting and revealed similar sizes of in vitro and in vivo expressed mARC1 (Figure 2.28). 
Thus, mARC1 is not processed in mitochondria and retains both identified targeting motifs 
during maturation.  
  
 
 
 
 
 
 
Detection of successful in vitro import into mitochondria is usually performed based 
on protection to external protease application or based on processing and truncation of the 
imported precursor. However, as mARC1 is exposed to the cytosol and not processed 
following successful import, mitochondrial translocation was monitored based on the 
proposed ability of mARC1 to form a complex with its electron donors cytochrome b5 
reductase and cytochrome b5 in the outer mitochondrial membrane.  
First, mARC1 complex formation was determined by expression of the protein in 
HEK-293 cells. Mitochondria were purified and extracts were loaded on Blue Native-PAGE 
(BN-PAGE) to characterize mARC1 oligomerization in the outer membrane and to thus 
define the native mARC1 protein pattern to be expected upon successful in vitro import. 
Western blot detection of the C-terminal myc-tag revealed mARC1 to reside in three high 
oligomeric protein complexes each of which of more than 350 kDa in size, while mitochondria 
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Figure 2.28 mARC1 is not processed. mARC1 
and mARC1-myc were translated in vitro as 
described in figure 2.27 and in parallel expressed in 
HEK-293 cells for 48 h. Each 4 µl lysate and 30 µg 
cell extract, respectively, were loaded on a 12% 
SDS gel with subsequent Western blotting. In vitro 
translated (IVT) mARC1 was detected by overnight 
exposure to an X-ray film, while mARC1 expressed 
in vivo was subsequently detected by anti-mARC1 
antibody staining. Images of both detections were 
merged for final size comparisons. 
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purified from untransfected cells did not show any of these signals, thus ensuring antibody 
specificity and successful transient expression of mARC1 (Figure 2.29 A).    
Successful in vitro import of mARC1 was expected to reproduce the complexes seen 
after cellular expression of the protein in HEK-293 cells. The incubation of in vitro 
synthesized precursors with purified mitochondria indeed resulted in a time-dependent 
formation of similar high-oligomeric structures, suggesting successful import of mARC1 
(Figure 2.29 B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These complexes were also detected upon depletion of the membrane potential by 
valinomycin, demonstrating, as usual for proteins residing in the outer mitochondrial 
Figure 2.29 Mitochondrial in vitro import of mARC1. (A) Mitochondria were enriched from HEK-
293 cells expressing mARC1-myc or from untransfected cells and mitochondrial proteins were 
extracted from enriched mitochondria by detergent application. Proteins were loaded on a 4-16% 
Bis-Tris acrylamide gradient BN-PAGE with subsequent western blotting. mARC1-myc containing 
complexes were detected by anti-myc antibody detection. Arrows point at high molecular weight 
bands that were also identified upon in vitro import of mARC1-myc in (B). (B) Import of in vitro 
translated mARC1-myc occurred into mitochondria purified from HEK-293 cells. Import reactions 
were performed at 37°C and stopped after 5, 15 or 45 min. Membrane potential deficient 
mitochondria (-Ψ) were obtained by the addition of 20 µg/ml valinomycin prior to the import 
reaction. After import, mitochondrial proteins were extracted by detergent application and 
subsequently loaded on a 4-16% Bis-Tris acrylamide gradient BN-PAGE, followed by western 
blotting. Radioactive signals were detected by 2 weeks exposure to an X-ray cassette. 
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membrane (Walther and Rapaport, 2009), that an intact membrane potential is not required 
for mitochondrial transport of mARC1. Since the general function of N-terminal MTS is based 
on an intact membrane potential, the membrane potential independent integration of mARC1 
into the outer mitochondrial membrane indicated that the MTS does not contribute to mARC1 
targeting in a conventional manner. Depletion of external ATP significantly decreased the 
efficiency of complex formation, illustrating that extramitochondrial ATP is required for 
mARC1 assembly into high oligomeric structures. The specificity of complex formations was 
ensured by application of mARC1-precursors in absence of mitochondria, which did not 
result in any detectable mARC1-specific oligomers (Figure 2.29 B).  
In summary, mARC1 is directed to the outer mitochondrial membrane based on its 
bipartite N-terminal targeting motif. With the transmembrane domain constituting the critical 
signal for correct sorting, mARC1 is a novel member of the small family of signal-anchored 
outer mitochondrial membrane proteins. The membrane potential independent but ATP 
requiring mechanism of membrane insertion results in an N(in)-C(out) orientation of mARC1 
and its final integration into high-oligomeric protein complexes 
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3 Discussion 
3.1 Maturation of mammalian SO 
3.1.1 Moco-dependent mitochondrial localization of SO 
The formation of functional SO implies a complex and highly organized multi-step maturation 
procedure. The transport of SO and Moco to mitochondria, the mitochondrial processing of 
SO, the integration of Moco and heme as well as homodimerization need to occur in a 
defined order to ensure efficient SO maturation.  
In the current study, Moco was identified as a key component of SO assembly, which 
does not only ensure mitochondrial localization, but also heme integration and dimerization. 
In absence of Moco, about 70% of SO was not found in mitochondria but instead 
mislocalized to the cytosol, although processing of the N-terminal targeting peptide revealed 
that the protein was initially imported into mitochondria. Since anchoring of SO in the inner 
mitochondrial membrane resulted in mitochondrial localization in absence of Moco, unfolded 
and Moco-free SO was proposed to undergo a passive backshift to the cytosol.  
Cofactor-dependent mitochondrial localization has been described earlier for 
cytochrome c, which requires the heme cofactor as well as the heme integrating cytochrome 
c heme lyase to ensure efficient localization in the mitochondrial IMS (Dumont et al., 1988, 
Nargang et al., 1988). Similarly, IMS proteins of the Mia40-dependent import pathway have 
been found outside of mitochondria in absence of Mia40 (Chacinska et al., 2004). Such a 
folding-mediated trapping of small IMS proteins has also been described for Tim13, which 
contains four conserved cysteine residues binding a zinc ion as a cofactor. Application of 
external chelators after in vitro import of Tim13 to mitochondria resulted in re-appearance of 
Tim13 outside of mitochondria and thus in reverse translocation after zinc loss and unfolding 
of the protein (Lutz et al., 2003). These retrograde movements across the TOM complex are 
possible in respect to the small size of the respective proteins on the one hand and 
considering that folding depicts the only vectorial driving force towards the IMS on the other 
hand. The TOM complex is known to be a passive translocation channel undergoing only 
weak interactions with the passing proteins (Ungermann et al., 1994). Unfolded small 
proteins therefore tend to bi-directionally diffuse through the TOM complex and thus do not 
achieve efficient mitochondrial targeting. However, all of the described proteins lack N-
terminal pre-sequences, become imported independently of the membrane potential and 
therefore belong to IMS proteins that require so-called folding-trap mechanisms for 
mitochondrial import (Neupert and Herrmann, 2007).  
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SO was in contrast shown to contain a bipartite N-terminal targeting signal and its 
molecular weight of more than 50 kDa as a monomer considerably exceeds those of the 
small IMS proteins. Furthermore, its import was shown in a previous study to be based on 
the classical pre-sequence pathway, which requires ATP and an intact membrane potential 
across the inner mitochondrial membrane (Ono and Ito, 1984). Unlike small IMS proteins, SO 
therefore receives an additional driving force for mitochondrial sorting based on its N-terminal 
targeting signal. Thus, SO combines the N-terminal bipartite targeting peptide with the ATP- 
and membrane potential-dependent translocation across the inner mitochondrial membrane 
of the members of the pre-sequence pathway with a cofactor-dependent trapping mechanism 
known for members of the folding-trap/Mia40 import pathway. 
 N-terminal targeting signals are essential elements triggering mitochondrial transport 
and depletion of the latter from the respective proteins usually prevents mitochondrial 
localization. In most cases, these motifs are not only essential, but also sufficient for 
targeting (Baker et al., 2007). The N-terminal domain of SO is also required for mitochondrial 
routing and its depletion results in cytosolic accumulation of the precursor. However, the N-
terminal sorting signal of SO was not sufficient for mitochondrial localization, given that the 
integration of Moco was additionally required for mitochondrial retention. Absence of Moco 
finally resulted in a backwards translocation to the cytosol.  
Other exceptions in which MTS are not entirely sufficient for mitochondrial sorting are 
highlighted by a number of proteins with dual subcellular localizations. A single translation 
product of the mitochondrial cysteine desulfurase Nfs1 was shown to localize to mitochondria 
and the nucleus (Naamati et al., 2009). The Nfs1 distribution mechanism was determined to 
require at least partial mitochondrial entry of all precursors. The authors proposed minor 
nuclear import, which was suggested to occur after reverse translocations of Nfs1 sub-
populations to the cytosol. Similarly, eclipsed amounts of mitochondrial aconitase were 
identified in the cytosol and were suggested to appear upon reverse translocation from 
mitochondria (Regev-Rudzki et al., 2005). In addition, a small fraction of the cytosolic 
signaling protein Ecsit was found in mitochondria, while the mechanism of its dual distribution 
remained uncharacterized (Vogel et al., 2007). The probably best understood mechanism of 
reverse translocation-mediated dual localization of a protein is displayed by fumarase. 
Fumarase is a mitochondrial matrix protein becoming imported based on a conservative N-
terminal targeting motif. A fraction of fumarase was shown to move in a retrograde fashion to 
the cytosol following its mitochondrial processing, thus resulting in a dual localization of the 
protein (Knox et al., 1998). This particular proportion, destined as the cytosolic pool, 
therefore does not completely cross the TOM complex while being in transit to the 
mitochdondria, because a C-terminal folding event outside of mitochondria constitutes a 
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reverse driving force towards the cytosol (Sass et al., 2001). These described examples 
resemble SO in a way, that all proteins contain N-terminal MTS, which not in all cases result 
in mitochondrial localization but permit reverse translocations to the cytosol. In contrast to 
SO, these retrograde movements however depict a cellular instrument to achieve dual 
subcellular localization of a single translation product. Further, folding mediated by Moco 
integration essentially contributes to mitochondrial import of SO, while C-terminal folding of 
fumarase constitutes an active driving force for backwards translocation to the cytosol. 
The reverse translocation in absence of Moco indicated an active function of Moco for 
the mitochondrial import of SO. Consistently, a chimeric SO-TIM50 variant anchored in the 
inner mitochondrial membrane was not completely translocated across the TOM complex, 
but the C-terminal domain partially remained exposed to the cytosol if Moco was not present. 
The incorporation of Moco in contrast resulted in folding of the protein and a completion of 
the transport across the TOM complex. Therefore, two distinct mechanisms appear to drive 
SO translocation across the outer mitochondrial membrane: The N-terminal targeting signal 
directs the SO N-terminus across the outer and inner mitochondrial membrane, while the C-
terminus is not imported and remains exposed to the cytosol. The integration of Moco is 
required as a second translocation mechanism to pull the entire protein across the outer 
mitochondrial membrane. In absence of Moco, SO apparently undergoes bidirectional 
Brownian thermal motion upon cleavage by the IMP the complex, resulting in reverse 
translocation of a major population of SO. Integration of Moco seems to ratchet the Brownial 
motion and to drive translocation of the C-terminal domain across the outer membrane. Still, 
in absence of Moco, 30% of SO remained mitochondrial and was not re-exported to the 
cytosol. While the N-terminal part of SO is actively targeted towards the mitochondrial matrix, 
the remaining part of the protein requires Moco integration to shift the equilibrium of passive 
diffusion towards the IMS to complete translocation. In absence of Moco and after cleavage 
by the IMP complex, no direction is favored and SO may move towards both the cytosol and 
IMS. The mitochondrial fraction of Moco-deficient SO may therefore arise from SO arrested 
in the TOM complex and another subpopulation which randomly enters the IMS. The majority 
of SO however undergoes a complete reverse translocation to the cytosol, although not 
triggered by an apparent driving force as described for fumarase (Sass et al., 2001). The 
cytosolic accumulation of SO may occur since its N-terminal targeting signal is processed in 
mitochondria and once SO has left the TOM complex in the reverse direction, the signal for 
re-entering mitochondria is lost. Furthermore, diffusion towards the cytosol may be favored in 
respect to the narrow space between outer and inner boundary membrane, which might 
interfere with passive protein entry, as also observed for small IMS proteins mainly 
accumulating outside of mitochondria if not folded (Lutz et al., 2003, Chacinska et al., 2004).    
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The bipartite mechanism of mitochondrial import of SO resembles the translocation of 
yeast cytochrome b2 (Glick et al., 1993). In analogy to SO, cytochrome b2 contains a bipartite 
N-terminal targeting signal and is cleaved by IMP1 to generate a soluble IMS protein 
(Nunnari et al., 1993). Cytochrome b2 contains a non-covalently bound heme as a single 
cofactor, which is required during import to pull the C-terminal domain of the protein across 
the outer mitochondrial membrane. Prevention of heme integration and thus of folding of the 
heme domain resulted in an arrest of translocation within the TOM complex, while the 
incorporation of heme was required to shift the Brownian thermal motion of the C-terminal 
domain towards the IMS (Esaki et al., 1999). The mitochondrial maturation of SO and 
cytochrome b2 therefore reveal striking mechanistic parallels, with each depending on two 
distinct events, both being essential for the efficient completion of protein translocation 
towards the IMS.  
 
3.1.2 The SO import vs. other proteins with bipartite targeting signals  
The Moco-dependent mitochondrial maturation of SO depicts a novel connection between 
the classical pre-sequence pathway and folding-trap mechanisms of small IMS proteins. 
Both, N-terminal pre-sequence and cofactor-mediated trapping are required to ensure 
comprehensive mitochondrial localization of SO. As described above, a related mechanism 
was also found for yeast cytochrome b2, which resembles SO in respect to its analogous 
bipartite N-terminal targeting signal. However, such a demand on these two distinct 
mechanisms triggering a complete translocation towards the mitochondrial IMS is not 
common to all proteins containing bipartite N-terminal targeting signals, but rather unique to 
SO and cytochrome b2 as known so far.  
Therefore, the question arises of why these two proteins require two distinct 
mechanisms for targeting, while other proteins containing bipartite targeting signals are 
efficiently targeted to mitochondria solely based on their N-terminal targeting signals. 
Most IMS proteins are small and are targeted according to the folding trap pathway, 
while the sub-group of soluble proteins with bipartite targeting signals is rather small. Apart 
from SO and cytochrome b2 (Cytb2), the pro-apoptotic protein SMAC/DIABLO (Burri et al., 
2005), the soluble fraction of the dual localized yeast Mcr1 (Haucke et al., 1997), the 
apoptotic DNase endonuclease G (EndoG) (Ohsato et al., 2002, Neupert and Herrmann, 
2007) as well as the heme-synthesizing coproporphyrinogen oxidase (CPO) (Grandchamp et 
al., 1978, Neupert and Herrmann, 2007) are known IMS proteins with bipartite N-terminal 
targeting signals.  
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To address why cytochrome b2 and SO may need additional cofactor integration for 
mitochondrial transport, both proteins were compared to the pool of other proteins containing 
bipartite targeting signals. The demand on cofactor integration may be based on two 
conceivable reasons: First, the MTS of SO and cytochrome b2 may be considerably weaker 
than those of the other proteins, suggesting that the driving force exerted by the MTS might 
not be strong enough to complete translocation of the whole protein across the outer 
membrane. Second, the size of SO and cytochrome b2 might be larger, resulting in an 
incomplete translocation in spite of a functional mitochondrial targeting signal. Therefore, 
both parameters were compared among all mentioned proteins with bipartite targeting 
signals (Table 3.1). The matrix targeting capability of the proteins were thereby analyzed by 
MITOPROT II and the obtained percentages expressing the probability of matrix targeting 
were taken as an indicator for the strength of the N-terminal targeting signal (Dinur-Mills et 
al., 2008). While SO was predicted to contain a MTS with more than 90% probability, the 
MTS of cytochrome b2 revealed 83% prediction. SO and cytochrome b2 thereby achieve 
higher matrix localization scores than EndoG, Mcr1 and CPO. Since the MTS of all the 
compared proteins are sufficient for mitochondrial targeting as known so far, the scores 
obtained for SO and cytochrome b2 suggest that their MTS are likewise strong enough to 
permit complete mitochondrial import.   
 
 
 
 
 
 
 
Notably, SO and cytochrome b2 reveal a considerably larger size in their mature form 
compared to other proteins containing bipartite N-terminal targeting signals. These 
differences of more than 20 kDa could explain, why SO and cytochrome b2 may need 
cofactor integration as an additional driving force for translocation across the TOM complex. 
Since a hydrophobic stop-transfer signal arrests MTS-mediated translocation across the TIM 
complex, a long C-terminal end of the protein may not completely enter the IMS but remain 
exposed to the cytosol. Shorter C-termini may in contrast be completely imported into the 
IMS before translocation becomes arrested. The import of SO and cytochrome b2 may 
therefore represent a mechanism two ensure translocation of bigger soluble proteins into the 
Protein MTS prediction (%)1 Mature protein size (kDa) species 
SO 92.6 53 mouse 
Cytb2 82.6 57 yeast 
SMAC 98.7 24 mouse 
EndoG 76.3 27 human 
Mcr1 75 27 yeast 
CPO 60 34 human 
Tab. 3.1 Comparison of IMS proteins with bipartite N-terminal targeting signals 
1
Predictions according to Mitoprot II (Claros and Vincens, 1996) 
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narrow IMS. As the comparisons of table 3.1 and the resulting hypothesis are based on only 
few known examples of proteins with bipartite targeting signals, an experimental verification 
would be essential and could be achieved by artificially elongating the C-terminus of 
SMAC/DIABLO, for instance. According to the outlined theory, increasing the size of the 
mature protein to more than 50 kDa should interfere with complete translocation across the 
TOM complex and result in partial C-terminal exposure to the cytosol.     
 The principle stated above does however not apply to proteins with bipartite targeting 
signals, which do not become cleaved but remain anchored in the inner mitochondrial 
membrane. Yeast Yme2 contains an N-terminal targeting signal followed by a single 
transmembrane domain and is therefore expected to be imported by a similar stop transfer 
mechanism (Neupert and Herrmann, 2007). The IMS domain of the protein thereby reveals a 
molecular weight of ~60 kDa. However, Yme2 is not soluble and anchoring in the inner 
membrane accompanied by lateral diffusion of the transmembrane domain may constitute a 
driving force towards the IMS, which may be analogous to cofactor mediated trapping of 
large soluble IMS proteins. Thus, also larger inner membrane proteins may well be imported 
based on this anchor-diffusion model (Glick et al., 1991). Similarly, the anchored SO-TIM50 
chimera revealed only minor C-terminal exposure to the cytosol in absence of Moco. 
Anchoring seems in this case to replace cofactor triggered translocation across the outer 
membrane.  
 Taken together, mitochondrial proteins exposing large IMS domains and containing 
bipartite N-terminal targeting signals appear to require two distinct mechanisms for efficient 
mitochondrial import. The N-termini of these proteins are translocated based on N-terminal 
targeting signals, while the C-terminal domains seem to require additional driving forces for 
transfer across the TOM complex. The C-termini of integral inner membrane proteins may be 
imported based on the anchor-diffusion model, as already proposed by Glick et al. (1991), 
while large soluble IMS proteins seem to require cofactor-mediated folding for a vectorial 
transfer of the C-terminus across the outer membrane.  
 
3.1.3 The role of heme and dimerization in the mitochondrial maturation of SO 
In spite of several striking similarities between the assembly mechanisms of SO and 
cytochrome b2, the maturation of SO is more complex, which additionally requires integration 
of a second cytochrome b5 type heme cofactor. Therefore, and considering the related 
function of heme in the maturation of cytochrome b2, the question arose of why only Moco 
but not heme can mediate the second part of SO import by trapping the protein in the IMS.  
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Integration of heme cofactors result in folding of the respective domains and have been 
shown to contribute to trapping of cytochrome c (Dumont et al., 1988) and cytochrome b5 
(Esaki et al., 1999) in the mitochondrial IMS. These data suggest that following heme 
incorporation into proteins, reverse translocations to the cytosol are prohibited.  
Nevertheless, SO was not trapped in mitochondria when Moco was not present, 
allowing the conclusion that heme integration could not rescue SO localization or that heme 
integration was prohibited. Considering the observations of Esaki et al. (1999), the principle 
capability of the SO heme cofactor to mediate trapping was analyzed. The isolated heme 
domain was only efficiently targeted to mitochondria upon heme integration, while heme 
depletion resulted in a diffuse cellular distribution of the construct. The mechanisms 
triggering the non-mitochondrial localization of the heme domain in absence of its cofactor 
may follow the cofactor-dependent mitochondrial trapping of the small IMS proteins. After 
processing, the isolated heme domain accounts for a molecular weight of ~10 kDa and 
seems, in analogy to the small IMS proteins, to bi-directionally diffuse through the TOM 
complex if not folded. These observations confirmed that following heme-mediated folding of 
the SO heme domain, a reverse translocation to the cytosol is prevented. Thus, upon 
hypothetical integration of heme into the N-terminal heme domain in absence of Moco, at 
least the heme domain of full-length SO should remain mitochondrial. The diffuse cellular 
distribution of SO in absence of Moco in contrast suggests that SO entirely leaves 
mitochondria if Moco is not present. 
In conclusion, the heme cofactor seems not to be efficiently incorporated into SO in 
vivo if Moco is not present and therefore does not rescue the mitochondrial localization of 
SO. In contrast to the in vivo situation in HEK cells, overexpression of Moco-deficient SO in 
E. coli revealed the incorporation of heme, demonstrating that heme integration is not strictly 
dependent on prior Moco incorporation. However, recombinantely expressed SO is 
accumulating in E. coli and therefore constantly exposed to heme integration. In contrast, 
when expressed in mammalian cells, the reverse translocation from mitochondria in absence 
of Moco kinetically competes with heme integration. Assuming that heme integration is a 
kinetically less favored event in absence of Moco, SO would integrate heme in E. coli due to 
high expression and accumulation, but would not incorporate heme in vivo where the reverse 
translocation occurs presumably faster than heme integration. Given the fact that 30% of the 
Moco-deficient SO was located to mitochondria, heme integration might have occurred in 
those cases preventing the retrograde backshift of a fraction of SO in absence of Moco. 
Therefore, the presence of the apo-SO Moco binding domain appears to slow down heme 
integration significantly and ultimately Moco insertion becomes the rate limiting step in the 
overall SO maturation process. 
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Apart from prosthetic groups, oligomerization events are also conceivable to 
contribute to trapping mechanisms of proteins in the IMS. Given the fact that a monomeric 
variant of SO localized to mitochondria, oligomerization does not seem to be required for 
mitochondrial retention of SO. Since Moco-deficient SO mainly forms monomers, Moco 
integration apparently presents a prerequisite for dimerization, thus inducing structural 
rearrangements of the dimerization domain allowing oligomerization. In contrast to heme 
integration, which can occur upon overexpression in E. coli in absence of Moco, efficient 
dimerization appears to be strictly dependent on prior Moco integration.  
The overall in vivo maturation of SO therefore is subject to a molecular hierarchy. The 
integration of Moco thereby occurs first, which is in line with the crystal structure of holo SO, 
demonstrating that Moco is deeply buried within the protein (Kisker et al., 1997). In this 
respect, Moco was previously proposed to be either incorporated prior to or during 
completion of SO folding and dimerization (Mendel, 2007). Upon Moco binding, integration of 
heme and dimerization can occur efficiently, while both events do not seem to depend on 
each other, since heme deficient SO revealed adequate dimerization and monomeric SO 
displayed regular heme integration.     
 
3.1.4 Processing of SO in the IMS 
Following N-terminal translocation across the inner membrane, SO was shown in this study 
to be processed by the IMP complex in order to become released as a soluble protein. This 
was determined by shRNA mediated knockdown of the IMMP1 gene product and co-
expression of SO in HEK-293 cells. Considering the half-life of endogenous SO being 
approximately four days (Ono and Ito, 1982a), the effect of 24 h IMP1 downregulation were 
only apparent upon the transient expression of SO following transfection.   
SO far, not many other mitochondrial proteins are known to be processed by this 
protease and all hitherto characterized substrates were identified in S. cerevisiae. The only 
identified yeast substrates are the mitochondria encoded Cox2, which is co-translationally 
inserted into the inner membrane by Oxa1 prior to Imp-mediated processing (Ott and 
Herrmann, 2010), nuclear encoded Mcr1 (Hahne et al., 1994), Gut2 (Esser et al., 2004), 
cytochrome c1 and cytochrome b2 (Nunnari et al., 1993). In addition, the murine variant of 
SMAC/DIABLO was shown to be processed by the IMP complex in S. cerevisiae (Burri et al., 
2005). 
 In the current study, the identification of SO as a novel substrate of the IMP complex 
occurred in a mammalian system and therefore represents the first experimental confirmation 
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of a functional IMP complex in mammals. IMP1, which was shown by downregulation of its 
mRNA to mediate processing of SO, does not follow obvious consensus motifs for cleavage 
(Chen et al., 1999). The precise IMP cleavage site within the SO protein is unclear, while the 
unprocessed SO-TIM50 chimera suggested processing to occur between residues 66-86. 
Further, the crystallization of mature chicken SO purified from liver tissue revealed residues 
1-80 not to be present in the mature protein, suggesting IMP cleavage to take place adjacent 
to residues 80 of chicken SO (Kisker et al., 1997). 
 Cytochrome b2 was shown to be processed in two steps, with MPP mediated 
cleavage of the matrix exposed N-terminus preceding IMP cleavage in the IMS (Gasser et 
al., 1982). Such a double cleavage was suggested to occur for all proteins with bipartite 
targeting signals (Schmidt et al., 2010) and may also apply for SO maturation. This could be 
further investigated by purification of MPP and incubation with SO precursors in vitro or by 
shRNA-mediated downregulation of MPP in cell culture in order to monitor potential changes 
of the SO processing pattern. 
 Efficient IMP cleavage of cytochrome b2 is dependent on a correctly folded heme 
domain that is stabilized by the bound cofactor (Glick et al., 1993). IMP-mediated processing 
of SO in contrast does not seem to require cofactor-mediated folding but can occur before 
Moco integration into SO, since SO was released as a soluble protein from mitochondria in 
absence of Moco. Thus, integrating IMP cleavage into the hierarchy of SO assembly, Moco 
integration and processing seem to occur independent on each other. 
 
3.1.5 Moco stabilization 
As isolated Moco has been shown to be intrinsically instable (Deistung and Bray, 1989), its 
cellular transport and stabilization following its cytosolic synthesis has been subject to 
intensive debates in the past (Hille, 2002, Schwarz and Mendel, 2006, Mendel, 2007). Fast 
association of Moco with either its apo-proteins or stabilizing Moco binding proteins has been 
proposed and could occur co-translationally in the cytosol (Schwarz et al., 2009). Co-
translational integration into the family of mitochondrial Moco-enzymes would however 
interfere with mitochondrial transport and consistently, the findings of the current study 
support a selective association of SO and Moco in the mitochondrial IMS. The functional 
trapping of SO demonstrates that Moco associated with SO does not cross the TOM channel 
and remains inside mitochondria. In addition, the folded monomeric Moco-containing domain 
of SO comprises a diameter of approximately 4 nm (Kisker et al., 1997), while the diameter 
of the open pore of the TOM complex accounts for a maximum of only 2 nm (Ahting et al., 
1999). A combined import of any Moco–SO complex across the TOM pore therefore appears 
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to be very unlikely, but SO and Moco rather seem to enter mitochondria independently. In the 
cytosol, Moco association with SO presumably is prohibited by association of chaperones to 
SO, which keep the latter in an import competent state. This further raises the question of 
how Moco is stabilized during its transport to mitochondria. In the green algae 
Chlamydomonas reinhardtii, a Moco carrier protein was identified (Fischer et al., 2006a) and 
a novel class of Moco-binding proteins was recently reported for Arabidopsis thaliana (Kruse 
et al., 2010). Similar Moco-binding chaperons, which stabilize Moco and promote Moco 
insertion into apo–proteins, were however not found in animals so far. Alternatively, Moco 
may be stabilized in the reducing environment of the animal cell for some time and thereby 
passively diffuse into the mitochondrial IMS.  
The quantitative analysis of the mitochondrial Moco population revealed an 
uncharacterized pool of SO-independent Moco, which approximately corresponded to the 
same amount of Moco as bound by SO. Both mARC proteins are expected to contribute 
significantly to this population of Moco, thus potentially indicating mitochondria to lack further 
abundant Moco proteins or significant populations of free Moco. This in turn suggests a rapid 
association of Moco with its mitochondrial apo-enzymes and is in line with the proposed 
immediate association of SO and Moco to ensure trapping in the IMS. 
 
3.1.6 Assembly and maturation of SO    
The findings of the first part of this study in aggregate allowed to build a model summarizing 
the complex mitochondrial maturation of SO (Figure 3.1). SO and Moco are synthesized in 
the cytosol and become transferred to mitochondria separately.  
While Moco may enter the IMS by passive diffusion through porins of the outer 
mitochondrial membrane, SO is actively imported to mitochondria based on its bipartite N-
terminal targeting signal. The ATP- and membrane-potential dependent translocation across 
the inner mitochondrial membrane is arrested by a hydrophobic stop-transfer motif 
downstream of the N-terminal matrix signal (Ono and Ito, 1982b).  
SO is subsequently released from the inner membrane by IMP mediated cleavage to 
generate a soluble protein. In absence of Moco, this results in reverse translocation of SO to 
the cytosol, as SO translocation across the outer membrane is not completed if Moco is not 
present. Alternatively, binding of Moco initiates SO folding and constitutes an additional 
driving force for a vectorial translocation of the SO C-terminal domain across the TOM 
complex. Following Moco insertion into SO and completion of import, heme integration and 
homodimerization occur independent on each other to accomplish the hierarchical assembly 
of SO.  
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3.2 Sub-cellular localization and sorting of human mARC1 
3.2.1 Localization of mARC1 to the outer mitochondrial membrane 
In a screen for the missing third component of the pro-drug activating N-reductive system, 
mARC2 was identified as the fifth eukaryotic Moco-containing enzyme (Havemeyer et al., 
2006). It was isolated from enriched outer mitochondrial membrane fractions and 
consistently, mARC2 was recently detected in purified rat liver outer mitochondrial 
membranes (Neve et al., 2012). Contradictingly, mARC2 was also identified during a large 
scale proteomic characterization of mouse liver inner mitochondrial membranes (Da Cruz et 
al., 2003). Furthermore, the subcellular localization of a close homologue, mARC1, has not 
been studied so far. However, the high degree of similarities to mARC2 in respect to 
sequence and function strongly suggests a similar subcellular distribution of both enzymes.  
 In the second part of this work, the sub-cellular localization of mARC1 was 
determined and revealed its integration into the outer mitochondrial membrane. This was 
shown by PK and trypsin treatments of purified mitochondria, which resulted in degradation 
Figure 3.1 Assembly and maturation of mammalian SO. SO is depicted with its N-terminal 
targeting signal (black), its hydrophobic stop-transfer signal (blue), its heme domain (orange) 
and the Moco- and dimerization domain (green). See text for details. IM, inner membrane; 
IMP, inner membrane peptidase; IMS, IMS; OM, outer membrane; TOM, translocase of the 
outer membrane. 
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of mARC1 from intact mitochondria. The depletion of full-length mARC1 following PK 
exposure was accompanied by the simultaneous appearance of a truncated fragment of 
about 30 kDa. The very weak intensity of the corresponding protein band after PK treatment 
suggested, that this fragment has derived from incomplete degradation of the cytosolic C-
terminal core of mARC1, which presumably reflects the tight folding of this domain. However, 
swelling of the outer mitochondrial membrane resulted in complete degradation of mARC1 
and also prevented formation of the truncated fragment seen upon PK treatment of intact 
mitochondria. The more efficient degradation of mARC1 following outer membrane disruption 
may be attributed to the increased PK accessibility of the protein, which would be reflected 
by the concomitant degradation of the protein from both terminal ends.  
Furthermore, the size of the truncated fragment following PK treatment appears about 
5 kDa smaller than the full-length protein, while a protease protected fragment seen upon a 
hypothetic inverse N(out)-C(in) membrane orientation of mARC1 is expected to be 2 kDa 
smaller than the full-length fragment. The difference of 5 kDa may well be attributed to the 
size of the N-terminal targeting signal and the transmembrane domain, suggesting PK to 
cleave efficiently between transmembrane domain and the folded cytosolic core of the 
catalytic mARC1 domain.     
In conclusion, mARC1 was defined to expose its C-terminal core domain to the 
cytosol, while the soluble N-terminus is facing the mitochondrial IMS.  
  Assuming a similar localization of mARC1 and mARC2, these results are in line with 
the previous studies detecting mARC2 in purified outer membrane fractions (Havemeyer et 
al., 2006, Neve et al., 2012). The mitochondrial protease treatment approach conducted in 
this study in addition addressed and clarified the membrane orientation of mARC 1 and thus 
for the first time affords a comprehensive view of mARC protein localization. The enzymatic 
activity of mARC requires its integration into a three-component enzyme system, in which 
electrons are transferred from NADH cytochrome b5 reductase via cytochrome b5 to mARC 
(Wahl et al., 2010). Both, NADH cytochrome b5 reductase (Borgese and Pietrini, 1986, 
Borgese et al., 1996) as well as cytochrome b5 (Fukushima et al., 1972, Ito, 1980) are well-
known components of the outer mitochondrial membrane exposing their catalytic domains to 
the cytosol. The current findings of an N(in)-C(out) orientation of mARC1 in the outer 
mitochondrial membrane are thus in well agreement with the catalytic interplay of the three 
components, which all expose their functional domains to the cytosol to build an efficient 
inter-molecular electron transport chain.    
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3.2.2 Targeting of mARC1 to the outer mitochondrial membrane           
The localization of mARC1 to the outer mitochondrial membrane is defined by its N-terminal 
region, which is composed of a weak MTS and a downstream transmembrane domain. 
Fusion of the transmembrane domain with GFP revealed the latter to be sufficient for 
mitochondrial sorting of mARC1. Considering its N-terminal transmembrane segment, which 
is required for targeting and membrane anchoring, mARC1 is classified as a novel and only 
the fifth known signal-anchored protein. All members of this small group of proteins share 
anchoring to the outer mitochondrial membrane based on their N-terminal transmembrane 
domains (Shore et al., 1995). In analogy to mARC1, the transmembrane segment of signal-
anchored proteins is in most cases sufficient for mitochondrial targeting, which was also 
found for TOM20 (Kanaji et al., 2000) and TOM70 (Suzuki et al., 2002) as two prominent 
representatives of this protein family.  
 Although the transmembrane domain is adequate for correct sorting when fused to 
GFP and recombinantly expressed in HEK-293 cells, the N-terminus of mARC1 contains an 
additional MTS. This motif is comparatively weak, as illustrated by the inefficient 
mitochondrial sorting of a fusion of residues 1-20 to GFP and the presence of only two basic 
residues with a much less amphipathic character compared to other classical N-terminal 
MTS (Table 3.2) (Neupert and Herrmann, 2007). In previous studies, the soluble N-terminal 
domain upstream of the transmembrane segment of signal-anchored proteins was shown to 
have supportive functions by increasing the efficiency of targeting, which is primary mediated 
by the transmembrane domain. Investigations of a fusion of dihydrofolate reductase with the 
N-terminal bitopic domain of yeast Tom70 revealed the three basic residues upstream of the 
transmembrane segment to enhance the rate of outer membrane insertion (McBride et al., 
1992). In spite of similarities to the N-terminus of mARC1, the N-termini of other signal-
anchored proteins could however not be shown to be autonomous MTS. This is also 
illustrated by the parameters depicted in table 3.2, in which the soluble N-termini of all 
currently known signal-anchored proteins are compared. The parameters of the MTS of SO, 
TIM50, SMAC and cytochrome b2 (Cytb2) are also shown in the table for better comparability 
(shaded blue). 
Predictions conducted by MITOPROT II revealed the mARC1 N-terminus to constitute 
a MTS with 65% probability. This was clearly below the values calculated for SO, TIM50, 
SMAC as well as Cytb2 and is thus in line with the less number of basic residues and the 
weak mitochondrial targeting efficiency of residues 1-20 of mARC1 when fused to GFP. The 
MTS predictions of mARC1 in contrast exceed the scores obtained for the N-termini of 
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Tom70, TOM20 and OM45. Since the number of basic residues is quite similar among 
mARC1 and the latter three components and all proteins exhibit the same subcellular 
localization, the weak N-terminal MTS of mARC1 may have similar supportive functions 
during mitochondrial targeting. 
 
 
Consequently, the mARC1 N-terminus may thus function as a primary receptor for the 
outer mitochondrial membrane, as described for the analogous segments of other signal-
anchored proteins such as TOM70 and TOM20 (McBride et al., 1992, Kanaji et al., 2000, 
Suzuki et al., 2002). The similarities between the soluble N-termini of mARC1 and other 
signal-anchored proteins suggest a smooth transition between outer membrane receptor and 
weak MTS of signal-anchored proteins. In any case, the downstream transmembrane 
domain seems to ensure correct localization and to suppress potential weak matrix signals 
within the upstream segment, which do thus not affect import in a conventional manner and 
ultimately not drive the protein to the mitochondrial matrix. Yeast Mcr1 is another signal-
anchored protein with higher MTS scores than mARC1 which will be discussed later.  
The mechanisms by which signal-anchored proteins enter the outer mitochondrial 
membrane are not completely understood. The import of TOM20 and TOM70 was however 
shown not to essentially require pre-existing primary TOM20 and TOM70 receptors (Ahting 
et al., 2005) and OM45 was recently shown to adopt a helical transmembrane conformation 
in artificial bilayers (Merklinger et al., 2012). Since signal-anchor domains of the known 
signal-anchored proteins are functionally interchangeable (Ahting et al., 2005), Dukanovic 
and Rapaport (2011) proposed a common initial membrane insertion step of all signal 
anchored proteins.  
Protein compartment size (residues)1 MTS prediction (%)2 basic residues species 
mARC1 OM 20 65 2 human 
Tom70 OM 10 35 3 yeast 
TOM20 OM 5 20 1 human 
OM45 OM 5 40 1 yeast 
Mcr1 OM/IMS 11 75 4 yeast 
SO IMS 20 92.6 4 mouse 
TIM50 IM 27 99.3 5 human 
SMAC IMS 20 97.9 4 human 
Cytb2 IMS 27 82.6 7 yeast 
Tab. 3.2 Analysis of matrix-targeting capability of different protein N-termini  
1
Soluble domains N-terminal of transmembrane segments 
2
Predictions according to Mitoprot II (Claros and Vincens, 1996) 
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While TOM20 and TOM70 are thought to require a pre-existing TOM complex for 
correct assembly after their initial membrane insertion, the TOM complex was proposed to be 
dispensable for the assembly of the other signal-anchored proteins (Dukanovic and 
Rapaport, 2011). Accordingly, mARC1 may also insert into an artificial bilayer in absence of 
the TOM complex, while its N-terminal targeting signal suggests an interaction to the primary 
import receptors TOM20 and TOM22. Potential interactions of mARC1 to the primary TOM 
import receptors could be probed in vitro following heterologous expression and purification 
of TOM20/22 fragments and mARC1, respectively. Binding could be analyzed by pull-down 
and immunoprecipitation experiments or biochemically characterized by isothermal titration 
calorimetry and surface plasmon resonance spectroscopy. Alternatively, cross-linking during 
in vitro import of mARC1 with subsequent co-immunoprecipitations could be used to identify 
interactions to any TOM components.     
These putative interactions to the primary TOM receptors seem not to be strictly 
essential, as the mARC1 transmembrane domain was shown to be an autonomous targeting 
signal, but they may increase the efficiency of targeting. Still, a fusion of the mARC1-
transmembrane domain with GFP revealed a complete mitochondrial localization in cell 
culture, indicating an efficient mitochondrial targeting even in absence of the N-terminal MTS. 
However, considering the extended two-days expression of the construct in cell culture, the 
long cellular accumulation of the construct may finally result in a comprehensive 
mitochondrial localization. This system may therefore not be sensitive enough to detect 
potential decreased mitochondrial targeting efficiencies due to the lack of a functional IMS. 
The cooperating effect of the mARC1-MTS could rather be experimentally tested by 
repeating the in vitro import experiments with a truncated mARC1 variant lacking residues 1-
20 or with a variant in which both positively charged residues of the MTS are exchanged by a 
neutral residue. The time dependent formation of the high-oligomeric complexes seen upon 
in vitro mitochondrial import could then be taken as a measure for the efficiency of complex 
formations in WT and truncated mARC1 variants.     
It is currently unknown, if signal anchored proteins become membrane inserted co- or 
post-translationally, but the N-terminal MTS of mARC1 may facilitate immediate transfer of 
the translating ribosome to mitochondria and an efficient and rapid insertion into the outer 
mitochondrial membrane.  
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3.2.3 Outer membrane targeting of mARC1 vs inner membrane sorting of SO 
A comparison of the primary structures of mARC1 and SO reveals surprising similarities, as 
both mitochondrial Moco enzymes share an N-terminal MTS followed by a hydrophobic 
transmembrane domain. Interestingly, these related N-terminal motifs confer different sub-
mitochondrial localizations of both proteins, with the transmembrane domain of SO traversing 
the inner mitochondrial membrane and mARC1 being anchored in the outer membrane.  
What are the mechanistic frameworks determining inner or outer mitochondrial 
membrane localization of SO and mARC1, respectively? And what are the parameters 
defining inner or outer membrane insertion of signal-anchored proteins and proteins with 
bipartite targeting signals in general? 
SO and mARC1 are directed to their destined membrane solely based on their N-
terminal regions, which thus also define association to the inner or outer membrane. The 
MTS were already compared in table 3.2, now the transmembrane segments of both proteins 
as well as of other signal-anchored proteins or inner membrane/IMS proteins with a bipartite 
targeting signal are compared in table 3.3. Depicted hydrophobicity scores were calculated 
with the program HydroMCalc (Tossi et al., 2002).  
 
 
 
      
 
 
 
 
 
The calculations of table 3.3 reveal the signal-anchored proteins TOM20, Tom70 and 
OM45 to contain a transmembrane segment of moderate hydrophobicity. Considering the 
lack of a functional MTS, these proteins do not receive a driving force towards the inner 
mitochondrial membrane but insert into the outer membrane. The mARC1 protein displays a 
stronger MTS prediction than other signal-anchored proteins, which appears to be balanced 
Protein Compartment Hydrophobicity1 size (residues) species 
mARC1 OM 2.4 20 human 
Tom70 OM 1.02 18 yeast 
TOM20 OM 1.71 18 human 
OM45 OM 1.43 17 yeast 
Mcr1 OM/IMS 2.01 20 yeast 
SO IMS 2.78 17 mouse 
TIM50 IM 2.77 20 human 
SMAC IMS 1.22 19 human 
Cytb2 IMS 1.38 17 yeast 
Cue1 ER 4.58 19 yeast 
Tab. 3.3 TM domain comparison between signal-anchored proteins and inner 
membrane/IMS proteins with bipartite targeting signals  
1
Predictions according to (Tossi et al., 2002) 
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by a more hydrophobic transmembrane domain, ultimately resulting in the same 
submitochondrial localization. SO and other proteins with bipartite targeting signals residing 
in the inner membrane or the IMS are characterized by even stronger N-terminal MTS. The 
hydrophobicity scores of the transmembrane domains appear divergent, with SO revealing a 
comparably strong value, while the transmembrane segments of SMAC or cytochrome b2 
depict only moderate degrees of hydrophobicity. 
Comparing mARC1 with SO or the other proteins containing bipartite targeting motifs, 
mARC1 contains a weaker MTS, which is apparently not sufficient to drive the downstream 
transmembrane motif across the outer mitochondrial membrane. A weak MTS as seen for 
mARC1 seems to result in transmembrane domain mediated insertion into the outer 
mitochondrial membrane, while, as illustrated by SO, a stronger MTS may even translocate a 
more hydrophobic transmembrane segment across the outer membrane. Targeting to the 
inner or outer mitochondrial membrane may thus be regulated by the opposing forces of 
MTS and transmembrane domain.  
In this context, yeast Mcr1 is a very interesting intermediate protein. Similar to SO and 
mARC1, Mcr1 contains an N-terminal MTS and a downstream transmembrane domain, 
which were shown to mediate dual localization of the protein to the outer membrane and to 
the IMS (Hahne et al., 1994). This is achieved by two distinct import mechanisms, with the 
intermembrane space form of Mcr1 entering the Tom40 import channel and being 
transported to the Tim23 complex, while the outer mitochondrial membrane isoform is 
inserted independent on Tom40 or the primary Tom import receptors (Meineke et al., 2008). 
These two independent mechanisms suggest that sorting of both isoforms diverge early, 
already before entering the TOM complex.  
 Notably, this dual distribution is also reflected in the parameters of tables 3.2 and 3.3. 
The MTS of Mcr1 appears to be stronger than the MTS of all other signal-anchored proteins 
including mARC1, but weaker than the motifs of the proteins with classical bipartite targeting 
signals. The hydrophobicity scores of the Mcr1 transmembrane domain likewise reveal 
intermediate values, which seem to be low enough to allow passage of a proportion of the 
proteins across the outer membrane, but also strong enough to permit retention of a sub-
population of the proteins in the outer mitochondrial membrane. Consistent with this 
hypothesis, weakening the hydrophobicity of the Mcr1 transmembrane domain by mutating 
two alanines in the middle of the hydrophobic motif against glutamine prevented outer 
membrane arrest and caused a complete IMS localization of the protein (Haucke et al., 
1997).    
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These mechanistic insights into Mcr1 trafficking further support the concept of the 
outer membrane localization of mARC1 compared to the inner membrane/IMS localization of 
SO to be controlled by the strength of the MTS and the degree of hydrophobicity within the 
downstream transmembrane domain. However, the import pathways of both Mcr1 isoforms 
are subject to two distinct mechanisms and membrane insertions of signal-anchored proteins 
are independent of the TOM complex. Further, a lateral opening of TOM40 was not observed 
so far and is under debate due to thermodynamic considerations (Rapaport, 2005). In 
aggregate, sorting of signal-anchored proteins and proteins with bipartite targeting-signals 
might be based on the strengths of the parameters shown in tables 3.2 and 3.3, while 
sensing these signals and sorting decisions must occur before translocation or membrane 
insertion, respectively, initiates.   
As only five signal-anchored proteins and a limited number of proteins with bipartite 
targeting signals are known, the quantitative significances of the analyses shown in tables 
3.2 and 3.3 are rather low. The outlined coherencies could therefore be experimentally tested 
by introducing additional basic residues into the mARC1-MTS or by exchanging the mARC1-
MTS against the stronger MTS of SO. According to the hypothesis stated above, increasing 
the strength of the mARC1-MTS would cause inner membrane targeting of the modified 
protein. Alternatively, weakening of the SO-MTS might result in a premature arrest of SO-
translocation in the outer mitochondrial membrane.   
The sorting of mARC1 and other signal-anchored proteins to the outer mitochondrial 
membrane does not only have to be differentiated from inner membrane targeting, but also 
from mislocalization to the ER. Targeting to the ER is based on strongly hydrophobic motifs 
(Hegde and Keenan, 2011). Cue1 was chosen as a representative for a signal-anchored 
protein of the ER membrane (Biederer et al., 1997) and the hydrophobicity scores depicted in 
table 3.3 reveal a significantly higher hydrophobicity of Cue1 compared to all mitochondrial 
membrane proteins. Consistent with these differences, increasing the hydrophobicity of 
transmembrane segments of signal-anchored proteins has been shown to cause 
mislocalization to the ER (Waizenegger et al., 2003). Furthermore, Merklinger et al. (2012) 
observed that insertion of OM45 into artificial lipid bilayers is significantly increased when 
exposing the protein to an outer membrane-like lipid composition compared to a bilayer with 
ER-like lipid composition. This suggests that apart from the degree of hydrophobicity, target-
membrane compositions may also constitute cellular sorting-signals for signal-anchored 
proteins. 
The cellular trafficking of mARC1 and other signal-anchored proteins thus appears to 
be subject to a fine-tuned mechanism, with minor modifications in the N-terminal domain or 
the target membrane potentially causing protein mislocalizations.  
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3.2.4 In vitro import of mARC1 
The in vitro characterization of the mitochondrial import of mARC1 revealed characteristics 
typical for proteins residing in the outer mitochondrial membrane (Dukanovic and Rapaport, 
2011). Therefore, mARC1 was not processed during import and did not require a membrane 
potential across the inner mitochondrial membrane. This is consistent with a supportive 
function of the mARC1-MTS in mediating efficient outer membrane targeting of the protein, 
rather than a conventional and membrane potential-dependent role of the MTS in 
mitochondrial import of mARC1. The depletion of external ATP from the import buffer 
however significantly interfered with successful targeting of mARC1. ATP might be required 
for the release of mARC1 from cytosolic chaperons and thereby being essential for an 
efficient integration into the outer membrane. A similar role of external ATP during 
mitochondrial import has been described earlier for other membrane-anchored proteins 
(Wachter et al., 1994).  
Interestingly, membrane integration of mARC1 resulted in the formation of high-
oligomeric complexes as depicted by BN-PAGE following in vitro import or 48 h expression of 
mARC1 in cell culture, suggesting that mARC1 is part of these complexes in its final and 
active form. Given the molecular weight of mARC1, cytochrome b5 reductase and 
cytochrome b5 (total ~90 kDa), one can speculate that these three proteins might form a 
large multimeric complex with several copies per subunit. However, mARC1 and cytochrome 
b5 reductase have been shown to be monomeric following expression in E. coli, while 
cytochrome b5 revealed the formation of homo-dimeric complexes (Wahl et al., 2010). 
Alternatively, mARC1 may be part of a so far unknown membrane-bound multienzyme 
complex hosting other yet to be identified proteins. Isolation and characterization of these 
complexes could occur by co-immunoprecipitation of mARC1 with subsequent mass-
spectrometric identifications of the co-precipitated components. The identified candidates 
could in the next steps be confirmed by appropriate and specific antibodies, which would be 
added to the mitochondrial in vitro import reactions of mARC1 prior to BN-PAGE analyses. 
Assuming a co-association of mARC1 and the respective candidate protein in the same 
complexes, addition of the antibodies should result in a shift of the complex seen on BN-
PAGE. Another strategy to confirm potential components of the high-oligomeric structures 
could involve cross-linking of the complexes with subsequent identification of the proteins by 
western blotting using specific antibodies.   
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3.2.5 Assembly and maturation of mARC1 
In summary, the findings of the second party of this study, the mitochondrial maturation of 
mARC1, can be illustrated in a model (Figure 3.2).  
 Following its cytosolic translation, mARC1 may be bound by chaperones guiding the 
protein to the outer mitochondrial membrane and preventing the transmembrane domain 
from being exposed to the cytosol. Release from chaperones might thus represent the ATP- 
dependent step of the mitochondrial import of mARC1. Insertion into the outer mitochondrial 
membrane is triggered by the N-terminal region of mARC1, which is composed of a weak 
MTS and a downstream transmembrane domain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The MTS is supposed to function as a supportive receptor for the outer mitochondrial 
membrane and considering the known interactions of these motifs with the primary TOM 
receptors, the mARC1-MTS might initially interact with TOM20 and TOM22 to afford first 
contacts between the protein and its target membrane. The membrane insertion of mARC1 
Figure 3.2 Assembly and maturation of human mARC1. mARC1 is depicted with its N-terminal 
targeting signal (black), its transmembrane domain (blue) and its catalytic core (dark gray). mARC1 
is part of unknown multiprotein complexes (X) in the outer mitochondrial membrane. Cytochrome b5 
reductase (Cytb5R) and cytochrome b5 (Cytb5) are shown with their transmembrane domains 
(blue). See text for details. C, chaperone (green circle); F, flavin adenine dinucleotide; H, heme; IM, 
inner membrane; IMS, IMS; M, Moco; OM, outer membrane; TOM, translocase of the outer 
membrane. 
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occurs membrane potential independently and is mediated by the transmembrane domain, 
which constitutes the targeting signal and membrane anchor, thus defining mARC1 as a 
novel signal-anchored protein of the outer mitochondrial membrane. 
 Thereby, mARC1 exposes its catalytic core domain to the cytosol and presumably 
integrates Moco after insertion into the outer membrane in analogy to the unfolded 
translocation of all mitochondrial proteins. Following membrane insertion and Moco 
integration, mARC1 builds an intermolecular electron-transport chain with cytochrome b5 
reductase and cytochrome b5 but also forms high-oligomeric structures of currently unknown 
identity.    
 
 
 
 
 
 
 
 
Dissertation Julian Klein                                                                           Material and methods                 
 
82 
 
4 Material and methods 
4.1 Material 
4.1.1 Organisms 
Different prokaryotic and eukaryotic organisms were used during the current study. E. coli 
cells were used for plasmid amplification and protein expression and are listed in table 4.1. 
Mammalian cells were used for localization studies and protein expression and are listed in 
table 4.2., while N. crassa cells (table 4.3) were used for nit-1 reconstitution assays. 
  
Strain Reference Genotype Purpose 
DH5α (Hanahan, 1983) F-, supE44, ΔlacU169, (ɸ80lacZ  
ΔM15),  hsdR17, endA1, 
gyrA96, thi-1, relA1, recA56 
Plasmid 
amplification 
TP1000 (Palmer et al., 1996) F-, ΔlacU169, araD139, 
rpsL150, relA1, ptsF, rbsR, flbB, 
(ΔmobAB) 
Protein expression 
in E. coli 
BL21 (Weiner et al., 1994) F-, ompT, hsdS(rB-mB-), dcm+, 
Tetr, galλ (DE3), endA, The 
[argU, proL, camr] 
Protein expression 
in E. coli 
 
Strain Reference Description Purpose 
HEK-293 (Graham et al., 1977) Human embryonic 
kidney cells 
Protein localization, 
mitochondrial purification, 
general protein expression  
MOCS1-/- 
fibroblasts 
Jochen Reiss, 
University of Göttingen 
Human fibroblasts, 
ΔMOCS1 
Protein localization 
WT 
fibroblasts 
Jochen Reiss, 
University of Göttingen 
Human fibroblasts, 
WT 
Protein localization 
HEP-G2 (Knowles et al., 1980) Human liver 
carcinoma cells 
Protein localization 
HeLA cells (Scherer et al., 1953) Human cervical 
carcinoma cells 
Protein localization 
Tab. 4.1 E. coli cells used in this study 
Tab. 4.2 Mammalian cells used in this study 
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4.1.2 Plasmids 
Empty plamids (table 4.4) from different companies were used for cloning and subsequent 
expression of proteins. 
 
Plasmid Resistance Source Purpose 
pQE80 Ampicillin Qiagen Protein expression in E. coli 
pcDNA3.1 
myc/HisA 
Ampicillin Invitrogen General protein expression in 
mammalian cells, protein localization 
studies 
pEGFP-N1 Kanamycin Clontech Protein localization 
pJET1.2 Ampicillin Fermentas Expression of IMMP1l shRNA 
 
4.1.3 Enzymes and chemicals 
Enzymes for cloning and DNA modifications were purchased from Fermentas, New England 
Biolabs, Roche and Stratagene. Cell culture media and buffers were purchased from PAA 
laboratories. Chemicals and solutions were obtained from Applichem, Biomol, Fluka, Merck, 
MP Biomedicals, Promega, Riedel deHaen, Roche, Roth, Serva, Sigma-Aldrich and VWR-
Prolabo.     
 
 
 
 
 
Strain Reference Genotype/description Purpose 
nit-1 (Nason et al., 1971) FGSC : 34, allele : 34547, 
mating type : a/A linkage 
group: IR, genetic 
background : M, mutagen : UV 
nit-1 reconstitution assay 
Tab. 4.3 N. crassa cells used in this study 
Tab. 4.4 Plasmids used in this study 
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4.1.4 Antibodies 
Different primary (table 4.5) and secondary (table 4.6) antibodies from different companies 
were used for western blot detection or immunocytochemistry.  
 
Antibody Dilution Source Application 
Mouse monoclonal to SO 1:1000 Abcam Western blot, 
immunocytochemistry 
Mouse monoclonal to actin  1:400 Santa Cruz Western blot 
Rabbit polyclonal to IMMP1L 1:500 Abgent Western blot 
Rabbit polyclonal to MOSC1 1:1000 Abcam Western blot 
Rabbit polyclonal to smac/diablo 1:1000 Abcam Western blot 
Mouse monoclonal to VDAC 1:1000 Abcam Western blot 
Mouse monoclonal to gephyrin 
(3B11) 
1:20 (Smolinsky et al., 
2008) 
Western blot 
Mouse monoclonal to myc-tag 
(9E10) 
1:5 Cell supernatant Western blot, 
immunocytochemistry 
Rabbit polyclonal to GFP 1:1000 Abcam Western blot 
Mouse monoclonal to HSP60 1:2000 Biomol Western blot 
Rabbit polyclonal to MFN2 1:1000 Sigma Western blot 
Mouse monoclonal to COX4 1:500 Santa Cruz Western blot 
 
 
 
 
 
 
 
Antibody Dilution Source Purpose 
Goat anti-mouse HRP coupled 1:10000 Santa Cruz Western blot 
Donkey anti-rabbit HRP coupled 1:10000 Pierce Western blot 
Alexa Fluor 488 anti-mouse 1:200 Invitrogen Immunocytochemistry 
Tab. 4.5 Primary antibodies used in this study 
Tab. 4.6 Secondary antibodies used in this study 
Dissertation Julian Klein                                                                           Material and methods                 
 
85 
 
4.2 Methods 
4.2.1 Biochemical methods 
4.2.1.1 Expression of recombinant SO variants in E. coli 
Different variants of mouse SO were expressed in E. coli strain TP1000 in this study. 
Therefore, the respective plasmids were transformed into the E. coli cells, which were then 
plated on agar medium. Single colonies were selected and grown over night at 37°C in LB 
medium (10 g/l tryptone, 10 g/l NaCl, 5 g yeast extract/l) containing the respective antibiotics 
(100 µg/ml ampicillin, 25 µg/ml kanamycin). 50 ml of precultures were each added to 3l of 
main cultures, which were grown for 3 h at 25°C and 90 rpm shaking. Expressions of SO 
variants were induced by the addition of 0.1 mM IPTG and 150 µM Na-molybdate and cells 
were harvested after further 48 h incubation at 25°C and 90 rpm shaking.  
4.2.1.2 E. coli cell disruption 
E. coli cells were disrupted after expression of recombinant proteins according to the 
following protocol:  
1) Cell pellets were thawn on ice and subsequently resuspended in ~20 ml lysis buffer (100 
mM Tris pH 7.5, 300 mM NaCl, 15 mM imidazole). 
2) Cells were opened by means of the cell disruptor (Constant systems) at 2.5 kbar. 
3) The sample was sonicated on ice for 2 min to shear genomic DNA (50% interval).  
4) Finally, a 40 min centrifugation (20.000 x g) was applied to get rid of cell particles. The 
obtained crude extract (supernatant) was used for further purification steps 
 
4.2.1.3 Purification of recombinantly expressed SO variants  
 
All SO variants were expressed from pQE80 in fusion with an N-terminal His-tag. The binding 
of Nickel to histidines facilitated affinity purification of the variants by means of a Ni-NTA 
matrix. For this purpose, Ni-NTA matrix (Qiagen) was filled into a column and protein crude 
extract was loaded onto the matrix. After one step of washing with lysis buffer, the proteins 
were eluted from the matrix by the addition of an elution buffer buffer (100 mM Tris pH 7.5, 
300 mM NaCl, 400 mM imidazole). Imidazole strongly binds Nickel and removes the protein 
from the matrix. Since the eluted proteins were only enriched but not purified, an additional 
anion exchange chromatography was performed, which was used in combination with a 
Aekta FPLC system. Therefore, the Ni-NTA eluted protein was diluted 1:5 in 50 mM 
Tris/acetate pH 8.0 and applieded on a SourceQ 30ml matrix (15 µm particles, Dr. Maisch). 
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All bound proteins were stepwise eluted from the matrix by application of a salt gradient (0-1 
M NaCl) and according to their affinity to the matrix based on their negative charges.       
 
4.2.1.4 Concentration of purified proteins  
 
Purified proteins were concentrated by means of Amicon Ultra Centrifugal Filters (Millipore). 
Depending on the molecular weight of the proteins, size exclusions of 3-100 kDa were 
chosen. The centrifugations occurred at 4°C and according to the instructions of the 
manufacturer.  
 
4.2.1.5 Analytical size exclusion chromatography 
 
Size exclusion chromatography separates proteins according to their size. This can either be 
used for purification purposes or to determine the oligomerization status of a given protein. In 
the current study, size exclusion chromatography (column: ACQUITY BEH200; 1.7 µm 
particles; Waters) was used with an HPLC system (Agilent) to characterize the 
oligomerization of different SO variants. The analysis was performed as described by the 
supplier.  
 
4.2.1.6 Buffer exchange 
 
Buffer exchange was performed with PD10 columns (GE Healthcare). Therefore, the 
columns were equilibrated with the target buffer, followed by application of 2.5 ml of protein. 
Proteins were finally eluted by the addition of 3.5 ml of target buffer.   
 
4.2.1.7 Determination of protein concentration 
 
The concentration of purified proteins was determined by means of a Nanodrop 
Spectrophotometer (Thermo Scientific) based on the Lambert-Beer Law. Concentrations of 
protein crude extracts or mitochondria were determined by means of the Bradford solution, 
which is based on the binding of Coomassie Brilliant Blue G-250 (Rotiquant) to aromatic and 
basic residues of the protein. The accompanying change in absorption maxima (465 nm to 
595 nm) was determined by means of a photometer (Thermo Electron Corporation) and 
taken as a measure for the amount of protein relative to a standard protein curve.  
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4.2.1.8 SDS-PAGE 
 
Sodium-dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is performed to 
separate denatured proteins according to their electrophoretic mobility. SDS is an anionic 
detergent which denatures and negatively charges proteins. Depending on the size of the 
proteins, different amounts of SDS will bind and provide a negative charge which correlates 
to the size of the protein. Thereby, proteins will be separated in the gel according to their 
size. The gel consists of an upper stacking gel and a lower resolving gel with varying 
percentages of acrylamide (depending on the molecular weight of the proteins of interest). 
Before loading the samples on the stacking gel, they were denatured by the addition of 5x 
SDS-loading dye (50% glycerol, 3.5% SDS, 15% β-mercaptoethanol, 0.02% bromophenol 
blue) and 5 min heating at 95°C. Afterwards, the gel was stained with Coomassie Blue 
solution (40% methanol, 10% acetic acid, 0.2% Coomassie Brilliant Blue G 250) and 
destained with destaining solution (40% methanol, 10% acetic acid) or further analyzed by 
Western blot.  
 
4.2.1.9 Western blot 
 
After SDS PAGE, Western blot was used to specifically detect proteins of interest by 
immunostaining. In the current study, the proteins of the SDS gel were transferred to a 
polyvinylidifluorid (PVDF) membrane by means of a semi-dry blotting system (C.B.S. 
Scientific). The transfer was conducted with transfer buffer (25 mM Tris, 192 mM glycine, 
10% methanol) and three sheets of whatman paper on each side of the gel and membrane. 
After transfer, the membrane was blocked 1 hour with 5% milk in TBST buffer. The 
incubation with the primary and secondary antibodies occurred as recommended by the 
manufacturers. After both antibody incubations, the membrane was washed 4 times for 5 min 
with TBST. The secondary antibodies used in this study were coupled to horseradish 
peroxidase and finally visualized by SuperSignal West Pico/Femto Chemiluminescent 
substrate (Thermo Scientific). The signals were detected by means of an Enhanced 
Chemiluminescence Camera System (Decon).    
 
4.2.1.10 Blue Native-PAGE 
 
Blue Native-PAGE (BN-PAGE) was applied to separate native protein complexes according 
to their sizes. In the current study 4%-16% acrylamide gradient gels were applied. Therefore, 
4.5 ml of a 4% and 16% acrylamide solution, respectively, were each mixed with 20 µl 20% 
APS and 3 µl TEMED in a gradient gel mixer to cast the BN-gel. The stacking gel was 
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composed of 7 ml 4% acrylamide solution, 30 µl 20% APS and 10 µl TEMED. Before loading, 
the samples were supplied with 10x BN-loading dye (5% Coomassie blue G, 500 mM ε-
amino n-caproic acid, 100 mM Bis-Tris pH 7.0). All empty wells were filled with empty well 
buffer (20 mM Bis-Tris pH 7.4, 50 mM NaCl, 10% glycerol) and as a molecular weight marker 
a mix of 10 mg/ml thyroglobulin, 10 mg/ml ferritin, 10 mg/ml BSA and empty well buffer was 
used. 50 mM Bis-Tris pH 7.0 was used as the anode buffer during the run, while the cathode 
buffer was composed of 50 mM tricine, 15 mM Bis-Tris (unbuffered) and 0.02% Coomassie 
blue G. After the entry of the samples into the resolving gel, the cathode buffer was 
exchanged against a coomassie free equivalent. The gel was run at 10 mAmp and 600 volts 
at 4°C.    
 
4.2.1.11 Sulfite:Cytochrome c assay 
 
SO activity was photometrically determined based on the increased absorption of reduced 
cytochrome c compared to the oxidized form at 550 nm. The measurements occurred at 
room temperature by means of an ELISA reader in a 96-well plate. Following components 
were mixed in the wells: 
 
8 µl 1 M Tris/Acetat pH 8.0 
10 µl 5 mM deoxycholic acid 
35 µl 0.5 mM KCN 
108 µl SuOx buffer (0.1 M Tris/acetate pH 8.0 + 0.1 mM EDTA) 
12 µl cytochrome c (10 mg/ml) 
 
Afterwards, 0-15 µl SO was added. In case less than 15 µl were added, SuOx buffer was 
used to fill the protein solution to 15 µl.  
The reaction was started by the addition of 12 µl Na-sulfite (5 mM), followed by a direct 
starting of OD measurement in the ELISA reader. 30 measurements at 550 nm in time 
intervals of 4 sec were conducted to determine the catalytic activity of SO.  
  
4.2.1.12 HPLC Form A analysis                                                                                            
 
Moco and can be detected and quantified by means of its fluorescing oxidation product Form 
A via HPLC. Moco gets oxidized to Form A in an acidic reaction with I2/Kl/HCl solution. The 
fluorescence spectra of Form A (excitation 370 nm, emission 450 nm) allow the detection of 
the component after elution from the HPLC column. 
Moco oxidation to Form A occurred as follows: 
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1) 140 µl of the sample were supplied with 17.5 µl acidic oxidation mix (1.5/2% I2/Kl solution 
in 1M HCl) and incubated at room temperature in the dark overnight. 
2) The sample was centrifuged for 5 min at 15000 rpm, the yellowish supernatant was taken. 
3) 20 µl of freshly prepared 1% ascorbic acid solution was added to the supernatant to 
reduce the residual I2.  
4) 70 µl 1M Tris (unbuffered) and 5 µl 1 M MgCl2 were added. 
5) 5 µl alkaline phosphatase (1:10 diluted in 20 mM Tris pH 8.3) was added; the reaction was 
conducted for 30 min at room temperature in the dark.  
6) Samples were centrifuged for 5 min at 21.000 x g, the supernatant was put into a new 
tube. 
7) After another 1:10 dilution, the samples were transferred into HPLC tubes to start the 
analysis. 
 
HPLC analysis was performed on a reverse phase column (250 x 4.6 mm 5 µm C18, Dr. 
Maisch GmbH). Elution of FormA occurred by application of a methanol gradient. 
 
4.2.1.13 Nit-1 assay                                                                                                                                                
 
The nit-1 assay was used to detect free Moco in mitochondrial extracts and protein solutions. 
The assay was conducted as follows: 
1) 1-20 µl protein (~2.5-50 µg) was pipetted to 19.5 µl nit-1 extract (containing 2 mM GSH) 
on ice. As a reference, one sample was not incubated with cell extracts but otherwise treated 
as all other samples.   
2) Samples were degased in a desiccator and incubated over night at 4°C in the dark.  
3) Samples were taken out of the desiccator and 1/10 volume of 1% NADPH was added, 
followed by an incubation time of 10 min at room temperature.  
4) 1.5 volumes of degased 0.1 mM FAD/0.1 mM KNO3 (1:2) was added. Samples were 
incubated for 20 min at room temperature in the dark. 
5) Samples were heated at 95°C for 5 min and subsequently cooled on ice for a few min. 
6) Finally, 2.5 volumes of SA/NED (1:1) solution were added. After 30 min of incubation at 
room temperature, samples were centrifuged and analysed in the ELISA reader at 540 nm 
on a multi-well plate.  
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4.2.1.14 TCA precipitation 
 
TCA precipitation was conducted to precipitate proteins in solution in this study. Therefore, 
20 µl of a 72% TCA solution were each added to 100 µl protein solution. After 30 min 
incubation on ice, samples were centrifuged at maximum speed for another 30 min at 4°C. 
The precipitated protein pellets were rinsed with ice cold acetone two times and each 
centrifuged for 10 min at 4°C. Finally, the pellets were dried for 20 min in the fume hood and 
resolved in 30 µl SDS loading dye by shaking at 1.600 x rpm at 50°C.     
 
 
4.2.2 Molecular biological methods 
4.2.2.1 Cloning 
For cloning, DNA fragments were first amplified by PCR from cDNA libraries or plasmid 
templates. After purification, PCR products and target vectors were digested by the 
respective restriction enzymes and ligated by means of a T4 DNA ligase. To ensure efficient 
ligation, a four to one insert:vector ratio was applied during the ligation process. The ligated 
plasmids were finally transformed into E. coli strain DH5α. Single colonies were analysed by 
colony PCR and DNA plasmids were tested on the correct sequence by restriction digest and 
sequencing (GATC Biotech AG).    
4.2.2.2 Plasmid amplification and purification 
For plasmid amplification, single colonies of E. coli strain DH5α containing the plasmid were 
grown over night in LB medium containing the appropriate antibiotics. Plasmid extraction and 
purification occurred by means of the NucleoSpin Plasmid (Macherey-Nagel) according to 
the instructions of the manufacturer.  
4.2.2.3 Site directed mutagenesis 
For the introduction of defined mutations into plasmid DNA, sense and antisense primers of 
the desired region containing the mutation were designed. The mutations were introduced by 
means of the QuikChange Lightning Site Directed Mutagenesis Kit (Stratagene) and 
according to the protocol supplied by the manufacturer.  
4.2.2.4 Fusion PCR 
Fusion of two DNA fragments occurred by fusion PCR. Therefore, both DNA fragments were 
first amplified by PCR. The forward primer for the amplification of the second fragment 
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contained 10 nucleotides at the 5’ end complementary to the 3’ end of the first fragment. 
Both PCR products were fused by seven PCR cycles with an annealing temperature 
corresponding to the overlapping part of the two fragments. Finally, the product was 
amplified by 30 cycles after the addition of the respective forward and reverse primers.    
 
4.2.3 Cell biological methods 
4.2.3.1 Cultivation of mammalian cells 
All mammalian cell types were cultivated in Dulbecco’s modified eagle medium (D-MEM) 
supplied with 10% fetal calf serum (FCS) and 2mM L-glutamate at 37°C and 10% CO2. The 
cells were adherently grown on 10 cm dishes and detached by trypsin/EDTA application 2-3 
times a week to dilute cells 1:4 or 1:8. 
4.2.3.2 Transfection of mammalian cells  
The transfection of plasmid DNA into mammalian cells occurred to transiently induce the 
expression of genes from pcDNA3.1, pEGFP-N1 or the pJET1.2 vector. HEK-293 cells as 
well as human fibroblasts were transfected with PEI (polyethylenimine, 1mg/ml, pH 7.4). For 
the transfection of a 10 cm plate, 51.2 µl PEI were added to 1ml of D-MEM medium without 
FCS and glutamate. Transfections of smaller plates were adjusted accordingly. After 
incubation for 5 min at room temperature, 12.8 µg DNA was added and incubation was 
continued for another 20 min. Finally, the mixture was added to the cells. For co-
transfections of two plasmids on a 10 cm plate, 70 µl PEI were added to 1ml of D-MEM 
medium without additives. Each 12.8 µg DNA were added and incubated as described 
above.  
4.2.3.3 shRNA mediated knockdown of gene products 
In the current study, the human IMP1 mRNA was downregulated by shRNA. Therefore, an 
appropriate RNA region was first predicted by an online shRNA design tool (Invitrogen). The 
region containing the highest probability of efficient gene product knockdown was chosen 
and sense and antisense primers representing the desired region were synthesized. In 
parallel, the CMV promoter was amplified by PCR and each fused to the sense and 
antisense fragments by fusion PCR. Finally, both constructs were separately ligated into the 
pJET1.2 vector and subsequently co-transfected into HEK-293 cells. The efficiency of 
knockdown was determined 24 h after transfection by anti-IMP1 Western blotting of the cell 
lysate.      
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4.2.3.4 Harvesting and disruption of mammalian cultured cells 
Cultured cells were detached by trypsin/EDTA application and pelleted for 5 min at 800 x g. 
After rinsing cells once with PBS, they were resuspended in the buffer of choice and 
sonicated two times for 20 sec. Finally, disrupted cells were centrifuged at 21.000 x g at 4°C 
for 10 min and the protein content of the supernatant was determined by means of the 
Bradford reagent. 
4.2.3.5 Microscopic preparations 
Proteins and cell organells were visualized by confocal laser microscopy and fluorescence 
microscopy in the current study. Proteins were either visualized by posttranslational fusion to 
GFP or by immunocytochemistry. In any case, HEK-293 cells or human fibroblasts were 
grown and transfected in 12-well plates on collagenized cover slips. After 48 h of protein 
expression, cells were washed three times with PBS and fixed by 20 min incubation in 4% 
paraformaldehyde. After additional three washing steps, cells expressing GFP tagged 
proteins were directly mounted on microscope slides containing a drop of Mowiol solution (20 
g Mowiol in 80 ml PBS and 40 ml glycerol containing ¼ volume bleaching protection: 2.5 g n-
propylgallat in 50 ml PBS and 50 ml glycerol). Preparations were dried over night at 37°C 
and subsequently analyzed by microscopy. Cells destined for immunocytochemistry were not 
immediately mounted after fixation but first incubated in 0.2% Tween-20 in PBS for 20 min to 
permeabilize the cells. After three steps of washing with PBS, cells were briefly incubated 
with 1% BSA and afterwards covered with the primary antibody (in PBS, concentrations 
according to the manufacturer) for one hour at 37°C. Cells were washed three times with 
PBS and incubated with the secondary antibody (1:200 dilution in PBS) for another hour at 
37°C. After three washing steps with PBS, cells were finally mounted on microscope slides 
as described above.      
4.2.3.6 Staining of mitochondria 
Mitochondria were visualized in the current study by means of Mitotracker Red CMXRos 
(Invitrogen). A 1mM stock solution in anhydrous DMSO was diluted 1:20000 in D-MEM 
medium and incubated for 2 h with the cells at 37°C prior to fixation. The dye was visualized 
by fluorescence microscopy or confocal laser microscopy by excitation at 543 nm.    
4.2.3.7 Confocal laser microscopy 
Microscopic preparations were analyzed by a Nikon Eclipse Ti confocal microscope. Green 
fluorescent dyes were excited at 488 nm, red fluorescent dyes were excited at 543 nm. 
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4.2.3.8 Determination of the Pearson Correlation Coefficient  
The Pearson Correlation Coefficient (PCC) was determined to quantify the degree of 
colocalization of two dyes in a microscopic preparation. The PCC values were determined by 
means of the Volocity software (Perkin Elmer).  
 
4.2.4 Methods to study mitochondrial localization and import of proteins 
4.2.4.1 Enrichment of mitochondria  
Mitochondria were enriched from cultured cells according to the following protocol:  
1) Cultured cells were scraped from 10 cm plates in 5 ml PBS and pelleted at 800 x g.                                      
2) Cells were resuspended in 3 ml solution A (20 mM Hepes pH 7.6, 220 mM mannitol, 70 
mM sucrose, 1 mM EDTA, 0.5 mM PMSF, 2 mg/ml fatty acid free BSA).                                           
3) The suspension was transferred to a teflon homogenizer (Sartorius) and homogenized 
with 20 strokes at 1000 rpm.                                                                                                        
4) The homogenate was centrifuged at 800 x g, 4°C for 5 min and the supernatant containing 
mitochondria was collected. 
5)  The pellet was resuspended in 3 ml solution A and steps 3-4 were repeated 1-2 times. 
6)  The supernatants were were combined and centrifuged at 12.000 x g, 4°C for 5 min. 
7) The supernatant was removed and the pellets were resuspended in 1 ml of solution B 
(solution A lacking PMSF and BSA) and centrifuged at 12.000 x g, 4°C for 5 min. 
8)  Mitochondrial pellets were carefully resuspended in an appropriate volume of solution B 
and concentrations were determined by means of the Bradford reagent.    
The enrichment of mitochondria from murine liver occurred as described above. The liver 
was cut into small pieces before pottering. 
4.2.4.2 Purification of mitochondria 
To obtain mitochondria of high purity, mitochondria were first enriched as described above. 
200-500 µl crude mitochondria were subsequently loaded on a discontinuous density 
gradient of 0.5 ml 80% (v/v) on the bottom, 2 ml 52% (v/v) in between and 2 ml 26% (v/v) 
percoll on the top in a 13 x 51 mm centrifuge tube. The 80% percoll solution was prepared by 
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mixing 4 parts 100% percoll with 1 part of 5x solution B to maintain isotonic conditions during 
the centrifugation procedure. The 52% and 26% percoll solutions were diluted from the 80% 
percoll solution with 1x solution B. The gradient was centrifuged at 23000rpm for 45 min at 
4°C in a Beckman MLS-50 rotor. The fraction containing the purified mitochondria was 
carefully aspirated from the 26%-52% interface, diluted to a final volume of 1.5 ml with 
solution B and centrifuged at 16.000 x g, 4°C for 10 min to remove residual percoll. This 
washing step was repeated once or twice. The final pellet of purified mitochondria was 
resuspended in solution B.    
4.2.4.3 Na2CO3 extraction of mitochondrial proteins 
For the separation of soluble and membrane bound mitochondrial proteins, enriched 
mitochondria were resuspended in 0.1M Na2CO3, pH 11.5 to a concentration of 0.3 mg/ml. 
Mitochondria were incubated 30 min on ice and centrifuged at 100000g for one hour at 4°C. 
The pellet was washed with H2O and resuspended in SDS loading buffer. The supernatant 
was precipitated with TCA as described above.  
4.2.4.4 Protease treatment of mitochondria 
The submitochondrial localization of proteins was determined by means of external PK and 
trypsin addition in this study. Either, the localization of endogenous proteins were 
determined, or proteins were first transiently expressed in cell culture from a plasmid. 
Mitochondria were enriched as described above and concentrated to 1 mg/ml. PK and 
trypsin were freshly prepared and dissolved in 10 mM Hepes pH 7.6 to a concentration of 5 
mg/ml. 2 µl of protease were added to 100 µl of mitochondria to obtain a final concentration 
of 100 µg/ml. The samples were incubated at 10 min on ice and inhibition of PK occurred by 
PMSF with a final concentration of 1 mM for further 10 min on ice. Trypsin was inhibited by 
means of a specific trypsin inhibitor using 30x excess of inhibitor compared to trypsin. Finally, 
mitochondrial proteins were precipitated by TCA as described above and digestions were 
analyzed by Western blot.  
4.2.4.5 Hypotonic swelling of mitochondria  
The outer mitochondrial membrane was selectively disrupted by hypotonic swelling of 
mitochondria in 10 mM Hepes pH 7.6 for 15 min at 4°C. Efficiency and selectivity of outer 
membrane disruption was examined by PK treatment and subsequent Western blotting with 
antibodies detecting marker proteins of the respective mitochondrial subcompartments.  
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4.2.4.6 In vitro translation 
Proteins were synthesized in a cell free reticulocyte lysate system as radioactive precursors 
for mitochondrial in vitro import studies. Transcription and translation occurred by means of 
the TnT Coupled Reticulocyte Lysate Systems (Promega). As a DNA template, 1 µg pcDNA 
3.1 containing the respective coding sequence was applied. In respect to the T7 promoter of 
the plasmid, transcription was conducted by a T7 RNA polymerase in the assay. The 
proteins were radioactively labeled during translation by the addition of 35S methionine 
(Hartmann Analytic). The translation occurred according to the protocol of the manufacturer 
and translation was stopped by the addition of 5x stop translation buffer (to 1x; 1.25 M 
sucrose, 10 mM methionine). The efficiency of translation was determined by SDS-PAGE 
and Western blot. The Western blot membrane was exposed to a Fuji medical X-ray film for 
12 h and the film was developed in a CURIX 80 system (AGFA).  
4.2.4.7 Mitochondrial in vitro import studies 
To study the import of a protein into mitochondria in vitro, mitochondria were first enriched 
from HEK-293 cells and the precursor protein was synthesized in vitro. Mitochondria were 
pelleted and gently resuspended in import buffer (250 mM sucrose, 5 mM magnesium 
acetate, 80 mM potassium acetate, 10 mM sodium succinate, 1 mM DTT freshly from stock, 
0.1 mM ATP pH 7.4 freshly from stock, 20 mM Hepes-KOH pH 7.6) to a final concentration of 
1 mg/ml. Import reactions were each carried out with 100 µl mitochondria and 5 µl radioactive 
precursor in 1.5 ml Eppendorf tubes at 37°C and 400 rpm shaking under eight conditions:    
A1) 5 min import reaction, +ΔΨ                                                                                                            
A2) 15 min import reaction, +ΔΨ  
A3) 45 min import reaction, +ΔΨ  
A4) 45 min import reaction, -ΔΨ (addition of 2 µl 1 mg/ml valinomycin prior to the import 
reaction) 
A5) 45 min import reaction, +ΔΨ, -ATP (preparation of import buffer without ATP) 
 
After the import reaction, samples A1-A5 were centrifuged at 12.000 x g for 5 min and rinsed 
with 150 µl import buffer lacking ATP and DTT. Pellets were resuspended in 100 µl detergent 
buffer (1% digitonin, 20mM Bis-Tris, 50mM NaCl, 10% glycerol) and incubated 30 min on ice. 
Samples were centrifuged at maximum speed and supernatants were loaded on BN-PAGE 
with subsequent Western blotting. The Western blot membrane was exposed to an X-ray 
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cassette (Fuji) for at least one week and signals were detected by a Typhoon Trio Variable 
Mode Imager (Amersham Biosciences). 
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5 Appendix 
5.1 Primers 
Name Sequence (RESTRICTION SITE), 5’→3’ Purpose 
5’FW FLMSO-GFP cccAAGCTTatgctgctgcagctatacag Cloning, SO 
3’REV MSO ohne stop1  ccgGAATTCtgggaccacctgaacatggac Cloning, SO 
5’FW ohneleaderMSO-
GFP 
cccAAGCTTatggagtcaccacggatgtactc Cloning, SO 
153-for  cagcGAGCTCatggagtcaccacggatg Cloning, SO  
154-rev ctgcagGTCGACttatgggaccacctgaac Cloning, SO  
His119Ala sense cacaaaatttgtggacctggctccaggaggaccatcaaa Mutagenesis, SO 
His119Ala antisense ttttgatggtcctcctggagccaggtccacaaattttgtg Mutagenesis, SO 
His144Ala sense gccctctatgctgtggccaaccagccccatgt Mutagenesis, SO 
His144Ala antisense acatggggctggttggccacagcatagagggc Mutagenesis, SO 
Arg367His sense catggcttccctgtacacgtggtggttcctggtg Mutagenesis, SO 
Arg367His antisense caccaggaaccaccacgtgtacagggaagccatg Mutagenesis, SO 
Lys380Arg sense tgcccgtcatgtcagatggctcggcagag Mutagenesis, SO 
Lys380Arg antisense ctctgccgagccatctgacatgacgggca Mutagenesis, SO 
Gly531Asp sense tctggaaccttcgggacgtactcagcaatgc Mutagenesis, SO 
Gly531Asp antisense gcattgctgagtacgtcccgaaggttccaga Mutagenesis, SO 
5’FW TIM50 atggcggcctcggcggctctgtt                    Cloning, SO-TIM50 
3’REV TIM50 tcagggctgcttggagcgaggcc Cloning, SO-TIM50 
5’FW 
TIMmembraneÜberhang 
gataactcaaggactattgcgctctggatcgccggtttgctc
gga 
Cloning, SO-TIM50 
3’REV TIMmembrane aaaaatatagacgatgct Cloning, SO-TIM50 
5’FW MSOTIMüberhang agcatcgtctatatttttcacaacaaccctaaaactggagtc
tgggta 
Cloning, SO-TIM50 
3’REV MSOTIM agtccttgagttatcatca Cloning, SO-TIM50 
5’FWmARC1-GFP cccAAGCTTatgggcgccgccggctcctc Cloning, mARC1 
3’REVmARC1-GFP cggGGTACCaactggcccagcaggtacacag Cloning, mARC1 
3’RevmARC1pcDNA ccgGAATTCctggcccagcaggtacacag Cloning, mARC1 
3’RevmARC1pcdnastop ccgGAATTCttactggcccagca Cloning, mARC1 
3’RevmARC1erste20 cggGGTACCaagggccgggattgcgcgagga Cloning, mARC1 
3’RevmARC1erste44 cggGGTACCaatgcgcggcgccaggcgacag Cloning, mARC1 
5’FWmARC1hydrophob cccAAGCTTatggggtggctcggggttgcc Cloning, mARC1 
5’FWmARC1ohneleader cccAAGCTTatgtggcccacgcggcgccggcg Cloning, mARC1 
Tab. 5.1 Primers used in this study 
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5.2 Constructs 
CDS Construct Restriction sites Source 
MSO  pcDNA3.1:WT-MSO HindIII+EcoRI this study 
MSO pcDNA3.1: WT-MSO, stop codon HindIII+EcoRI this study 
MSO pcDNA3.1: WT-MSO, Δaa1-80 HindIII+EcoRI this study 
MSO pcDNA3.1: WT-MSO, Δaa166-546   HindIII+EcoRI this study 
MSO  pcDNA3.1: MSO-R367H-K380R, stop codon HindIII+EcoRI this study 
MSO pcDNA3.1: MSO-R367H-H380R HindIII+EcoRI this study 
MSO  pcDNA3.1: MSO-H119A-H144A, stop codon HindIII+EcoRI this study 
MSO pcDNA3.1: MSO-H119-H144A, Δaa166-546 HindIII+EcoRI this study 
MSO pcDNA3.1: MSO-G531D, stop codon HindIII+EcoRI this study 
MSO  pcDNA3.1: WT-MSO, Δaa64-84, Insert: aa66-
86 of mouse TIM50  
HindIII+EcoRI this study 
MSO pcDNA3.1: MSO-R367H-K380R, Δaa64-84, 
Insert: aa66-86 of mouse TIM50 
HindIII+EcoRI this study 
MSO pQE80: WT-MSO, Δaa1-80 SacI+SalI this study 
MSO  pQE80: MSO-R367H-K380R, Δaa1-80 SacI+SalI this study 
MSO pQE80: MSO-H119A-H144A, Δaa1-80 SacI+SalI this study 
MSO  pQE80: MSO-G531D, Δaa1-80 SacI+SalI this study 
Human 
IMP1 
shRNA 
pJET1.2: CMV promoter fused to base pairs 
91-111 of the human IMMP1L coding 
sequence, sense sequence  
- this study 
Human 
IMP1 
shRNA 
pJET1.2: CMV promoter fused to base pairs 
91-111 of the human IMMP1L coding 
sequence, antisense sequence  
- this study 
mARC1 pcDNA3.1: WT-mARC1 HindIII+EcoRI this study 
mARC1 pcDNA3.1: WT-mARC1, stop codon HindIII+EcoRI this study 
mARC1 pcDNA3.1: WT-mARC1, Δaa1-20+stop codon HindIII+EcoRI this study 
mARC1 pcDNA3.1: WT-mARC1, Δaa1-40+stop codon HindIII+EcoRI this study 
mARC1 pEGFP-N1: WT-mARC1 HindIII+KpnI this study 
mARC1  pEGFP-N1: WT-mARC1, Δaa1-20 HindIII+KpnI this study 
mARC1 pEGFP-N1: WT-mARC1, Δaa1-40 HindIII+KpnI this study 
mARC1 pEGFP-N1: WT-mARC1, Δaa21-40 HindIII+KpnI this study 
Tab. 5.2 Constructs used in this study 
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5.3 Sequences 
5.3.1 Mouse SO: 
Depicted is the peptide sequence of MSO with highlighted individual domains:  
underlined: cleaved mitochondrial targeting sequence; (Kisker et al., 1997)    
fat: predicted N-terminal MTS; http://ihg.gsf.de/ihg/mitoprot.html   
yellow: predicted transmembrane domain; http://phobius.sbc.su.se/ 
red: heme domain; (Kisker et al., 1997) 
green: Moco domain; (Kisker et al., 1997) 
blue: dimerization domain; (Kisker et al., 1997) 
 
        10         20         30         40         50         60  
MLLQLYRSVV VRLPQAIRVK STPLRLCIQA CSTNDSLEPQ HPSLTFSDDN SRTRRWKVMG  
 
        70         80         90        100        110        120  
TLLGLGVVLV YHEHRCRASQ ESPRMYSKED VRSHNNPKTG VWVTLGSEVF DVTKFVDLHP  
 
       130        140        150        160        170        180  
GGPSKLMLAA GGPLEPFWAL YAVHNQPHVR ELLAEYKIGE LNPEDSMSPS VEASDPYADD  
 
       190        200        210        220        230        240  
PIRHPALRIN SQRPFNAEPP PELLTEGYIT PNPIFFTRNH LPVPNLDPHT YRLHVVGAPG  
 
       250        260        270        280        290        300  
GQSLSLSLDD LHKFPKHEVT VTLQCAGNRR SEMSKVKEVK GLEWRTGAIS TARWAGARLC  
 
       310        320        330        340        350        360  
DVLAQAGHRL CDSEAHVCFE GLDSDPTGTA YGASIPLARA MDPEAEVLLA YEMNGQPLPR  
 
       370        380        390        400        410        420  
DHGFPVRVVV PGVVGARHVK WLGRVSVESE ESYSHWQRRD YKGFSPSVDW DTVNFDLAPS  
 
       430        440        450        460        470        480  
IQELPIQSAI TQPQDGAIVE SGEVTIKGYA WSGGGRAVIR VDVSVDGGLT WQEAELEGEE  
 
       490        500        510        520        530        540  
QCPRKAWAWR IWQLKAQVPA EQKELNIICK AVDDSYNVQP DTVAPIWNLR GVLSNAWHRV  
 
 
HVQVVP  
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5.3.2 Human mARC1: 
Depicted is the peptide sequence of mARC1 with its dual mitochondrial targeting signal: 
fat: N-terminal MTS; according to this study 
yellow: predicted transmembrane domain; http://phobius.sbc.su.se/  
 
 
        10         20         30         40         50         60 
MGAAGSSALA RFVLLAQSRP GWLGVAALGL TAVALGAVAW RRAWPTRRRR LLQQVGTVAQ  
 
        70         80         90        100        110        120  
LWIYPVKSCK GVPVSEAECT AMGLRSGNLR DRFWLVINQE GNMVTARQEP RLVLISLTCD  
 
       130        140        150        160        170        180  
GDTLTLSAAY TKDLLLPIKT PTTNAVHKCR VHGLEIEGRD CGEATAQWIT SFLKSQPYRL  
 
       190        200        210        220        230        240  
VHFEPHMRPR RPHQIADLFR PKDQIAYSDT SPFLILSEAS LADLNSRLEK KVKATNFRPN  
 
       250        260        270        280        290        300  
IVISGCDVYA EDSWDELLIG DVELKRVMAC SRCILTTVDP DTGVMSRKEP LETLKSYRQC  
 
       310        320        330  
DPSERKLYGK SPLFGQYFVL ENPGTIKVGD PVYLLGQ  
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